ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
37166_at	3-hydroxyanthranilate 3,4-dioxygenase(HAAO)	Homo sapiens				GO:0006569~tryptophan catabolic process,GO:0010043~response to zinc ion,GO:0019805~quinolinate biosynthetic process,GO:0034354~'de novo' NAD biosynthetic process from tryptophan,GO:0043420~anthranilate metabolic process,GO:0046686~response to cadmium ion,GO:0046874~quinolinate metabolic process,GO:0055114~oxidation-reduction process,GO:0070050~neuron cellular homeostasis,	GO:0005829~cytosol,GO:0070062~extracellular exosome,	GO:0000334~3-hydroxyanthranilate 3,4-dioxygenase activity,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0008198~ferrous iron binding,GO:0009055~electron carrier activity,	IPR010329:3-hydroxyanthranilic acid dioxygenase,IPR011051:RmlC-like cupin domain,IPR014710:RmlC-like jelly roll fold,IPR016700:3-hydroxyanthranilate 3, 4-dioxygenase, metazoan,	hsa00380:Tryptophan metabolism,hsa01100:Metabolic pathways,		PIRSF017681:3-hydroxyanthranilate 3,4-dioxygenase, animal type,		3D-structure,Alternative splicing,Complete proteome,Cytoplasm,Dioxygenase,Iron,Metal-binding,Oxidoreductase,Polymorphism,Proteomics identification,Pyridine nucleotide biosynthesis,Reference proteome,	binding site:Dioxygen,binding site:Substrate,chain:3-hydroxyanthranilate 3,4-dioxygenase,helix,metal ion-binding site:Iron; catalytic,sequence variant,splice variant,strand,turn,
34467_g_at	5-hydroxytryptamine receptor 4(HTR4)	Homo sapiens				GO:0007186~G-protein coupled receptor signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007210~serotonin receptor signaling pathway,GO:0007214~gamma-aminobutyric acid signaling pathway,GO:0007268~chemical synaptic transmission,GO:0032098~regulation of appetite,	GO:0005737~cytoplasm,GO:0005768~endosome,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,	GO:0004993~G-protein coupled serotonin receptor activity,	IPR000276:G protein-coupled receptor, rhodopsin-like,IPR001520:5-Hydroxytryptamine 4 receptor,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04726:Serotonergic synapse,			SM01381:SM01381,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Endosome,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Polymorphism,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:5-hydroxytryptamine receptor 4,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
40350_at	ADAM metallopeptidase domain 23(ADAM23)	Homo sapiens				GO:0006508~proteolysis,GO:0007155~cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007417~central nervous system development,	GO:0005576~extracellular region,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0004222~metalloendopeptidase activity,GO:0005178~integrin binding,GO:0005515~protein binding,GO:0008237~metallopeptidase activity,	IPR000742:Epidermal growth factor-like domain,IPR001590:Peptidase M12B, ADAM/reprolysin,IPR001762:Blood coagulation inhibitor, Disintegrin,IPR002870:Peptidase M12B, propeptide,IPR006586:ADAM, cysteine-rich,IPR013032:EGF-like, conserved site,IPR013111:EGF, extracellular,IPR024079:Metallopeptidase, catalytic domain,				SM00050:DISIN,SM00608:ACR,	Alternative splicing,Cell adhesion,Cell membrane,Cleavage on pair of basic residues,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Integrin,Membrane,Proteomics identification,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Disintegrin and metalloproteinase domain- containing protein 23,compositionally biased region:Cys-rich,disulfide bond,domain:Disintegrin,domain:EGF-like,domain:Peptidase M12B,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,region of interest:May bind the integrin receptor,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
1575_at	ATP binding cassette subfamily B member 1(ABCB1)	Homo sapiens		h_mrpPathway:Multi-Drug Resistance Factors,h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,	Defense mechanisms,	GO:0000086~G2/M transition of mitotic cell cycle,GO:0002481~antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,GO:0002485~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent,GO:0002489~antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,GO:0002591~positive regulation of antigen processing and presentation of peptide antigen via MHC class I,GO:0006810~transport,GO:0006855~drug transmembrane transport,GO:0042493~response to drug,GO:0042908~xenobiotic transport,GO:0045332~phospholipid translocation,GO:0055085~transmembrane transport,GO:0072089~stem cell proliferation,	GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0070062~extracellular exosome,	GO:0005215~transporter activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008559~xenobiotic-transporting ATPase activity,GO:0042626~ATPase activity, coupled to transmembrane movement of substances,GO:0090554~phosphatidylcholine-translocating ATPase activity,GO:0090555~phosphatidylethanolamine-translocating ATPase activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04976:Bile secretion,hsa05206:MicroRNAs in cancer,	120080~Colchicine resistance,612244~Inflammatory bowel disease 13,		SM00382:AAA,	Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Glycoprotein,Hydrolase,Membrane,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transmembrane,Transmembrane helix,Transport,	chain:Multidrug resistance protein 1,domain:ABC transmembrane type-1 1,domain:ABC transmembrane type-1 2,domain:ABC transporter 1,domain:ABC transporter 2,glycosylation site:N-linked (GlcNAc...),modified residue,nucleotide phosphate-binding region:ATP 1,nucleotide phosphate-binding region:ATP 2,sequence conflict,sequence variant,topological domain:Cytoplasmic,transmembrane region,
40294_at	ATP binding cassette subfamily B member 9(ABCB9)	Homo sapiens				GO:0002474~antigen processing and presentation of peptide antigen via MHC class I,GO:0002481~antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,GO:0002485~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent,GO:0002489~antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,GO:0002591~positive regulation of antigen processing and presentation of peptide antigen via MHC class I,GO:0015031~protein transport,GO:0015833~peptide transport,GO:0035672~oligopeptide transmembrane transport,GO:0055085~transmembrane transport,	GO:0005764~lysosome,GO:0005765~lysosomal membrane,GO:0005769~early endosome,GO:0005783~endoplasmic reticulum,GO:0016021~integral component of membrane,GO:0030176~integral component of endoplasmic reticulum membrane,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015421~oligopeptide-transporting ATPase activity,GO:0015440~peptide-transporting ATPase activity,GO:0022891~substrate-specific transmembrane transporter activity,GO:0042803~protein homodimerization activity,	IPR003439:ABC transporter-like,IPR003593:AAA+ ATPase domain,IPR011527:ABC transporter, transmembrane domain, type 1,IPR017871:ABC transporter, conserved site,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa02010:ABC transporters,hsa04142:Lysosome,			SM00382:AAA,	Alternative splicing,ATP-binding,Complete proteome,Lysosome,Membrane,Nucleotide-binding,Peptide transport,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	chain:ATP-binding cassette sub-family B member 9,compositionally biased region:Poly-Glu,domain:ABC transmembrane type-1,domain:ABC transporter,modified residue,nucleotide phosphate-binding region:ATP,sequence variant,signal peptide,splice variant,transmembrane region,
32439_at	ATPase H+/K+ transporting beta subunit(ATP4B)	Homo sapiens				GO:0006813~potassium ion transport,GO:0006814~sodium ion transport,GO:0007155~cell adhesion,GO:0010243~response to organonitrogen compound,GO:0032496~response to lipopolysaccharide,GO:0034220~ion transmembrane transport,GO:1902600~hydrogen ion transmembrane transport,	GO:0005886~plasma membrane,GO:0005890~sodium:potassium-exchanging ATPase complex,	GO:0005515~protein binding,GO:0008900~hydrogen:potassium-exchanging ATPase activity,	IPR000402:Sodium/potassium-transporting ATPase subunit beta,	hsa00190:Oxidative phosphorylation,hsa04966:Collecting duct acid secretion,hsa04971:Gastric acid secretion,				Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Hydrogen ion transport,Ion transport,Membrane,Potassium,Potassium transport,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,Transport,	chain:Potassium-transporting ATPase subunit beta,disulfide bond,glycosylation site:N-linked (GlcNAc...),topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
39469_s_at	ATPase phospholipid transporting 8A2(ATP8A2)	Homo sapiens				GO:0003011~involuntary skeletal muscle contraction,GO:0007409~axonogenesis,GO:0007568~aging,GO:0008285~negative regulation of cell proliferation,GO:0010842~retina layer formation,GO:0010976~positive regulation of neuron projection development,GO:0010996~response to auditory stimulus,GO:0040018~positive regulation of multicellular organism growth,GO:0042472~inner ear morphogenesis,GO:0042755~eating behavior,GO:0043588~skin development,GO:0045332~phospholipid translocation,GO:0048194~Golgi vesicle budding,GO:0048666~neuron development,GO:0050884~neuromuscular process controlling posture,GO:0050908~detection of light stimulus involved in visual perception,GO:0060052~neurofilament cytoskeleton organization,GO:0061092~positive regulation of phospholipid translocation,	GO:0000139~Golgi membrane,GO:0001750~photoreceptor outer segment,GO:0005768~endosome,GO:0005794~Golgi apparatus,GO:0005802~trans-Golgi network,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,		615268~Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4,			Alternative splicing,ATP-binding,Cell membrane,Cell projection,Chromosomal rearrangement,Complete proteome,Disease mutation,Endosome,Golgi apparatus,Hydrolase,Lipid transport,Magnesium,Membrane,Mental retardation,Metal-binding,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase IB,metal ion-binding site:Magnesium,modified residue,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
33685_at	ATPase phospholipid transporting 8B3(ATP8B3)	Homo sapiens				GO:0007030~Golgi organization,GO:0007339~binding of sperm to zona pellucida,GO:0045332~phospholipid translocation,	GO:0002080~acrosomal membrane,GO:0005789~endoplasmic reticulum membrane,GO:0005794~Golgi apparatus,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0000287~magnesium ion binding,GO:0004012~phospholipid-translocating ATPase activity,GO:0005524~ATP binding,	IPR001757:Cation-transporting P-type ATPase,IPR006539:Phospholipid-transporting  P-type ATPase, subfamily IV,IPR008250:P-type ATPase, A  domain,IPR018303:P-type ATPase, phosphorylation site,IPR023214:HAD-like domain,IPR023299:P-type ATPase, cytoplasmic domain N,					Alternative splicing,ATP-binding,Complete proteome,Cytoplasmic vesicle,Endoplasmic reticulum,Hydrolase,Lipid transport,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,Transport,	active site:4-aspartylphosphate intermediate,chain:Probable phospholipid-transporting ATPase IK,metal ion-binding site:Magnesium,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
33027_at	ArfGAP with GTPase domain, ankyrin repeat and PH domain 4(AGAP4)	Homo sapiens				GO:0043547~positive regulation of GTPase activity,		GO:0005096~GTPase activator activity,GO:0046872~metal ion binding,	IPR001164:Arf GTPase activating protein,IPR001849:Pleckstrin homology domain,IPR002110:Ankyrin repeat,IPR011993:Pleckstrin homology-like domain,IPR020683:Ankyrin repeat-containing domain,				SM00105:ArfGap,SM00233:PH,SM00248:ANK,	ANK repeat,Complete proteome,GTPase activation,Metal-binding,Polymorphism,Reference proteome,Repeat,Zinc,Zinc-finger,	chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 4,chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 6,domain:Arf-GAP,domain:PH,repeat:ANK 1,repeat:ANK 2,sequence variant,zinc finger region:C4-type,
1910_s_at	BCL2, apoptosis regulator(BCL2)	Homo sapiens	127.Mito-stress,152.altered_synaptic_signalling-neurodegenerative_disorders,38.Cell_cycle_arrest_and_apoptosis_ceramide,46.P13K_PTEN,83.Growth_factors_Survival_factors_Mitogens,86.Apoptosis_Nematode&_Vert,99.NF-kB_activation,	h_badPathway:Regulation of BAD phosphorylation,h_ceramidePathway:Ceramide Signaling Pathway,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_hsp27Pathway:Stress Induction of HSP Regulation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il7Pathway:IL-7 Signal Transduction,h_keratinocytePathway:Keratinocyte Differentiation,h_melanocytePathway:Melanocyte Development and Pigmentation Pathway,h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling,h_p53Pathway:p53 Signaling Pathway,h_prionPathway:Prion Pathway,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,		GO:0000209~protein polyubiquitination,GO:0001503~ossification,GO:0001541~ovarian follicle development,GO:0001656~metanephros development,GO:0001658~branching involved in ureteric bud morphogenesis,GO:0001662~behavioral fear response,GO:0001782~B cell homeostasis,GO:0001836~release of cytochrome c from mitochondria,GO:0001952~regulation of cell-matrix adhesion,GO:0002320~lymphoid progenitor cell differentiation,GO:0002326~B cell lineage commitment,GO:0002931~response to ischemia,GO:0003014~renal system process,GO:0006470~protein dephosphorylation,GO:0006582~melanin metabolic process,GO:0006808~regulation of nitrogen utilization,GO:0006915~apoptotic process,GO:0006959~humoral immune response,GO:0006974~cellular response to DNA damage stimulus,GO:0007015~actin filament organization,GO:0007409~axonogenesis,GO:0007565~female pregnancy,GO:0007569~cell aging,GO:0008283~cell proliferation,GO:0008284~positive regulation of cell proliferation,GO:0008584~male gonad development,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008631~intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0009314~response to radiation,GO:0009636~response to toxic substance,GO:0009791~post-embryonic development,GO:0010039~response to iron ion,GO:0010224~response to UV-B,GO:0010332~response to gamma radiation,GO:0010468~regulation of gene expression,GO:0010507~negative regulation of autophagy,GO:0010523~negative regulation of calcium ion transport into cytosol,GO:0010559~regulation of glycoprotein biosynthetic process,GO:0014031~mesenchymal cell development,GO:0014042~positive regulation of neuron maturation,GO:0014911~positive regulation of smooth muscle cell migration,GO:0016049~cell growth,GO:0018105~peptidyl-serine phosphorylation,GO:0018107~peptidyl-threonine phosphorylation,GO:0021747~cochlear nucleus development,GO:0022612~gland morphogenesis,GO:0022898~regulation of transmembrane transporter activity,GO:0030279~negative regulation of ossification,GO:0030307~positive regulation of cell growth,GO:0030308~negative regulation of cell growth,GO:0030318~melanocyte differentiation,GO:0030336~negative regulation of cell migration,GO:0030890~positive regulation of B cell proliferation,GO:0031069~hair follicle morphogenesis,GO:0031103~axon regeneration,GO:0031647~regulation of protein stability,GO:0032469~endoplasmic reticulum calcium ion homeostasis,GO:0032835~glomerulus development,GO:0032848~negative regulation of cellular pH reduction,GO:0032880~regulation of protein localization,GO:0033033~negative regulation of myeloid cell apoptotic process,GO:0033077~T cell differentiation in thymus,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0033689~negative regulation of osteoblast proliferation,GO:0034097~response to cytokine,GO:0035094~response to nicotine,GO:0035265~organ growth,GO:0040018~positive regulation of multicellular organism growth,GO:0042100~B cell proliferation,GO:0042149~cellular response to glucose starvation,GO:0042493~response to drug,GO:0042542~response to hydrogen peroxide,GO:0043029~T cell homeostasis,GO:0043066~negative regulation of apoptotic process,GO:0043085~positive regulation of catalytic activity,GO:0043375~CD8-positive, alpha-beta T cell lineage commitment,GO:0043496~regulation of protein homodimerization activity,GO:0043497~regulation of protein heterodimerization activity,GO:0043524~negative regulation of neuron apoptotic process,GO:0043583~ear development,GO:0045069~regulation of viral genome replication,GO:0045636~positive regulation of melanocyte differentiation,GO:0046671~negative regulation of retinal cell programmed cell death,GO:0046902~regulation of mitochondrial membrane permeability,GO:0048041~focal adhesion assembly,GO:0048536~spleen development,GO:0048538~thymus development,GO:0048546~digestive tract morphogenesis,GO:0048599~oocyte development,GO:0048743~positive regulation of skeletal muscle fiber development,GO:0048753~pigment granule organization,GO:0048873~homeostasis of number of cells within a tissue,GO:0050853~B cell receptor signaling pathway,GO:0051384~response to glucocorticoid,GO:0051402~neuron apoptotic process,GO:0051607~defense response to virus,GO:0051881~regulation of mitochondrial membrane potential,GO:0051902~negative regulation of mitochondrial depolarization,GO:0051924~regulation of calcium ion transport,GO:0055085~transmembrane transport,GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0071310~cellular response to organic substance,GO:0071456~cellular response to hypoxia,GO:0072593~reactive oxygen species metabolic process,GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2000378~negative regulation of reactive oxygen species metabolic process,GO:2000811~negative regulation of anoikis,GO:2001234~negative regulation of apoptotic signaling pathway,GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005741~mitochondrial outer membrane,GO:0005783~endoplasmic reticulum,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031965~nuclear membrane,GO:0031966~mitochondrial membrane,GO:0043209~myelin sheath,GO:0046930~pore complex,	GO:0002020~protease binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0015267~channel activity,GO:0016248~channel inhibitor activity,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0042803~protein homodimerization activity,GO:0043565~sequence-specific DNA binding,GO:0046982~protein heterodimerization activity,GO:0051434~BH3 domain binding,GO:0051721~protein phosphatase 2A binding,	IPR002475:Bcl2-like,IPR003093:Apoptosis regulator, Bcl-2 protein, BH4,IPR004725:Apoptosis regulator, Bcl-2/ BclX,IPR013278:Apoptosis regulator, Bcl-2,IPR020717:Apoptosis regulator, Bcl-2, BH1 motif, conserved site,IPR020726:Apoptosis regulator, Bcl-2, BH2 motif, conserved site,IPR020728:Apoptosis regulator, Bcl-2, BH3 motif, conserved site,IPR020731:Apoptosis regulator, Bcl-2, BH4 motif, conserved site,IPR026298:Blc2 family,	hsa04064:NF-kappa B signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04141:Protein processing in endoplasmic reticulum,hsa04151:PI3K-Akt signaling pathway,hsa04210:Apoptosis,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04510:Focal adhesion,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05145:Toxoplasmosis,hsa05152:Tuberculosis,hsa05161:Hepatitis B,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05215:Prostate cancer,hsa05222:Small cell lung cancer,	Leukemia/lymphoma, B-cell, 2~Leukemia/lymphoma, B-cell, 2,		SM00265:BH4,	3D-structure,Alternative splicing,Apoptosis,Chromosomal rearrangement,Complete proteome,Disease mutation,Endoplasmic reticulum,Membrane,Mitochondrion,Mitochondrion outer membrane,Nucleus,Phosphoprotein,Polymorphism,Proto-oncogene,Reference proteome,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:Apoptosis regulator Bcl-2,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:BH1,short sequence motif:BH2,short sequence motif:BH3,short sequence motif:BH4,site:Cleavage; by caspase-3,splice variant,strand,transmembrane region,turn,
37454_at	C-C motif chemokine ligand 13(CCL13)	Homo sapiens	109.Chemokine_families,			GO:0002548~monocyte chemotaxis,GO:0006874~cellular calcium ion homeostasis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007010~cytoskeleton organization,GO:0007165~signal transduction,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0008360~regulation of cell shape,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048245~eosinophil chemotaxis,GO:0048247~lymphocyte chemotaxis,GO:0050729~positive regulation of inflammatory response,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,	GO:0005102~receptor binding,GO:0008009~chemokine activity,GO:0048020~CCR chemokine receptor binding,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04064:NF-kappa B signaling pathway,			SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Inflammatory response,Polymorphism,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 13, long chain,chain:C-C motif chemokine 13, medium chain,chain:C-C motif chemokine 13, short chain,disulfide bond,helix,modified residue,sequence conflict,sequence variant,signal peptide,strand,
36703_at	C-C motif chemokine ligand 25(CCL25)	Homo sapiens				GO:0001954~positive regulation of cell-matrix adhesion,GO:0002548~monocyte chemotaxis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007166~cell surface receptor signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0030593~neutrophil chemotaxis,GO:0043547~positive regulation of GTPase activity,GO:0048247~lymphocyte chemotaxis,GO:0060326~cell chemotaxis,GO:0070098~chemokine-mediated signaling pathway,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:1903237~negative regulation of leukocyte tethering or rolling,	GO:0005576~extracellular region,GO:0005615~extracellular space,	GO:0005179~hormone activity,GO:0008009~chemokine activity,GO:0031735~CCR10 chemokine receptor binding,GO:0042379~chemokine receptor binding,	IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04672:Intestinal immune network for IgA production,			SM00199:SCY,	Alternative splicing,Chemotaxis,Complete proteome,Cytokine,Disulfide bond,Inflammatory response,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 25,disulfide bond,sequence variant,signal peptide,splice variant,
1403_s_at	C-C motif chemokine ligand 5(CCL5)	Homo sapiens	109.Chemokine_families,18.Cytokine_astocytes,22.Cytokine-chemokine_CNS,33.GProt-coupled_Rec_T_Cell_med_Inflamm,34.Chemokines_in_EAE,	h_eosinophilsPathway:The Role of Eosinophils in the Chemokine Network of Allergy,		GO:0000165~MAPK cascade,GO:0002407~dendritic cell chemotaxis,GO:0002548~monocyte chemotaxis,GO:0002676~regulation of chronic inflammatory response,GO:0006816~calcium ion transport,GO:0006874~cellular calcium ion homeostasis,GO:0006887~exocytosis,GO:0006935~chemotaxis,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007159~leukocyte cell-cell adhesion,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0009615~response to virus,GO:0009636~response to toxic substance,GO:0010535~positive regulation of activation of JAK2 kinase activity,GO:0010759~positive regulation of macrophage chemotaxis,GO:0010820~positive regulation of T cell chemotaxis,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0014911~positive regulation of smooth muscle cell migration,GO:0030335~positive regulation of cell migration,GO:0030593~neutrophil chemotaxis,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031584~activation of phospholipase D activity,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0033634~positive regulation of cell-cell adhesion mediated by integrin,GO:0034112~positive regulation of homotypic cell-cell adhesion,GO:0042102~positive regulation of T cell proliferation,GO:0042119~neutrophil activation,GO:0042327~positive regulation of phosphorylation,GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein,GO:0043491~protein kinase B signaling,GO:0043547~positive regulation of GTPase activity,GO:0043623~cellular protein complex assembly,GO:0043922~negative regulation by host of viral transcription,GO:0044344~cellular response to fibroblast growth factor stimulus,GO:0045070~positive regulation of viral genome replication,GO:0045071~negative regulation of viral genome replication,GO:0045089~positive regulation of innate immune response,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0045785~positive regulation of cell adhesion,GO:0045948~positive regulation of translational initiation,GO:0046427~positive regulation of JAK-STAT cascade,GO:0048245~eosinophil chemotaxis,GO:0048246~macrophage chemotaxis,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0050729~positive regulation of inflammatory response,GO:0050796~regulation of insulin secretion,GO:0050863~regulation of T cell activation,GO:0050918~positive chemotaxis,GO:0051262~protein tetramerization,GO:0051928~positive regulation of calcium ion transport,GO:0060326~cell chemotaxis,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0070098~chemokine-mediated signaling pathway,GO:0070100~negative regulation of chemokine-mediated signaling pathway,GO:0070233~negative regulation of T cell apoptotic process,GO:0070234~positive regulation of T cell apoptotic process,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071346~cellular response to interferon-gamma,GO:0071347~cellular response to interleukin-1,GO:0071356~cellular response to tumor necrosis factor,GO:0071407~cellular response to organic cyclic compound,GO:0090026~positive regulation of monocyte chemotaxis,GO:1901214~regulation of neuron death,GO:2000110~negative regulation of macrophage apoptotic process,GO:2000406~positive regulation of T cell migration,GO:2000503~positive regulation of natural killer cell chemotaxis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0004435~phosphatidylinositol phospholipase C activity,GO:0004672~protein kinase activity,GO:0005515~protein binding,GO:0008009~chemokine activity,GO:0016004~phospholipase activator activity,GO:0030298~receptor signaling protein tyrosine kinase activator activity,GO:0031726~CCR1 chemokine receptor binding,GO:0031729~CCR4 chemokine receptor binding,GO:0031730~CCR5 chemokine receptor binding,GO:0042056~chemoattractant activity,GO:0042379~chemokine receptor binding,GO:0042803~protein homodimerization activity,GO:0043621~protein self-association,GO:0046817~chemokine receptor antagonist activity,	IPR000827:CC chemokine, conserved site,IPR001811:Chemokine interleukin-8-like domain,	hsa04060:Cytokine-cytokine receptor interaction,hsa04062:Chemokine signaling pathway,hsa04620:Toll-like receptor signaling pathway,hsa04621:NOD-like receptor signaling pathway,hsa04623:Cytosolic DNA-sensing pathway,hsa04668:TNF signaling pathway,hsa05020:Prion diseases,hsa05120:Epithelial cell signaling in Helicobacter pylori infection,hsa05142:Chagas disease (American trypanosomiasis),hsa05164:Influenza A,hsa05168:Herpes simplex infection,hsa05323:Rheumatoid arthritis,	HIV-1 disease, delayed progression of~HIV-1 disease, delayed progression of,HIV-1 disease, rapid progression of~HIV-1 disease, rapid progression of,		SM00199:SCY,	3D-structure,Chemotaxis,Complete proteome,Cytokine,Direct protein sequencing,Disulfide bond,Glycoprotein,Inflammatory response,Oxidation,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:C-C motif chemokine 5,chain:RANTES(3-68),chain:RANTES(4-68),disulfide bond,glycosylation site:O-linked (GalNAc...); partial,helix,sequence conflict,sequence variant,signal peptide,site:Cleavage; by DPP4,site:Susceptible to oxidation,strand,
822_s_at	CASP2 and RIPK1 domain containing adaptor with death domain(CRADD)	Homo sapiens		h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_stressPathway:TNF/Stress Related Signaling,h_tnfr1Pathway:TNFR1 Signaling Pathway,		GO:0006919~activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0007165~signal transduction,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0042981~regulation of apoptotic process,GO:0071260~cellular response to mechanical stimulus,GO:2001235~positive regulation of apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0002020~protease binding,GO:0005515~protein binding,GO:0030674~protein binding, bridging,GO:0070513~death domain binding,	IPR000488:Death domain,IPR001315:Caspase Recruitment,IPR011029:Death-like domain,		614499~Mental retardation, autosomal recessive 34,		SM00005:DEATH,SM00114:CARD,	3D-structure,Alternative splicing,Apoptosis,Complete proteome,Cytoplasm,Disease mutation,Mental retardation,Nucleus,Proteomics identification,Reference proteome,	chain:Death domain-containing protein CRADD,domain:CARD,domain:Death,helix,strand,turn,
35595_at	CGRP receptor component(CRCP)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006383~transcription from RNA polymerase III promoter,GO:0006384~transcription initiation from RNA polymerase III promoter,GO:0007218~neuropeptide signaling pathway,GO:0032481~positive regulation of type I interferon production,GO:0045087~innate immune response,GO:0051607~defense response to virus,	GO:0001669~acrosomal vesicle,GO:0005654~nucleoplasm,GO:0005666~DNA-directed RNA polymerase III complex,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0009360~DNA polymerase III complex,	GO:0000166~nucleotide binding,GO:0001056~RNA polymerase III activity,GO:0001635~calcitonin gene-related peptide receptor activity,GO:0003899~DNA-directed RNA polymerase activity,GO:0005515~protein binding,	IPR005574:RNA polymerase II, Rpb4,IPR006590:RNA polymerase II, Rpb4, core,IPR010997:HRDC-like,				SM00657:RPOL4c,	Alternative splicing,Antiviral defense,Cell membrane,Complete proteome,DNA-directed RNA polymerase,Immunity,Innate immunity,Membrane,Nucleus,Receptor,Reference proteome,Transcription,	chain:DNA-directed RNA polymerase III subunit RPC9,modified residue,splice variant,
37814_g_at	DEAD-box helicase 51(DDX51)	Homo sapiens				GO:0006364~rRNA processing,GO:0010501~RNA secondary structure unwinding,	GO:0005730~nucleolus,GO:0016020~membrane,	GO:0003676~nucleic acid binding,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005524~ATP binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,				SM00487:DEXDc,SM00490:HELICc,	Acetylation,ATP-binding,Complete proteome,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Ribosome biogenesis,RNA-binding,rRNA processing,	chain:ATP-dependent RNA helicase DDX51,compositionally biased region:Arg-rich,domain:Helicase ATP-binding,domain:Helicase C-terminal,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEAD box,short sequence motif:Q motif,
32148_at	FERM, ARH/RhoGEF and pleckstrin domain protein 1(FARP1)	Homo sapiens				GO:0007416~synapse assembly,GO:0010923~negative regulation of phosphatase activity,GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,GO:0048813~dendrite morphogenesis,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005856~cytoskeleton,GO:0019898~extrinsic component of membrane,GO:0030054~cell junction,GO:0030175~filopodium,GO:0030425~dendrite,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,GO:0043197~dendritic spine,	GO:0005089~Rho guanyl-nucleotide exchange factor activity,GO:0008092~cytoskeletal protein binding,GO:0030676~Rac guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR000299:FERM domain,IPR000798:Ezrin/radixin/moesin like,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle,IPR014847:FERM adjacent (FA),IPR018979:FERM, N-terminal,IPR018980:FERM, C-terminal PH-like domain,IPR019747:FERM conserved site,IPR019748:FERM central domain,IPR019749:Band 4.1 domain,				SM00233:PH,SM00295:B41,SM00325:RhoGEF,SM01195:SM01195,SM01196:SM01196,	3D-structure,Alternative splicing,Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Developmental protein,Guanine-nucleotide releasing factor,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Synapse,Synaptosome,	chain:FERM, RhoGEF and pleckstrin domain- containing protein 1,compositionally biased region:Poly-Glu,domain:DH,domain:FERM,domain:PH 1,domain:PH 2,modified residue,sequence conflict,sequence variant,splice variant,
33293_at	Fas apoptotic inhibitory molecule 2(FAIM2)	Homo sapiens				GO:0002931~response to ischemia,GO:0006915~apoptotic process,GO:0021549~cerebellum development,GO:0021680~cerebellar Purkinje cell layer development,GO:0021681~cerebellar granular layer development,GO:0021702~cerebellar Purkinje cell differentiation,GO:0043066~negative regulation of apoptotic process,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:2001234~negative regulation of apoptotic signaling pathway,	GO:0016021~integral component of membrane,GO:0030054~cell junction,GO:0045121~membrane raft,GO:0045211~postsynaptic membrane,		IPR006214:Bax inhibitor 1-related,					Alternative splicing,Apoptosis,Cell junction,Cell membrane,Complete proteome,Glycoprotein,Membrane,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Synapse,Transmembrane,Transmembrane helix,	chain:Fas apoptotic inhibitory molecule 2,compositionally biased region:Poly-Ser,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,transmembrane region,
37905_r_at	G protein nucleolar 1 (putative)(GNL1)	Homo sapiens			General function prediction only,	GO:0002456~T cell mediated immunity,GO:0006974~cellular response to DNA damage stimulus,GO:0007165~signal transduction,GO:0042254~ribosome biogenesis,	GO:0005615~extracellular space,GO:0005634~nucleus,	GO:0003924~GTPase activity,GO:0005198~structural molecule activity,GO:0005525~GTP binding,	IPR006073:GTP binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Alternative splicing,Complete proteome,GTP-binding,Nucleotide-binding,Phosphoprotein,Proteomics identification,Reference proteome,	chain:Guanine nucleotide-binding protein-like 1,compositionally biased region:Asp/Glu-rich (highly acidic),modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,splice variant,
919_at	G protein subunit alpha 12(GNA12)	Homo sapiens		h_akap13Pathway:Rho-Selective Guanine Exchange Factor AKAP13 Mediates Stress Fiber Formation,h_myosinPathway:PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,h_par1pathway:Thrombin signaling and protease-activated receptors,		GO:0001701~in utero embryonic development,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007188~adenylate cyclase-modulating G-protein coupled receptor signaling pathway,GO:0007266~Rho protein signal transduction,GO:0007596~blood coagulation,GO:0008360~regulation of cell shape,GO:0010762~regulation of fibroblast migration,GO:0030154~cell differentiation,GO:0030168~platelet activation,GO:0032006~regulation of TOR signaling,GO:0032434~regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0042493~response to drug,GO:0042733~embryonic digit morphogenesis,	GO:0005834~heterotrimeric G-protein complex,GO:0005886~plasma membrane,GO:0005925~focal adhesion,GO:0031526~brush border membrane,	GO:0003924~GTPase activity,GO:0004871~signal transducer activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0019001~guanyl nucleotide binding,GO:0031683~G-protein beta/gamma-subunit complex binding,GO:0031752~D5 dopamine receptor binding,GO:0046872~metal ion binding,	IPR000469:G-protein alpha subunit, group 12,IPR001019:Guanine nucleotide binding protein (G-protein), alpha subunit,IPR011025:G protein alpha subunit, helical insertion,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04010:MAPK signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04270:Vascular smooth muscle contraction,hsa04730:Long-term depression,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,			SM00275:SM00275,	Alternative initiation,Complete proteome,GTP-binding,Lipoprotein,Magnesium,Membrane,Metal-binding,Nucleotide-binding,Palmitate,Polymorphism,Proteomics identification,Reference proteome,Transducer,	chain:Guanine nucleotide-binding protein subunit alpha-12,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,sequence conflict,sequence variant,
38103_at	GRB10 interacting GYF protein 2(GIGYF2)	Homo sapiens				GO:0007631~feeding behavior,GO:0008344~adult locomotory behavior,GO:0009791~post-embryonic development,GO:0017148~negative regulation of translation,GO:0021522~spinal cord motor neuron differentiation,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0035264~multicellular organism growth,GO:0044267~cellular protein metabolic process,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048873~homeostasis of number of cells within a tissue,GO:0050881~musculoskeletal movement,GO:0050885~neuromuscular process controlling balance,GO:0098609~cell-cell adhesion,	GO:0005913~cell-cell adherens junction,GO:0016020~membrane,	GO:0044822~poly(A) RNA binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR003169:GYF,		607688~Parkinson disease 11,		SM00444:GYF,	Acetylation,Alternative splicing,Coiled coil,Complete proteome,Disease mutation,Methylation,Neurodegeneration,Parkinson disease,Parkinsonism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:PERQ amino acid-rich with GYF domain- containing protein 2,compositionally biased region:Arg-rich,compositionally biased region:Gln-rich,compositionally biased region:Glu-rich,compositionally biased region:Poly-Gly,compositionally biased region:Pro-rich,domain:GYF,modified residue,region of interest:Required for GRB10-binding,sequence conflict,sequence variant,splice variant,
34703_f_at	HERV-H LTR-associating 1(HHLA1)	Homo sapiens					GO:0005576~extracellular region,							Alternative splicing,Complete proteome,Glycoprotein,Reference proteome,Secreted,Signal,	
39698_at	HOP homeobox(HOPX)	Homo sapiens		h_hopPathway:Hop Pathway in Cardiac Development,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001829~trophectodermal cell differentiation,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0007507~heart development,GO:0008016~regulation of heart contraction,GO:0016575~histone deacetylation,GO:0043393~regulation of protein binding,GO:0043415~positive regulation of skeletal muscle tissue regeneration,GO:0045596~negative regulation of cell differentiation,GO:0048286~lung alveolus development,GO:0051155~positive regulation of striated muscle cell differentiation,	GO:0005634~nucleus,GO:0005737~cytoplasm,	GO:0003677~DNA binding,GO:0005515~protein binding,	IPR001356:Homeodomain,IPR009057:Homeodomain-like,				SM00389:HOX,	Alternative splicing,Complete proteome,Cytoplasm,Developmental protein,Homeobox,Nucleus,Proto-oncogene,Reference proteome,Repressor,Transcription,Transcription regulation,	chain:Homeodomain-only protein,DNA-binding region:Homeobox; atypical,sequence conflict,splice variant,
1645_at	KiSS-1 metastasis-suppressor(KISS1)	Homo sapiens				GO:0007010~cytoskeleton organization,GO:0008285~negative regulation of cell proliferation,GO:0033686~positive regulation of luteinizing hormone secretion,GO:0043410~positive regulation of MAPK cascade,GO:0050806~positive regulation of synaptic transmission,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0060112~generation of ovulation cycle rhythm,GO:0060124~positive regulation of growth hormone secretion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0016324~apical plasma membrane,GO:0043005~neuron projection,GO:0043025~neuronal cell body,	GO:0005515~protein binding,GO:0031773~kisspeptin receptor binding,	IPR020207:Metastasis-suppressor KiSS-1,		614842~Hypogonadotropic hypogonadism 13 with or without anosmia,			Amidation,Cleavage on pair of basic residues,Complete proteome,Direct protein sequencing,Disease mutation,Hypogonadotropic hypogonadism,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Metastasis-suppressor KiSS-1,modified residue,peptide:Kisspeptin-10,peptide:Kisspeptin-13,peptide:Kisspeptin-14,peptide:Metastin,region of interest:Essential for receptor binding and receptor activation,sequence conflict,sequence variant,signal peptide,site:Cleavage; by MMP2 and MMP9,
34577_at	MAGE family member A9(MAGEA9)	Homo sapiens						GO:0005515~protein binding,	IPR002190:MAGE protein,IPR021072:Melanoma associated antigen, MAGE, N-terminal,				SM01373:SM01373,SM01392:SM01392,	Complete proteome,Polymorphism,Reference proteome,Tumor antigen,	chain:Melanoma-associated antigen 9,compositionally biased region:Poly-Glu,domain:MAGE,sequence conflict,
1786_at	MER proto-oncogene, tyrosine kinase(MERTK)	Homo sapiens				GO:0001779~natural killer cell differentiation,GO:0006468~protein phosphorylation,GO:0006909~phagocytosis,GO:0007166~cell surface receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0007283~spermatogenesis,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030168~platelet activation,GO:0032940~secretion by cell,GO:0034446~substrate adhesion-dependent cell spreading,GO:0043277~apoptotic cell clearance,GO:0043491~protein kinase B signaling,GO:0050766~positive regulation of phagocytosis,GO:0050900~leukocyte migration,GO:0051250~negative regulation of lymphocyte activation,GO:0060041~retina development in camera-type eye,GO:0060068~vagina development,GO:2000107~negative regulation of leukocyte apoptotic process,	GO:0001750~photoreceptor outer segment,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016028~rhabdomere,	GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013151:Immunoglobulin,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,		613862~Retinitis pigmentosa 38,		SM00060:FN3,SM00219:TyrKc,SM00409:IG,	3D-structure,ATP-binding,Complete proteome,Disease mutation,Disulfide bond,Glycoprotein,Immunoglobulin domain,Kinase,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Proto-oncogene,Receptor,Reference proteome,Repeat,Retinitis pigmentosa,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Proto-oncogene tyrosine-protein kinase Mer,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
38128_at	N-acetyltransferase 8B (putative, gene/pseudogene)(NAT8B)	Homo sapiens				GO:0001702~gastrulation with mouth forming second,GO:0010628~positive regulation of gene expression,GO:0018003~peptidyl-lysine N6-acetylation,GO:0043066~negative regulation of apoptotic process,GO:0044267~cellular protein metabolic process,GO:0050435~beta-amyloid metabolic process,	GO:0005789~endoplasmic reticulum membrane,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,GO:0016021~integral component of membrane,GO:0033116~endoplasmic reticulum-Golgi intermediate compartment membrane,	GO:0004468~lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,GO:0005515~protein binding,GO:0008080~N-acetyltransferase activity,	IPR000182:GNAT domain,IPR016181:Acyl-CoA N-acyltransferase,					Acyltransferase,Complete proteome,Endoplasmic reticulum,Membrane,Reference proteome,Signal-anchor,Transferase,Transmembrane,Transmembrane helix,	chain:Probable N-acetyltransferase 8,chain:Probable N-acetyltransferase 8B,domain:N-acetyltransferase,sequence conflict,sequence variant,transmembrane region,
40058_s_at	PDZ and LIM domain 5(PDLIM5)	Homo sapiens				GO:0051963~regulation of synapse assembly,GO:0061001~regulation of dendritic spine morphogenesis,GO:0061049~cell growth involved in cardiac muscle cell development,GO:0098609~cell-cell adhesion,	GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005913~cell-cell adherens junction,GO:0014069~postsynaptic density,GO:0015629~actin cytoskeleton,GO:0016020~membrane,GO:0043005~neuron projection,GO:0045211~postsynaptic membrane,	GO:0003779~actin binding,GO:0005080~protein kinase C binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042805~actinin binding,GO:0047485~protein N-terminus binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR001478:PDZ domain,IPR001781:Zinc finger, LIM-type,				SM00132:LIM,SM00228:PDZ,	3D-structure,Acetylation,Alternative splicing,Cell junction,Cell membrane,Complete proteome,Cytoplasm,Direct protein sequencing,LIM domain,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Reference proteome,Repeat,Synapse,Synaptosome,Zinc,	chain:PDZ and LIM domain protein 5,domain:LIM zinc-binding 1,domain:LIM zinc-binding 2,domain:LIM zinc-binding 3,domain:PDZ,helix,modified residue,sequence variant,strand,turn,
33922_at	PR/SET domain 2(PRDM2)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0008340~determination of adult lifespan,GO:0034968~histone lysine methylation,	GO:0005634~nucleus,	GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0008270~zinc ion binding,GO:0018024~histone-lysine N-methyltransferase activity,GO:0046872~metal ion binding,	IPR001214:SET domain,IPR007087:Zinc finger, C2H2,IPR009170:Predicted retinoblastoma binding protein (RIZ),IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,			PIRSF002395:retinoblastoma binding protein (RIZ),	SM00317:SET,SM00355:ZnF_C2H2,	3D-structure,Activator,Alternative initiation,Alternative splicing,Coiled coil,Complete proteome,DNA-binding,Isopeptide bond,Metal-binding,Methyltransferase,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Ubl conjugation,Zinc,Zinc-finger,	chain:PR domain zinc finger protein 2,compositionally biased region:Arg/Lys-rich (basic),compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Ser,compositionally biased region:Pro-rich,domain:SET,helix,modified residue,mutagenesis site,region of interest:Retinoblastoma protein binding,sequence conflict,sequence variant,short sequence motif:SH3-binding,splice variant,strand,turn,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,zinc finger region:C2H2-type 7; atypical,zinc finger region:C2H2-type 8; atypical,
35069_at	PRAME family member 1(PRAMEF1)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045596~negative regulation of cell differentiation,GO:0045892~negative regulation of transcription, DNA-templated,			IPR026271:PRAME family,			PIRSF038286:PRAME family protein,		Complete proteome,Leucine-rich repeat,Polymorphism,Reference proteome,Repeat,	chain:PRAME family member 1,repeat:LRR 1,repeat:LRR 2,repeat:LRR 3,sequence variant,
33371_s_at	RAB31, member RAS oncogene family(RAB31)	Homo sapiens				GO:0007264~small GTPase mediated signal transduction,GO:0031623~receptor internalization,GO:0032869~cellular response to insulin stimulus,GO:0043001~Golgi to plasma membrane protein transport,GO:0045055~regulated exocytosis,GO:0090382~phagosome maturation,	GO:0005622~intracellular,GO:0005769~early endosome,GO:0030670~phagocytic vesicle membrane,GO:0032588~trans-Golgi network membrane,GO:0045335~phagocytic vesicle,	GO:0003924~GTPase activity,GO:0005525~GTP binding,GO:0019003~GDP binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa04144:Endocytosis,				3D-structure,Complete proteome,Cytoplasmic vesicle,Endosome,Golgi apparatus,GTP-binding,Lipoprotein,Membrane,Nucleotide-binding,Phosphoprotein,Prenylation,Proteomics identification,Reference proteome,	chain:Ras-related protein Rab-31,helix,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,mutagenesis site,nucleotide phosphate-binding region:GTP,sequence conflict,short sequence motif:Effector region,strand,turn,
966_at, 967_g_at	RAD54-like (S. cerevisiae)(RAD54L)	Homo sapiens				GO:0000724~double-strand break repair via homologous recombination,GO:0000733~DNA strand renaturation,GO:0006281~DNA repair,GO:0006310~DNA recombination,GO:0007126~meiotic nuclear division,GO:0008340~determination of adult lifespan,GO:0010212~response to ionizing radiation,GO:0042493~response to drug,GO:0051276~chromosome organization,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0003677~DNA binding,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0036310~annealing helicase activity,	IPR000330:SNF2-related,IPR001650:Helicase, C-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03440:Homologous recombination,	114480~Breast cancer, invasive ductal,605027~Lymphoma, non-Hodgkin, somatic,Adenocarcinoma, colonic, somatic~Adenocarcinoma, colonic, somatic,		SM00487:DEXDc,SM00490:HELICc,	ATP-binding,Complete proteome,DNA damage,DNA repair,DNA-binding,Helicase,Hydrolase,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:DNA repair and recombination protein RAD54-like,domain:Helicase ATP-binding,domain:Helicase C-terminal,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,short sequence motif:DEGH box,
33080_s_at	RAP1 GTPase activating protein(RAP1GAP)	Homo sapiens				GO:0007165~signal transduction,GO:0043087~regulation of GTPase activity,GO:0043547~positive regulation of GTPase activity,GO:0045665~negative regulation of neuron differentiation,GO:0051056~regulation of small GTPase mediated signal transduction,GO:1903697~negative regulation of microvillus assembly,GO:1904425~negative regulation of GTP binding,GO:1904442~negative regulation of thyroid gland epithelial cell proliferation,GO:1990792~cellular response to glial cell derived neurotrophic factor,	GO:0000139~Golgi membrane,GO:0005769~early endosome,GO:0005829~cytosol,GO:0016020~membrane,GO:0030424~axon,GO:0030425~dendrite,GO:0043025~neuronal cell body,	GO:0003924~GTPase activity,GO:0005096~GTPase activator activity,GO:0005515~protein binding,GO:0017016~Ras GTPase binding,GO:0030695~GTPase regulator activity,GO:0042803~protein homodimerization activity,	IPR000331:Rap GTPase activating proteins domain,IPR003109:GoLoco motif,	hsa04015:Rap1 signaling pathway,			SM00390:GoLoco,	3D-structure,Alternative splicing,Complete proteome,Golgi apparatus,GTPase activation,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Rap1 GTPase-activating protein 1,domain:GoLoco,domain:Rap-GAP,helix,modified residue,sequence variant,splice variant,strand,turn,
606_at	Rho family GTPase 2(RND2)	Homo sapiens				GO:0007165~signal transduction,GO:0007264~small GTPase mediated signal transduction,GO:0048672~positive regulation of collateral sprouting,	GO:0002080~acrosomal membrane,GO:0005769~early endosome,	GO:0003924~GTPase activity,GO:0005515~protein binding,GO:0005525~GTP binding,GO:0047485~protein N-terminus binding,	IPR001806:Small GTPase superfamily,IPR005225:Small GTP-binding protein domain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,					Complete proteome,Cytoplasmic vesicle,GTP-binding,Lipoprotein,Membrane,Methylation,Nucleotide-binding,Prenylation,Reference proteome,	chain:Rho-related GTP-binding protein RhoN,lipid moiety-binding region:S-geranylgeranyl cysteine,modified residue,nucleotide phosphate-binding region:GTP,propeptide:Removed in mature form,short sequence motif:Effector region,
39908_at	TATA-box binding protein associated factor 6 like(TAF6L)	Homo sapiens			Transcription,	GO:0006338~chromatin remodeling,GO:0006352~DNA-templated transcription, initiation,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0043966~histone H3 acetylation,GO:0051090~regulation of sequence-specific DNA binding transcription factor activity,	GO:0000118~histone deacetylase complex,GO:0005634~nucleus,GO:0030914~STAGA complex,GO:0070062~extracellular exosome,	GO:0003677~DNA binding,GO:0003713~transcription coactivator activity,GO:0004402~histone acetyltransferase activity,GO:0005515~protein binding,GO:0046982~protein heterodimerization activity,	IPR004823:TATA box binding protein associated factor (TAF),IPR009072:Histone-fold,IPR011442:Domain of unknown function DUF1546,	hsa03022:Basal transcription factors,hsa05168:Herpes simplex infection,			SM00803:TAF,	Complete proteome,Direct protein sequencing,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:TAF6-like RNA polymerase II p300/CBP- associated factor-associated factor 65 kDa subunit 6L,modified residue,
1372_at	TNF alpha induced protein 6(TNFAIP6)	Homo sapiens				GO:0006954~inflammatory response,GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0030335~positive regulation of cell migration,GO:0030728~ovulation,GO:0050728~negative regulation of inflammatory response,	GO:0005615~extracellular space,	GO:0005515~protein binding,GO:0005540~hyaluronic acid binding,	IPR000538:Link,IPR000859:CUB domain,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,				SM00042:CUB,SM00445:LINK,	3D-structure,Cell adhesion,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Polymorphism,Reference proteome,Signal,	chain:Tumor necrosis factor-inducible gene 6 protein,disulfide bond,domain:CUB,domain:Link,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence variant,signal peptide,strand,
1331_s_at	TNF receptor superfamily member 25(TNFRSF25)	Homo sapiens		h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors ,		GO:0006915~apoptotic process,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007275~multicellular organism development,GO:0032496~response to lipopolysaccharide,GO:0033209~tumor necrosis factor-mediated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042981~regulation of apoptotic process,GO:0043410~positive regulation of MAPK cascade,GO:0097190~apoptotic signaling pathway,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,	GO:0004872~receptor activity,GO:0005031~tumor necrosis factor-activated receptor activity,	IPR000488:Death domain,IPR001368:TNFR/NGFR cysteine-rich region,IPR011029:Death-like domain,IPR022329:Tumour necrosis factor receptor 25,	hsa04060:Cytokine-cytokine receptor interaction,			SM00005:DEATH,SM00208:TNFR,	Alternative splicing,Apoptosis,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Tumor necrosis factor receptor superfamily member 25,disulfide bond,domain:Death,glycosylation site:N-linked (GlcNAc...),mutagenesis site,repeat:TNFR-Cys 1,repeat:TNFR-Cys 2,repeat:TNFR-Cys 3,repeat:TNFR-Cys 4,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
32680_at	TRAF2 and NCK interacting kinase(TNIK)	Homo sapiens				GO:0001934~positive regulation of protein phosphorylation,GO:0006468~protein phosphorylation,GO:0007010~cytoskeleton organization,GO:0007256~activation of JNKK activity,GO:0016055~Wnt signaling pathway,GO:0030033~microvillus assembly,GO:0031532~actin cytoskeleton reorganization,GO:0035556~intracellular signal transduction,GO:0046777~protein autophosphorylation,GO:0048814~regulation of dendrite morphogenesis,GO:0072659~protein localization to plasma membrane,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005856~cytoskeleton,GO:0016324~apical plasma membrane,GO:0048471~perinuclear region of cytoplasm,GO:0055037~recycling endosome,GO:0070062~extracellular exosome,	GO:0004672~protein kinase activity,GO:0004674~protein serine/threonine kinase activity,GO:0004702~receptor signaling protein serine/threonine kinase activity,GO:0005515~protein binding,GO:0005524~ATP binding,	IPR000719:Protein kinase, catalytic domain,IPR001180:Citron-like,IPR008271:Serine/threonine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR017441:Protein kinase, ATP binding site,				SM00036:CNH,SM00220:S_TKc,	3D-structure,Alternative splicing,ATP-binding,Complete proteome,Cytoplasm,Cytoskeleton,Endosome,Kinase,Neurogenesis,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Serine/threonine-protein kinase,Transferase,Wnt signaling pathway,	active site:Proton acceptor,binding site:ATP,chain:Traf2 and NCK-interacting protein kinase,domain:CNH,domain:Protein kinase,modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence variant,splice variant,
35213_at	WW domain binding protein 4(WBP4)	Homo sapiens				GO:0045292~mRNA cis splicing, via spliceosome,	GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005886~plasma membrane,GO:0016607~nuclear speck,	GO:0003676~nucleic acid binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0070064~proline-rich region binding,	IPR000690:Zinc finger, C2H2-type matrin,IPR001202:WW domain,IPR003604:Zinc finger, U1-type,IPR013085:Zinc finger, U1-C type,				SM00451:ZnF_U1,SM00456:WW,	3D-structure,Alternative splicing,Complete proteome,Metal-binding,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Spliceosome,Zinc,Zinc-finger,	chain:WW domain-binding protein 4,compositionally biased region:Lys-rich,domain:WW 1,domain:WW 2,mutagenesis site,sequence variant,strand,zinc finger region:Matrin-type,
40089_at	Williams-Beuren syndrome chromosome region 22(WBSCR22)	Homo sapiens				GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016569~covalent chromatin modification,GO:0031167~rRNA methylation,GO:0070476~rRNA (guanine-N7)-methylation,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0008168~methyltransferase activity,GO:0016435~rRNA (guanine) methyltransferase activity,GO:0044822~poly(A) RNA binding,	IPR013216:Methyltransferase type 11,IPR022238:Uncharacterised protein family, methyltransferase, Williams-Beuren syndrome,					Alternative splicing,Chromatin regulator,Complete proteome,Cytoplasm,Methyltransferase,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Ribosome biogenesis,rRNA processing,S-adenosyl-L-methionine,Transcription,Transcription regulation,Transferase,Ubl conjugation,Williams-Beuren syndrome,	chain:Uncharacterized methyltransferase WBSCR22,splice variant,
33684_at	Wnt family member 2B(WNT2B)	Homo sapiens				GO:0002062~chondrocyte differentiation,GO:0002088~lens development in camera-type eye,GO:0007275~multicellular organism development,GO:0008584~male gonad development,GO:0009267~cellular response to starvation,GO:0016055~Wnt signaling pathway,GO:0021871~forebrain regionalization,GO:0030182~neuron differentiation,GO:0045165~cell fate commitment,GO:0060070~canonical Wnt signaling pathway,GO:0060492~lung induction,GO:0060638~mesenchymal-epithelial cell signaling,GO:0061072~iris morphogenesis,GO:0061303~cornea development in camera-type eye,GO:0071425~hematopoietic stem cell proliferation,GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis,GO:0090263~positive regulation of canonical Wnt signaling pathway,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,	GO:0005109~frizzled binding,	IPR005817:Wnt,IPR009140:Wnt-2 protein,IPR018161:Wnt protein, conserved site,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,			SM00097:WNT1,	Alternative splicing,Complete proteome,Developmental protein,Disulfide bond,Extracellular matrix,Glycoprotein,Lipoprotein,Proteomics identification,Reference proteome,Secreted,Signal,Wnt signaling pathway,	chain:Protein Wnt-2b,glycosylation site:N-linked (GlcNAc...),sequence conflict,signal peptide,splice variant,
2090_i_at	Wnt family member 6(WNT6)	Homo sapiens				GO:0001658~branching involved in ureteric bud morphogenesis,GO:0007275~multicellular organism development,GO:0009798~axis specification,GO:0010628~positive regulation of gene expression,GO:0016055~Wnt signaling pathway,GO:0030182~neuron differentiation,GO:0042475~odontogenesis of dentin-containing tooth,GO:0045165~cell fate commitment,GO:0045893~positive regulation of transcription, DNA-templated,GO:0060684~epithelial-mesenchymal cell signaling,GO:0061303~cornea development in camera-type eye,GO:0070172~positive regulation of tooth mineralization,GO:0071300~cellular response to retinoic acid,GO:0072079~nephron tubule formation,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005788~endoplasmic reticulum lumen,GO:0005796~Golgi lumen,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0030666~endocytic vesicle membrane,GO:0070062~extracellular exosome,	GO:0005109~frizzled binding,	IPR005817:Wnt,IPR009143:Wnt-6 protein,IPR018161:Wnt protein, conserved site,	hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04916:Melanogenesis,hsa05166:HTLV-I infection,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05217:Basal cell carcinoma,			SM00097:WNT1,	Complete proteome,Developmental protein,Disulfide bond,Extracellular matrix,Glycoprotein,Lipoprotein,Reference proteome,Secreted,Signal,Wnt signaling pathway,	chain:Protein Wnt-6,glycosylation site:N-linked (GlcNAc...),signal peptide,
37953_s_at	acid sensing ion channel subunit 1(ASIC1)	Homo sapiens				GO:0006810~transport,GO:0006814~sodium ion transport,GO:0007165~signal transduction,GO:0007613~memory,GO:0008306~associative learning,GO:0009268~response to pH,GO:0010447~response to acidic pH,GO:0034220~ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0042391~regulation of membrane potential,GO:0046929~negative regulation of neurotransmitter secretion,GO:0050915~sensory perception of sour taste,GO:0070207~protein homotrimerization,GO:0070588~calcium ion transmembrane transport,GO:0071467~cellular response to pH,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0009986~cell surface,GO:0016021~integral component of membrane,GO:0045202~synapse,	GO:0005272~sodium channel activity,GO:0005515~protein binding,GO:0015280~ligand-gated sodium channel activity,GO:0022839~ion gated channel activity,GO:0044736~acid-sensing ion channel activity,	IPR001873:Na+ channel, amiloride-sensitive,IPR004724:Epithelial sodium channel,IPR020903:Na+ channel, amiloride-sensitive, conserved site,	hsa04750:Inflammatory mediator regulation of TRP channels,				Alternative splicing,Calcium,Calcium transport,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Amiloride-sensitive cation channel 2, neuronal,disulfide bond,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
40317_at	acid sensing ion channel subunit 2(ASIC2)	Homo sapiens				GO:0003026~regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,GO:0007268~chemical synaptic transmission,GO:0007417~central nervous system development,GO:0007422~peripheral nervous system development,GO:0007602~phototransduction,GO:0007605~sensory perception of sound,GO:0010447~response to acidic pH,GO:0010468~regulation of gene expression,GO:0015672~monovalent inorganic cation transport,GO:0019229~regulation of vasoconstriction,GO:0030193~regulation of blood coagulation,GO:0034220~ion transmembrane transport,GO:0034765~regulation of ion transmembrane transport,GO:0035418~protein localization to synapse,GO:0035725~sodium ion transmembrane transport,GO:0042391~regulation of membrane potential,GO:0043066~negative regulation of apoptotic process,GO:0050915~sensory perception of sour taste,GO:0050974~detection of mechanical stimulus involved in sensory perception,GO:0051965~positive regulation of synapse assembly,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0043025~neuronal cell body,GO:0043197~dendritic spine,	GO:0005515~protein binding,GO:0015280~ligand-gated sodium channel activity,GO:0022839~ion gated channel activity,GO:0044736~acid-sensing ion channel activity,	IPR001873:Na+ channel, amiloride-sensitive,IPR004724:Epithelial sodium channel,IPR020903:Na+ channel, amiloride-sensitive, conserved site,	hsa04742:Taste transduction,hsa04750:Inflammatory mediator regulation of TRP channels,				Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Ion channel,Ion transport,Membrane,Phosphoprotein,Polymorphism,Reference proteome,Sodium,Sodium channel,Sodium transport,Transmembrane,Transmembrane helix,Transport,	chain:Amiloride-sensitive cation channel 1, neuronal,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
34606_s_at	activating transcription factor 7(ATF7)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0016032~viral process,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0034399~nuclear periphery,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019899~enzyme binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,GO:0051019~mitogen-activated protein kinase binding,	IPR004827:Basic-leucine zipper domain,IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,IPR016378:Transcription factor, cyclic AMP-dependent,			PIRSF003153:cyclic AMP-dependent transcription factor, CRE-BP1 type,	SM00338:BRLZ,SM00355:ZnF_C2H2,	Activator,Alternative splicing,Complete proteome,Cytoplasm,DNA-binding,Host-virus interaction,Isopeptide bond,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	chain:Cyclic AMP-dependent transcription factor ATF-7,DNA-binding region:Basic motif,domain:Leucine-zipper,modified residue,splice variant,zinc finger region:C2H2-type,
39511_at	afadin, adherens junction formation factor(AFDN)	Homo sapiens				GO:0007155~cell adhesion,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0021987~cerebral cortex development,GO:0032880~regulation of protein localization,GO:0034332~adherens junction organization,GO:0034334~adherens junction maintenance,GO:0043547~positive regulation of GTPase activity,GO:0048854~brain morphogenesis,GO:0048872~homeostasis of number of cells,GO:0060019~radial glial cell differentiation,GO:0060563~neuroepithelial cell differentiation,GO:0070445~regulation of oligodendrocyte progenitor proliferation,GO:0090557~establishment of endothelial intestinal barrier,GO:0098609~cell-cell adhesion,	GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005913~cell-cell adherens junction,GO:0030054~cell junction,GO:0045177~apical part of cell,	GO:0005515~protein binding,GO:0008022~protein C-terminus binding,GO:0017016~Ras GTPase binding,GO:0098641~cadherin binding involved in cell-cell adhesion,	IPR000159:Ras-association,IPR000253:Forkhead-associated (FHA) domain,IPR001478:PDZ domain,IPR002710:Dilute,IPR008984:SMAD/FHA domain,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04520:Adherens junction,hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,			SM00228:PDZ,SM00240:FHA,SM00314:RA,SM01132:SM01132,	3D-structure,Acetylation,Alternative splicing,Cell adhesion,Cell junction,Chromosomal rearrangement,Coiled coil,Complete proteome,Phosphoprotein,Proteomics identification,Proto-oncogene,Reference proteome,Repeat,	chain:Afadin,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Glu/Lys-rich,compositionally biased region:Pro-rich,domain:Dilute,domain:FHA,domain:PDZ,domain:Ras-associating 1,domain:Ras-associating 2,helix,modified residue,sequence conflict,site:Breakpoint for translocation to form MLL- MLLT4,splice variant,strand,
37983_at	angiotensin II receptor type 1(AGTR1)	Homo sapiens		h_ace2Pathway:Angiotensin-converting enzyme 2 regulates heart function,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,		GO:0001558~regulation of cell growth,GO:0001822~kidney development,GO:0002018~renin-angiotensin regulation of aldosterone production,GO:0002034~regulation of blood vessel size by renin-angiotensin,GO:0003081~regulation of systemic arterial blood pressure by renin-angiotensin,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007200~phospholipase C-activating G-protein coupled receptor signaling pathway,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007266~Rho protein signal transduction,GO:0010744~positive regulation of macrophage derived foam cell differentiation,GO:0010873~positive regulation of cholesterol esterification,GO:0019229~regulation of vasoconstriction,GO:0019722~calcium-mediated signaling,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032430~positive regulation of phospholipase A2 activity,GO:0033864~positive regulation of NAD(P)H oxidase activity,GO:0034374~low-density lipoprotein particle remodeling,GO:0035813~regulation of renal sodium excretion,GO:0038166~angiotensin-activated signaling pathway,GO:0042127~regulation of cell proliferation,GO:0042312~regulation of vasodilation,GO:0050727~regulation of inflammatory response,GO:0050729~positive regulation of inflammatory response,GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,GO:0060326~cell chemotaxis,GO:0086097~phospholipase C-activating angiotensin-activated signaling pathway,GO:2000379~positive regulation of reactive oxygen species metabolic process,	GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0001596~angiotensin type I receptor activity,GO:0004945~angiotensin type II receptor activity,GO:0005515~protein binding,GO:0031711~bradykinin receptor binding,GO:0046982~protein heterodimerization activity,	IPR000190:Angiotensin II receptor type 1,IPR000248:Angiotensin II receptor family,IPR000276:G protein-coupled receptor, rhodopsin-like,IPR017452:GPCR, rhodopsin-like, 7TM,	hsa04020:Calcium signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04261:Adrenergic signaling in cardiomyocytes,hsa04270:Vascular smooth muscle contraction,hsa04614:Renin-angiotensin system,hsa04924:Renin secretion,hsa04925:Aldosterone synthesis and secretion,hsa05200:Pathways in cancer,	145500~Hypertension, essential,267430~Renal tubular dysgenesis,		SM01381:SM01381,	3D-structure,Cell membrane,Complete proteome,Disease mutation,Disulfide bond,G-protein coupled receptor,Glycoprotein,Lipoprotein,Membrane,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Transducer,Transmembrane,Transmembrane helix,	chain:Type-1 angiotensin II receptor,disulfide bond,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:S-palmitoyl cysteine,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
37954_at	annexin A8(ANXA8)	Homo sapiens				GO:0007032~endosome organization,GO:0007596~blood coagulation,GO:0016197~endosomal transport,GO:1900004~negative regulation of serine-type endopeptidase activity,GO:1900138~negative regulation of phospholipase A2 activity,	GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0031902~late endosome membrane,	GO:0005509~calcium ion binding,GO:0005544~calcium-dependent phospholipid binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0005547~phosphatidylinositol-3,4,5-trisphosphate binding,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0051015~actin filament binding,	IPR001464:Annexin,IPR009115:Annexin, type VIII,IPR018252:Annexin repeat, conserved site,IPR018502:Annexin repeat,				SM00335:ANX,	3D-structure,Alternative splicing,Annexin,Blood coagulation,Calcium,Calcium/phospholipid-binding,Complete proteome,Hemostasis,Metal-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,	chain:Annexin A8,chain:Annexin A8-like protein 2,helix,repeat:Annexin 1,repeat:Annexin 2,repeat:Annexin 3,repeat:Annexin 4,sequence conflict,sequence variant,splice variant,strand,turn,
34636_at	arachidonate 15-lipoxygenase(ALOX15)	Homo sapiens				GO:0001503~ossification,GO:0002820~negative regulation of adaptive immune response,GO:0006646~phosphatidylethanolamine biosynthetic process,GO:0006691~leukotriene metabolic process,GO:0006954~inflammatory response,GO:0010811~positive regulation of cell-substrate adhesion,GO:0019369~arachidonic acid metabolic process,GO:0019372~lipoxygenase pathway,GO:0030282~bone mineralization,GO:0030838~positive regulation of actin filament polymerization,GO:0034116~positive regulation of heterotypic cell-cell adhesion,GO:0034976~response to endoplasmic reticulum stress,GO:0035358~regulation of peroxisome proliferator activated receptor signaling pathway,GO:0035963~cellular response to interleukin-13,GO:0042060~wound healing,GO:0043277~apoptotic cell clearance,GO:0051122~hepoxilin biosynthetic process,GO:0055114~oxidation-reduction process,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0071277~cellular response to calcium ion,GO:1901074~regulation of engulfment of apoptotic cell,GO:2001303~lipoxin A4 biosynthetic process,	GO:0005811~lipid particle,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031234~extrinsic component of cytoplasmic side of plasma membrane,	GO:0004052~arachidonate 12-lipoxygenase activity,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0005546~phosphatidylinositol-4,5-bisphosphate binding,GO:0016702~oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,GO:0047977~hepoxilin-epoxide hydrolase activity,GO:0050473~arachidonate 15-lipoxygenase activity,GO:0051120~hepoxilin A3 synthase activity,GO:0097260~eoxin A4 synthase activity,	IPR000907:Lipoxygenase,IPR001024:Lipoxygenase, LH2,IPR001885:Lipoxygenase, mammalian,IPR013819:Lipoxygenase, C-terminal,IPR020833:Lipoxygenase, iron binding site,IPR020834:Lipoxygenase, conserved site,	hsa00590:Arachidonic acid metabolism,hsa00591:Linoleic acid metabolism,hsa01100:Metabolic pathways,hsa04726:Serotonergic synapse,			SM00308:LH2,	3D-structure,Alternative splicing,Calcium,Cell membrane,Complete proteome,Cytoplasm,Dioxygenase,Direct protein sequencing,Fatty acid metabolism,Iron,Lipid droplet,Lipid metabolism,Lipid-binding,Membrane,Metal-binding,Oxidoreductase,Polymorphism,Proteomics identification,Reference proteome,	chain:Arachidonate 15-lipoxygenase,domain:Lipoxygenase,domain:PLAT,metal ion-binding site:Iron; catalytic,metal ion-binding site:Iron; via carboxylate; catalytic,mutagenesis site,sequence conflict,sequence variant,
35648_at	autism susceptibility candidate 2(AUTS2)	Homo sapiens				GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0051571~positive regulation of histone H3-K4 methylation,GO:0060013~righting reflex,GO:0098582~innate vocalization behavior,GO:2000620~positive regulation of histone H4-K16 acetylation,	GO:0005634~nucleus,	GO:0003682~chromatin binding,	IPR023246:Autism susceptibility gene 2 protein,		615834~Mental retardation, autosomal dominant 26,			Alternative splicing,Autism,Autism spectrum disorder,Chromosomal rearrangement,Complete proteome,Mental retardation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Autism susceptibility gene 2 protein,compositionally biased region:His-rich,compositionally biased region:Ser-rich,modified residue,sequence conflict,sequence variant,splice variant,
33963_at	azurocidin 1(AZU1)	Homo sapiens				GO:0001774~microglial cell activation,GO:0006508~proteolysis,GO:0006954~inflammatory response,GO:0007205~protein kinase C-activating G-protein coupled receptor signaling pathway,GO:0008347~glial cell migration,GO:0010628~positive regulation of gene expression,GO:0010800~positive regulation of peptidyl-threonine phosphorylation,GO:0016485~protein processing,GO:0019730~antimicrobial humoral response,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0042117~monocyte activation,GO:0042535~positive regulation of tumor necrosis factor biosynthetic process,GO:0043066~negative regulation of apoptotic process,GO:0043114~regulation of vascular permeability,GO:0045123~cellular extravasation,GO:0045348~positive regulation of MHC class II biosynthetic process,GO:0045785~positive regulation of cell adhesion,GO:0045860~positive regulation of protein kinase activity,GO:0048246~macrophage chemotaxis,GO:0050725~positive regulation of interleukin-1 beta biosynthetic process,GO:0050754~positive regulation of fractalkine biosynthetic process,GO:0050766~positive regulation of phagocytosis,GO:0050829~defense response to Gram-negative bacterium,GO:0050930~induction of positive chemotaxis,GO:0051607~defense response to virus,GO:0060326~cell chemotaxis,GO:0070528~protein kinase C signaling,GO:0070944~neutrophil mediated killing of bacterium,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0019898~extrinsic component of membrane,GO:0035577~azurophil granule membrane,GO:0042582~azurophil granule,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0008233~peptidase activity,GO:0015643~toxic substance binding,GO:0043395~heparan sulfate proteoglycan binding,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,				SM00020:Tryp_SPc,	3D-structure,Antibiotic,Antimicrobial,Chemotaxis,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Heparin-binding,Membrane,Proteomics identification,Reference proteome,Serine protease homolog,Signal,Zymogen,	chain:Azurocidin,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...); partial,helix,mutagenesis site,region of interest:Hydrophobic,region of interest:Possesses antibiotic activity,sequence conflict,sequence variant,signal peptide,strand,turn,
40790_at	basic helix-loop-helix family member e40(BHLHE40)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0032922~circadian regulation of gene expression,GO:0043153~entrainment of circadian clock by photoperiod,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0045892~negative regulation of transcription, DNA-templated,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005794~Golgi apparatus,	GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001078~transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0001191~transcriptional repressor activity, RNA polymerase II transcription factor binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003705~transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003714~transcription corepressor activity,GO:0005515~protein binding,GO:0019904~protein domain specific binding,GO:0042803~protein homodimerization activity,GO:0043425~bHLH transcription factor binding,GO:0043426~MRF binding,GO:0046982~protein heterodimerization activity,GO:0070888~E-box binding,	IPR003650:Orange,IPR011598:Myc-type, basic helix-loop-helix (bHLH) domain,	hsa04710:Circadian rhythm,			SM00353:HLH,SM00511:ORANGE,	Biological rhythms,Complete proteome,Cytoplasm,DNA-binding,Isopeptide bond,Nucleus,Phosphoprotein,Reference proteome,Repressor,Transcription,Transcription regulation,Ubl conjugation,	chain:Class E basic helix-loop-helix protein 40,DNA-binding region:Basic motif,domain:Helix-loop-helix motif,domain:Orange,modified residue,
38201_at	branched chain amino acid transaminase 1(BCAT1)	Homo sapiens				GO:0000082~G1/S transition of mitotic cell cycle,GO:0006532~aspartate biosynthetic process,GO:0008152~metabolic process,GO:0008283~cell proliferation,GO:0008652~cellular amino acid biosynthetic process,GO:0009082~branched-chain amino acid biosynthetic process,GO:0009083~branched-chain amino acid catabolic process,GO:0009098~leucine biosynthetic process,GO:0009099~valine biosynthetic process,	GO:0005739~mitochondrion,GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0004084~branched-chain-amino-acid transaminase activity,GO:0030170~pyridoxal phosphate binding,GO:0042802~identical protein binding,GO:0052654~L-leucine transaminase activity,GO:0052655~L-valine transaminase activity,GO:0052656~L-isoleucine transaminase activity,	IPR001544:Aminotransferase, class IV,IPR005786:Branched-chain amino acid aminotransferase II,IPR018300:Aminotransferase, class IV, conserved site,	hsa00280:Valine, leucine and isoleucine degradation,hsa00290:Valine, leucine and isoleucine biosynthesis,hsa00770:Pantothenate and CoA biosynthesis,hsa01100:Metabolic pathways,hsa01130:Biosynthesis of antibiotics,hsa01210:2-Oxocarboxylic acid metabolism,hsa01230:Biosynthesis of amino acids,	Hyperleucinemia-isoleucinemia or hypervalinemia~Hyperleucinemia-isoleucinemia or hypervalinemia,	PIRSF006468:branched-chain amino acid aminotransferase, BCAT1 type,		3D-structure,Acetylation,Alternative splicing,Amino-acid biosynthesis,Aminotransferase,Branched-chain amino acid biosynthesis,Complete proteome,Cytoplasm,Polymorphism,Proteomics identification,Pyridoxal phosphate,Reference proteome,Transferase,	chain:Branched-chain-amino-acid aminotransferase, cytosolic,helix,modified residue,sequence conflict,sequence variant,strand,turn,
39094_at	bromodomain containing 4(BRD4)	Homo sapiens				GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006974~cellular response to DNA damage stimulus,GO:0010971~positive regulation of G2/M transition of mitotic cell cycle,GO:0016032~viral process,GO:0016569~covalent chromatin modification,GO:0032968~positive regulation of transcription elongation from RNA polymerase II promoter,GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0050727~regulation of inflammatory response,GO:1901407~regulation of phosphorylation of RNA polymerase II C-terminal domain,GO:2000002~negative regulation of DNA damage checkpoint,	GO:0000794~condensed nuclear chromosome,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005694~chromosome,GO:0005737~cytoplasm,	GO:0000993~RNA polymerase II core binding,GO:0002039~p53 binding,GO:0003682~chromatin binding,GO:0005515~protein binding,GO:0070577~lysine-acetylated histone binding,	IPR001487:Bromodomain,IPR018359:Bromodomain, conserved site,IPR027353:NET domain,				SM00297:BROMO,	3D-structure,Acetylation,Alternative splicing,Bromodomain,Chromatin regulator,Chromosomal rearrangement,Chromosome,Coiled coil,Complete proteome,DNA damage,Host-virus interaction,Isopeptide bond,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,	chain:Bromodomain-containing protein 4,compositionally biased region:Lys-rich,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Arg,compositionally biased region:Poly-Gln,compositionally biased region:Poly-His,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Ser-rich,domain:Bromo 1,domain:Bromo 2,helix,modified residue,sequence variant,site:Breakpoint for translocation to form BDR4-NUT fusion protein,splice variant,turn,
37172_at	carboxypeptidase B2(CPB2)	Homo sapiens		h_fibrinolysisPathway:Fibrinolysis Pathway,		GO:0003331~positive regulation of extracellular matrix constituent secretion,GO:0006508~proteolysis,GO:0007596~blood coagulation,GO:0009408~response to heat,GO:0010757~negative regulation of plasminogen activation,GO:0042493~response to drug,GO:0042730~fibrinolysis,GO:0051918~negative regulation of fibrinolysis,GO:0071333~cellular response to glucose stimulus,GO:0097421~liver regeneration,GO:2000346~negative regulation of hepatocyte proliferation,	GO:0005615~extracellular space,GO:0005623~cell,GO:0070062~extracellular exosome,	GO:0004181~metallocarboxypeptidase activity,GO:0008270~zinc ion binding,	IPR000834:Peptidase M14, carboxypeptidase A,IPR003146:Proteinase inhibitor, carboxypeptidase propeptide,IPR009020:Proteinase inhibitor, propeptide,	hsa04610:Complement and coagulation cascades,hsa04972:Pancreatic secretion,hsa04974:Protein digestion and absorption,			SM00631:Zn_pept,	3D-structure,Alternative splicing,Blood coagulation,Carboxypeptidase,Complete proteome,Direct protein sequencing,Disulfide bond,Fibrinolysis,Glycoprotein,Hemostasis,Hydrolase,Metal-binding,Metalloprotease,Polymorphism,Protease,Proteomics identification,Reference proteome,Secreted,Signal,Zinc,Zymogen,	active site:Nucleophile,chain:Carboxypeptidase B2,disulfide bond,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...); partial,helix,metal ion-binding site:Zinc,propeptide:Activation peptide,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
32469_at	carcinoembryonic antigen related cell adhesion molecule 3(CEACAM3)	Homo sapiens					GO:0016021~integral component of membrane,		IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,					Alternative splicing,Complete proteome,Glycoprotein,Immunoglobulin domain,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Carcinoembryonic antigen-related cell adhesion molecule 3,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence conflict,sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
33530_at	carcinoembryonic antigen related cell adhesion molecule 8(CEACAM8)	Homo sapiens				GO:0006955~immune response,GO:0050900~leukocyte migration,	GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	3D-structure,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Immunoglobulin domain,Lipoprotein,Membrane,Polymorphism,Reference proteome,Repeat,Signal,	chain:Carcinoembryonic antigen-related cell adhesion molecule 8,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),helix,lipid moiety-binding region:GPI-anchor amidated aspartate,propeptide:Removed in mature form,sequence variant,signal peptide,strand,turn,
37105_at, 679_at	cathepsin G(CTSG)	Homo sapiens				GO:0002003~angiotensin maturation,GO:0006468~protein phosphorylation,GO:0006508~proteolysis,GO:0006955~immune response,GO:0016485~protein processing,GO:0022617~extracellular matrix disassembly,GO:0032496~response to lipopolysaccharide,GO:0044130~negative regulation of growth of symbiont in host,GO:0044267~cellular protein metabolic process,GO:0050778~positive regulation of immune response,GO:0050832~defense response to fungus,GO:0070946~neutrophil mediated killing of gram-positive bacterium,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005886~plasma membrane,GO:0009986~cell surface,GO:0030141~secretory granule,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0008233~peptidase activity,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,	hsa04080:Neuroactive ligand-receptor interaction,hsa04142:Lysosome,hsa04614:Renin-angiotensin system,hsa05146:Amoebiasis,hsa05322:Systemic lupus erythematosus,			SM00020:Tryp_SPc,	3D-structure,Antibiotic,Antimicrobial,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Hydrolase,Polymorphism,Protease,Reference proteome,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Cathepsin G,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),helix,propeptide:Activation peptide,sequence variant,signal peptide,strand,turn,
37061_at	chitinase 1(CHIT1)	Homo sapiens				GO:0000272~polysaccharide catabolic process,GO:0005975~carbohydrate metabolic process,GO:0006032~chitin catabolic process,GO:0006955~immune response,GO:0009617~response to bacterium,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005764~lysosome,	GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0004568~chitinase activity,GO:0008061~chitin binding,GO:0008843~endochitinase activity,	IPR001223:Glycoside hydrolase, family 18, catalytic domain,IPR001579:Glycoside hydrolase, chitinase active site,IPR002557:Chitin binding domain,IPR011583:Chitinase II,IPR013781:Glycoside hydrolase, catalytic domain,IPR017853:Glycoside hydrolase, superfamily,	hsa00520:Amino sugar and nucleotide sugar metabolism,	614122~Chitotriosidase deficiency,		SM00494:ChtBD2,SM00636:Glyco_18,	3D-structure,Alternative splicing,Carbohydrate metabolism,Chitin degradation,Chitin-binding,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Glycosidase,Hydrolase,Lysosome,Polymorphism,Polysaccharide degradation,Proteomics identification,Reference proteome,Secreted,Signal,	active site:Proton donor,chain:Chitotriosidase-1,disulfide bond,domain:Chitin-binding type-2,helix,sequence variant,signal peptide,splice variant,strand,turn,
38482_at	claudin 7(CLDN7)	Homo sapiens				GO:0007162~negative regulation of cell adhesion,GO:0008284~positive regulation of cell proliferation,GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,GO:0032463~negative regulation of protein homooligomerization,GO:0043066~negative regulation of apoptotic process,GO:2000147~positive regulation of cell motility,	GO:0005886~plasma membrane,GO:0005923~bicellular tight junction,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016327~apicolateral plasma membrane,GO:0016328~lateral plasma membrane,	GO:0005198~structural molecule activity,GO:0005515~protein binding,GO:0042802~identical protein binding,GO:0050839~cell adhesion molecule binding,	IPR003552:Claudin-7,IPR004031:PMP-22/EMP/MP20/Claudin,IPR006187:Claudin,IPR017974:Claudin, conserved site,	hsa04514:Cell adhesion molecules (CAMs),hsa04530:Tight junction,hsa04670:Leukocyte transendothelial migration,hsa05160:Hepatitis C,				Alternative splicing,Cell junction,Cell membrane,Complete proteome,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Tight junction,Transmembrane,Transmembrane helix,	chain:Claudin-7,region of interest:Interactions with TJP1, TJP2 and TJP3,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
35169_at	collagen type XVI alpha 1 chain(COL16A1)	Homo sapiens				GO:0007155~cell adhesion,GO:0007229~integrin-mediated signaling pathway,GO:0007565~female pregnancy,GO:0030198~extracellular matrix organization,GO:0033622~integrin activation,GO:0033627~cell adhesion mediated by integrin,GO:0051894~positive regulation of focal adhesion assembly,GO:0071230~cellular response to amino acid stimulus,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005597~collagen type XVI trimer,GO:0005788~endoplasmic reticulum lumen,	GO:0005178~integrin binding,GO:0005515~protein binding,	IPR001791:Laminin G domain,IPR008160:Collagen triple helix repeat,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00210:TSPN,	Alternative splicing,Cell adhesion,Collagen,Complete proteome,Direct protein sequencing,Extracellular matrix,Glycoprotein,Hydroxylation,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Collagen alpha-1(XVI) chain,domain:TSP N-terminal,glycosylation site:N-linked (GlcNAc...),region of interest:Nonhelical region 1 (NC1),region of interest:Nonhelical region 10 (NC10),region of interest:Nonhelical region 2 (NC2),region of interest:Nonhelical region 3 (NC3),region of interest:Nonhelical region 4 (NC4),region of interest:Nonhelical region 5 (NC5),region of interest:Nonhelical region 6 (NC6),region of interest:Nonhelical region 7 (NC7),region of interest:Nonhelical region 8 (NC8),region of interest:Nonhelical region 9 (NC9),region of interest:Triple-helical region 1 (COL1) with 2 imperfections,region of interest:Triple-helical region 2 (COL2) with 2 imperfections,region of interest:Triple-helical region 3 (COL3),region of interest:Triple-helical region 4 (COL4) with 2 imperfections,region of interest:Triple-helical region 5 (COL5) with 3 imperfections,region of interest:Triple-helical region 6 (COL6) with 1 imperfection,region of interest:Triple-helical region 7 (COL7) with 1 imperfection,region of interest:Triple-helical region 8 (COL8) with 1 imperfection,region of interest:Triple-helical region 9 (COL9) with 3 imperfections,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,
32250_at	complement factor H(CFH)	Homo sapiens				GO:0006956~complement activation,GO:0006957~complement activation, alternative pathway,GO:0030449~regulation of complement activation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0005515~protein binding,GO:0008201~heparin binding,GO:0043395~heparan sulfate proteoglycan binding,	IPR000436:Sushi/SCR/CCP,	hsa04610:Complement and coagulation cascades,hsa05150:Staphylococcus aureus infection,	126700~Basal laminar drusen,235400~Hemolytic uremic syndrome, atypical, susceptibility to, 1,609814~Complement factor H deficiency,610698~Macular degeneration, age-related, 4,		SM00032:CCP,	3D-structure,Age-related macular degeneration,Alternative splicing,Complement alternate pathway,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hemolytic uremic syndrome,Immunity,Innate immunity,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Sushi,	chain:Complement factor H,disulfide bond,domain:Sushi 1,domain:Sushi 10,domain:Sushi 11,domain:Sushi 12,domain:Sushi 13,domain:Sushi 14,domain:Sushi 15,domain:Sushi 16,domain:Sushi 17,domain:Sushi 18,domain:Sushi 19,domain:Sushi 2,domain:Sushi 20,domain:Sushi 3,domain:Sushi 4,domain:Sushi 5,domain:Sushi 6,domain:Sushi 7,domain:Sushi 8,domain:Sushi 9,glycosylation site:N-linked (GlcNAc...),helix,sequence conflict,sequence variant,signal peptide,site:Not glycosylated,splice variant,strand,turn,
36317_at	coronin 2A(CORO2A)	Homo sapiens				GO:0030036~actin cytoskeleton organization,GO:0035556~intracellular signal transduction,	GO:0015629~actin cytoskeleton,GO:0017053~transcriptional repressor complex,	GO:0051015~actin filament binding,	IPR001680:WD40 repeat,IPR015048:Domain of unknown function DUF1899,IPR015505:Coronin,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,IPR027335:Coronin 2A,				SM00320:WD40,SM01166:SM01166,	Actin-binding,Coiled coil,Complete proteome,Polymorphism,Reference proteome,Repeat,WD repeat,	chain:Coronin-2A,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,sequence conflict,sequence variant,
1983_at	cyclin D2(CCND2)	Homo sapiens		h_cellcyclePathway:Cyclins and Cell Cycle Regulation,		GO:0001934~positive regulation of protein phosphorylation,GO:0007049~cell cycle,GO:0008284~positive regulation of cell proliferation,GO:0043066~negative regulation of apoptotic process,GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0051301~cell division,GO:1900087~positive regulation of G1/S transition of mitotic cell cycle,	GO:0000307~cyclin-dependent protein kinase holoenzyme complex,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005829~cytosol,GO:0031965~nuclear membrane,GO:0097129~cyclin D2-CDK4 complex,	GO:0005515~protein binding,GO:0019901~protein kinase binding,	IPR004367:Cyclin, C-terminal domain,IPR006671:Cyclin, N-terminal,IPR013763:Cyclin-like,IPR015451:Cyclin D,	hsa04068:FoxO signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04310:Wnt signaling pathway,hsa04390:Hippo signaling pathway,hsa04510:Focal adhesion,hsa04630:Jak-STAT signaling pathway,hsa04917:Prolactin signaling pathway,hsa05162:Measles,hsa05166:HTLV-I infection,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05206:MicroRNAs in cancer,	615938~Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3,		SM00385:CYCLIN,SM01332:SM01332,	Alternative splicing,Cell cycle,Cell division,Complete proteome,Cyclin,Cytoplasm,Disease mutation,Membrane,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Ubl conjugation,	chain:G1/S-specific cyclin-D2,sequence conflict,sequence variant,
38229_at	cytochrome P450 family 3 subfamily A member 5(CYP3A5)	Homo sapiens			Secondary metabolites biosynthesis, transport, and catabolism,	GO:0002933~lipid hydroxylation,GO:0006805~xenobiotic metabolic process,GO:0008202~steroid metabolic process,GO:0009822~alkaloid catabolic process,GO:0042737~drug catabolic process,GO:0070989~oxidative demethylation,	GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0031090~organelle membrane,GO:0043231~intracellular membrane-bounded organelle,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0016491~oxidoreductase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0070330~aromatase activity,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR002402:Cytochrome P450, E-class, group II,IPR002403:Cytochrome P450, E-class, group IV,IPR008072:Cytochrome P450, E-class, CYP3A,IPR017972:Cytochrome P450, conserved site,	hsa00140:Steroid hormone biosynthesis,hsa00830:Retinol metabolism,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00982:Drug metabolism - cytochrome P450,hsa01100:Metabolic pathways,hsa05204:Chemical carcinogenesis,	145500~Hypertension, salt-sensitive essential, susceptibility to,			Alternative splicing,Complete proteome,Endoplasmic reticulum,Heme,Iron,Membrane,Metal-binding,Microsome,Monooxygenase,Oxidoreductase,Polymorphism,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Cytochrome P450 3A5,metal ion-binding site:Iron (heme axial ligand),sequence conflict,sequence variant,
1391_s_at	cytochrome P450 family 4 subfamily A member 11(CYP4A11)	Homo sapiens		h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,	Secondary metabolites biosynthesis, transport, and catabolism,	GO:0001676~long-chain fatty acid metabolic process,GO:0003091~renal water homeostasis,GO:0003095~pressure natriuresis,GO:0006631~fatty acid metabolic process,GO:0006691~leukotriene metabolic process,GO:0019369~arachidonic acid metabolic process,GO:0019373~epoxygenase P450 pathway,GO:0032305~positive regulation of icosanoid secretion,GO:0036101~leukotriene B4 catabolic process,GO:0055078~sodium ion homeostasis,GO:0055114~oxidation-reduction process,GO:0097267~omega-hydroxylase P450 pathway,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0031090~organelle membrane,GO:0043231~intracellular membrane-bounded organelle,GO:0070062~extracellular exosome,	GO:0004497~monooxygenase activity,GO:0005506~iron ion binding,GO:0008392~arachidonic acid epoxygenase activity,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0018685~alkane 1-monooxygenase activity,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0050051~leukotriene-B4 20-monooxygenase activity,	IPR001128:Cytochrome P450,IPR002401:Cytochrome P450, E-class, group I,IPR002402:Cytochrome P450, E-class, group II,IPR017972:Cytochrome P450, conserved site,					Alternative splicing,Complete proteome,Direct protein sequencing,Endoplasmic reticulum,Heme,Iron,Membrane,Metal-binding,Microsome,Monooxygenase,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	binding site:Heme (covalent; via 1 link),chain:Cytochrome P450 4A11,compositionally biased region:Poly-Leu,metal ion-binding site:Iron (heme axial ligand),mutagenesis site,sequence conflict,sequence variant,splice variant,
31793_at, 31506_s_at	defensin alpha 1(DEFA1)	Homo sapiens				GO:0002227~innate immune response in mucosa,GO:0006935~chemotaxis,GO:0006955~immune response,GO:0019731~antibacterial humoral response,GO:0030520~intracellular estrogen receptor signaling pathway,GO:0031640~killing of cells of other organism,GO:0045087~innate immune response,GO:0050830~defense response to Gram-positive bacterium,GO:0050832~defense response to fungus,GO:0051607~defense response to virus,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005796~Golgi lumen,GO:0031012~extracellular matrix,GO:0035578~azurophil granule lumen,GO:0070062~extracellular exosome,		IPR002366:Defensin propeptide,IPR006080:Beta defensin/Neutrophil defensin,IPR006081:Mammalian defensins,IPR016327:Alpha-defensin,			PIRSF001875:alpha-defensin,	SM00048:DEFSN,	3D-structure,ADP-ribosylation,Antibiotic,Antimicrobial,Antiviral defense,Complete proteome,Defensin,Direct protein sequencing,Disulfide bond,Fungicide,Phosphoprotein,Reference proteome,Secreted,Signal,	chain:HP 1-56,disulfide bond,modified residue,peptide:Neutrophil defensin 1,peptide:Neutrophil defensin 2,signal peptide,strand,
34546_at	defensin alpha 4(DEFA4)	Homo sapiens				GO:0019730~antimicrobial humoral response,GO:0019731~antibacterial humoral response,GO:0031640~killing of cells of other organism,GO:0045087~innate immune response,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,GO:0050832~defense response to fungus,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005796~Golgi lumen,GO:0042582~azurophil granule,		IPR002366:Defensin propeptide,IPR006080:Beta defensin/Neutrophil defensin,IPR006081:Mammalian defensins,IPR016327:Alpha-defensin,			PIRSF001875:alpha-defensin,	SM00048:DEFSN,	3D-structure,Antibiotic,Antimicrobial,Complete proteome,Defensin,Direct protein sequencing,Disulfide bond,Fungicide,Polymorphism,Reference proteome,Secreted,Signal,	disulfide bond,peptide:Neutrophil defensin 4,sequence variant,signal peptide,strand,
34623_at	defensin alpha 5(DEFA5)	Homo sapiens				GO:0019731~antibacterial humoral response,GO:0031640~killing of cells of other organism,GO:0045087~innate immune response,GO:0050832~defense response to fungus,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005796~Golgi lumen,GO:0030133~transport vesicle,GO:0034774~secretory granule lumen,		IPR002366:Defensin propeptide,IPR006080:Beta defensin/Neutrophil defensin,IPR006081:Mammalian defensins,IPR016327:Alpha-defensin,			PIRSF001875:alpha-defensin,	SM00048:DEFSN,	3D-structure,Antibiotic,Antimicrobial,Complete proteome,Cytoplasmic vesicle,Defensin,Direct protein sequencing,Disulfide bond,Fungicide,Glycoprotein,Polymorphism,Reference proteome,Secreted,Signal,	disulfide bond,peptide:Defensin-5,sequence variant,signal peptide,strand,
40186_at	dual specificity phosphatase 9(DUSP9)	Homo sapiens		h_dspPathway:Regulation of MAP Kinase Pathways Through Dual Specificity Phosphatases,		GO:0000165~MAPK cascade,GO:0000187~activation of MAPK activity,GO:0000188~inactivation of MAPK activity,GO:0006470~protein dephosphorylation,GO:0007254~JNK cascade,GO:0035335~peptidyl-tyrosine dephosphorylation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0004721~phosphoprotein phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0005515~protein binding,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0017017~MAP kinase tyrosine/serine/threonine phosphatase activity,	IPR000340:Dual specificity phosphatase, catalytic domain,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR001763:Rhodanese-like domain,IPR008343:Mitogen-activated protein (MAP) kinase phosphatase,IPR020422:Dual specificity phosphatase, subgroup, catalytic domain,IPR024950:Dual specificity phosphatase,	hsa04010:MAPK signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,		PIRSF000939:dual specificity protein phosphatase (MAP kinase phosphatase),	SM00195:DSPc,SM00450:RHOD,	3D-structure,Complete proteome,Cytoplasm,Hydrolase,Phosphoprotein,Protein phosphatase,Reference proteome,	active site:Phosphocysteine intermediate,chain:Dual specificity protein phosphatase 9,domain:Rhodanese,domain:Tyrosine-protein phosphatase,helix,strand,turn,
34972_s_at	dynein axonemal heavy chain 17(DNAH17)	Homo sapiens				GO:0007018~microtubule-based movement,GO:0060285~cilium-dependent cell motility,	GO:0005737~cytoplasm,GO:0005858~axonemal dynein complex,GO:0005874~microtubule,GO:0030286~dynein complex,	GO:0003777~microtubule motor activity,GO:0005524~ATP binding,GO:0016887~ATPase activity,	IPR004273:Dynein heavy chain domain,IPR011704:ATPase, dynein-related, AAA domain,IPR013594:Dynein heavy chain, domain-1,IPR013602:Dynein heavy chain, domain-2,IPR024317:Dynein heavy chain, P-loop containing D4 domain,IPR024743:Dynein heavy chain, coiled coil stalk,IPR026983:Dynein heavy chain,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa05016:Huntington's disease,				Alternative splicing,ATP-binding,Cell projection,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Dynein,Microtubule,Motor protein,Nucleotide-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,	chain:Dynein heavy chain 17, axonemal,nucleotide phosphate-binding region:ATP,region of interest:AAA 1,region of interest:AAA 2,region of interest:AAA 3,region of interest:AAA 4,region of interest:AAA 5,region of interest:AAA 6,region of interest:Stalk,region of interest:Stem,repeat:LRR 1,repeat:LRR 10,repeat:LRR 11,repeat:LRR 12,repeat:LRR 13,repeat:LRR 2,repeat:LRR 3,repeat:LRR 4,repeat:LRR 5,repeat:LRR 6,repeat:LRR 7,repeat:LRR 8,repeat:LRR 9,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,sequence conflict,sequence variant,splice variant,
37096_at	elastase, neutrophil expressed(ELANE)	Homo sapiens		h_pepiPathway:Proepithelin Conversion to Epithelin and Wound Repair Control,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001878~response to yeast,GO:0002438~acute inflammatory response to antigenic stimulus,GO:0002523~leukocyte migration involved in inflammatory response,GO:0006508~proteolysis,GO:0006874~cellular calcium ion homeostasis,GO:0006909~phagocytosis,GO:0009411~response to UV,GO:0022617~extracellular matrix disassembly,GO:0030163~protein catabolic process,GO:0032496~response to lipopolysaccharide,GO:0042742~defense response to bacterium,GO:0043406~positive regulation of MAP kinase activity,GO:0044130~negative regulation of growth of symbiont in host,GO:0045079~negative regulation of chemokine biosynthetic process,GO:0045415~negative regulation of interleukin-8 biosynthetic process,GO:0045416~positive regulation of interleukin-8 biosynthetic process,GO:0048661~positive regulation of smooth muscle cell proliferation,GO:0050728~negative regulation of inflammatory response,GO:0050778~positive regulation of immune response,GO:0050922~negative regulation of chemotaxis,GO:0070947~neutrophil mediated killing of fungus,GO:1903238~positive regulation of leukocyte tethering or rolling,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0009986~cell surface,GO:0017053~transcriptional repressor complex,GO:0030141~secretory granule,GO:0070062~extracellular exosome,	GO:0001106~RNA polymerase II transcription corepressor activity,GO:0002020~protease binding,GO:0004175~endopeptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0005515~protein binding,GO:0008201~heparin binding,GO:0008233~peptidase activity,GO:0019955~cytokine binding,	IPR001254:Peptidase S1,IPR001314:Peptidase S1A, chymotrypsin-type,IPR009003:Trypsin-like cysteine/serine peptidase domain,IPR018114:Peptidase S1, trypsin family, active site,	hsa05202:Transcriptional misregulation in cancer,hsa05322:Systemic lupus erythematosus,	162800~Neutropenia, cyclic,202700~Neutropenia, severe congenital 1, autosomal dominant,		SM00020:Tryp_SPc,	3D-structure,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Hydrolase,Polymorphism,Protease,Reference proteome,Serine protease,Signal,Zymogen,	active site:Charge relay system,chain:Neutrophil elastase,disulfide bond,domain:Peptidase S1,glycosylation site:N-linked (GlcNAc...),helix,sequence variant,signal peptide,strand,turn,
31621_s_at	elastin(ELN)	Homo sapiens				GO:0007519~skeletal muscle tissue development,GO:0007585~respiratory gaseous exchange,GO:0008015~blood circulation,GO:0008283~cell proliferation,GO:0009887~organ morphogenesis,GO:0022617~extracellular matrix disassembly,GO:0030198~extracellular matrix organization,GO:0030833~regulation of actin filament polymerization,GO:0043149~stress fiber assembly,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005739~mitochondrion,GO:0071953~elastic fiber,	GO:0005201~extracellular matrix structural constituent,GO:0005515~protein binding,GO:0050840~extracellular matrix binding,	IPR003979:Tropoelastin,	hsa04974:Protein digestion and absorption,	123700~Cutis laxa, AD,185500~Supravalvar aortic stenosis,			Alternative splicing,Complete proteome,Disulfide bond,Extracellular matrix,Hydroxylation,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Williams-Beuren syndrome,	chain:Elastin,compositionally biased region:Ala-rich,compositionally biased region:Poly-Ala,disulfide bond,modified residue,sequence conflict,sequence variant,signal peptide,splice variant,
34249_at	epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)(EPM2A)	Homo sapiens				GO:0005977~glycogen metabolic process,GO:0005978~glycogen biosynthetic process,GO:0006470~protein dephosphorylation,GO:0006914~autophagy,GO:0007399~nervous system development,GO:0016239~positive regulation of macroautophagy,GO:0032007~negative regulation of TOR signaling,GO:0046959~habituation,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0005844~polysome,GO:0005886~plasma membrane,	GO:0004722~protein serine/threonine phosphatase activity,GO:0004725~protein tyrosine phosphatase activity,GO:0008138~protein tyrosine/serine/threonine phosphatase activity,GO:0019203~carbohydrate phosphatase activity,GO:0030246~carbohydrate binding,GO:2001070~starch binding,	IPR000340:Dual specificity phosphatase, catalytic domain,IPR000387:Protein-tyrosine/Dual specificity phosphatase,IPR002044:Carbohydrate binding module family 20,IPR013783:Immunoglobulin-like fold,IPR013784:Carbohydrate-binding-like fold,IPR016130:Protein-tyrosine phosphatase, active site,IPR020422:Dual specificity phosphatase, subgroup, catalytic domain,IPR024950:Dual specificity phosphatase,		254780~Epilepsy, progressive myoclonic 2A (Lafora),		SM00195:DSPc,SM01065:SM01065,	3D-structure,Alternative initiation,Alternative splicing,Autophagy,Carbohydrate metabolism,Cell membrane,Complete proteome,Cytoplasm,Disease mutation,Endoplasmic reticulum,Epilepsy,Glycogen metabolism,Hydrolase,Membrane,Nucleus,Phosphoprotein,Polymorphism,Protein phosphatase,Proteomics identification,Reference proteome,Ubl conjugation,	chain:Laforin,domain:CBM20,domain:Tyrosine-protein phosphatase,mutagenesis site,sequence conflict,sequence variant,splice variant,
1901_s_at	erb-b2 receptor tyrosine kinase 2(ERBB2)	Homo sapiens		h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,		GO:0000165~MAPK cascade,GO:0001934~positive regulation of protein phosphorylation,GO:0006351~transcription, DNA-templated,GO:0006468~protein phosphorylation,GO:0007165~signal transduction,GO:0007166~cell surface receptor signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007422~peripheral nervous system development,GO:0007507~heart development,GO:0007528~neuromuscular junction development,GO:0008045~motor neuron axon guidance,GO:0008283~cell proliferation,GO:0010628~positive regulation of gene expression,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030307~positive regulation of cell growth,GO:0032886~regulation of microtubule-based process,GO:0033088~negative regulation of immature T cell proliferation in thymus,GO:0038128~ERBB2 signaling pathway,GO:0042060~wound healing,GO:0042552~myelination,GO:0043406~positive regulation of MAP kinase activity,GO:0043547~positive regulation of GTPase activity,GO:0045727~positive regulation of translation,GO:0045765~regulation of angiogenesis,GO:0045785~positive regulation of cell adhesion,GO:0045943~positive regulation of transcription from RNA polymerase I promoter,GO:0045945~positive regulation of transcription from RNA polymerase III promoter,GO:0046777~protein autophosphorylation,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048709~oligodendrocyte differentiation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0071363~cellular response to growth factor stimulus,GO:0071364~cellular response to epidermal growth factor stimulus,GO:0090314~positive regulation of protein targeting to membrane,GO:2000145~regulation of cell motility,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0010008~endosome membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0016323~basolateral plasma membrane,GO:0016324~apical plasma membrane,GO:0031410~cytoplasmic vesicle,GO:0043209~myelin sheath,GO:0043235~receptor complex,GO:0048471~perinuclear region of cytoplasm,	GO:0001042~RNA polymerase I core binding,GO:0004672~protein kinase activity,GO:0004713~protein tyrosine kinase activity,GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0004716~receptor signaling protein tyrosine kinase activity,GO:0004888~transmembrane signaling receptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008022~protein C-terminus binding,GO:0016301~kinase activity,GO:0019838~growth factor binding,GO:0019903~protein phosphatase binding,GO:0042802~identical protein binding,GO:0043125~ErbB-3 class receptor binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0046982~protein heterodimerization activity,GO:0046983~protein dimerization activity,	IPR000494:EGF receptor, L domain,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR006211:Furin-like cysteine-rich domain,IPR006212:Furin-like repeat,IPR008266:Tyrosine-protein kinase, active site,IPR009030:Insulin-like growth factor binding protein, N-terminal,IPR011009:Protein kinase-like domain,IPR016245:Tyrosine protein kinase, EGF/ERB/XmrK receptor,IPR017441:Protein kinase, ATP binding site,IPR020635:Tyrosine-protein kinase, catalytic domain,	hsa04012:ErbB signaling pathway,hsa04020:Calcium signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04510:Focal adhesion,hsa04520:Adherens junction,hsa05200:Pathways in cancer,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05215:Prostate cancer,hsa05219:Bladder cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,	137800~Glioblastoma, somatic,211980~Adenocarcinoma of lung, somatic,613659~Gastric cancer, somatic,Ovarian cancer, somatic,~Ovarian cancer, somatic,,	PIRSF000619:tyrosine-protein kinase, EGF receptor type,	SM00219:TyrKc,SM00261:FU,	3D-structure,Activator,Alternative initiation,Alternative splicing,ATP-binding,Cell membrane,Chromosomal rearrangement,Complete proteome,Cytoplasm,Disulfide bond,Glycoprotein,Kinase,Membrane,Nucleotide-binding,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Signal,Transcription,Transcription regulation,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,	active site:Proton acceptor,binding site:ATP,chain:Receptor tyrosine-protein kinase erbB-2,disulfide bond,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,region of interest:Interaction with PIK3C2B,sequence variant,signal peptide,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,turn,
36234_at	eukaryotic translation initiation factor 4A1(EIF4A1)	Homo sapiens		h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_eifPathway:Eukaryotic protein translation,h_iresPathway:Internal Ribosome entry pathway,h_mtorPathway:mTOR Signaling Pathway,		GO:0000289~nuclear-transcribed mRNA poly(A) tail shortening,GO:0006413~translational initiation,GO:0006446~regulation of translational initiation,GO:0010468~regulation of gene expression,GO:0010501~RNA secondary structure unwinding,GO:0016032~viral process,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016020~membrane,GO:0016281~eukaryotic translation initiation factor 4F complex,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0000339~RNA cap binding,GO:0003676~nucleic acid binding,GO:0003725~double-stranded RNA binding,GO:0003729~mRNA binding,GO:0003743~translation initiation factor activity,GO:0004004~ATP-dependent RNA helicase activity,GO:0004386~helicase activity,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008135~translation factor activity, RNA binding,GO:0044822~poly(A) RNA binding,	IPR000629:RNA helicase, ATP-dependent, DEAD-box, conserved site,IPR001650:Helicase, C-terminal,IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal,IPR014001:Helicase, superfamily 1/2, ATP-binding domain,IPR014014:RNA helicase, DEAD-box type, Q motif,IPR027417:P-loop containing nucleoside triphosphate hydrolase,	hsa03013:RNA transport,			SM00487:DEXDc,SM00490:HELICc,	3D-structure,Acetylation,Alternative splicing,ATP-binding,Complete proteome,Helicase,Host-virus interaction,Hydrolase,Initiation factor,Nucleotide-binding,Phosphoprotein,Protein biosynthesis,Proteomics identification,Reference proteome,RNA-binding,	chain:Eukaryotic initiation factor 4A-I,domain:Helicase ATP-binding,domain:Helicase C-terminal,helix,modified residue,nucleotide phosphate-binding region:ATP,short sequence motif:DEAD box,short sequence motif:Q motif,strand,turn,
1855_at	fibroblast growth factor 3(FGF3)	Homo sapiens				GO:0000165~MAPK cascade,GO:0007165~signal transduction,GO:0007267~cell-cell signaling,GO:0007275~multicellular organism development,GO:0008284~positive regulation of cell proliferation,GO:0008543~fibroblast growth factor receptor signaling pathway,GO:0009653~anatomical structure morphogenesis,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0030154~cell differentiation,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0043547~positive regulation of GTPase activity,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0051781~positive regulation of cell division,GO:0055026~negative regulation of cardiac muscle tissue development,	GO:0005576~extracellular region,GO:0005622~intracellular,	GO:0004713~protein tyrosine kinase activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005104~fibroblast growth factor receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR002209:Heparin-binding growth factor/Fibroblast growth factor,IPR008996:Cytokine, IL-1-like,	hsa04010:MAPK signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04810:Regulation of actin cytoskeleton,hsa05200:Pathways in cancer,hsa05218:Melanoma,	610706~Deafness, congenital with inner ear agenesis, microtia, and microdontia,		SM00442:FGF,	Complete proteome,Developmental protein,Differentiation,Disease mutation,Glycoprotein,Growth factor,Mitogen,Proto-oncogene,Reference proteome,Secreted,Signal,	chain:INT-2 proto-oncogene protein,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
35367_at	galectin 3(LGALS3)	Homo sapiens				GO:0002548~monocyte chemotaxis,GO:0006397~mRNA processing,GO:0008380~RNA splicing,GO:0030593~neutrophil chemotaxis,GO:0030855~epithelial cell differentiation,GO:0042129~regulation of T cell proliferation,GO:0045087~innate immune response,GO:0045806~negative regulation of endocytosis,GO:0048245~eosinophil chemotaxis,GO:0048246~macrophage chemotaxis,GO:0050860~negative regulation of T cell receptor signaling pathway,GO:0050918~positive chemotaxis,GO:0070232~regulation of T cell apoptotic process,GO:0071674~mononuclear cell migration,GO:0071677~positive regulation of mononuclear cell migration,GO:0090280~positive regulation of calcium ion import,GO:1902041~regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:2000521~negative regulation of immunological synapse formation,GO:2001189~negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,GO:2001200~positive regulation of dendritic cell differentiation,GO:2001237~negative regulation of extrinsic apoptotic signaling pathway,	GO:0001772~immunological synapse,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005681~spliceosomal complex,GO:0005737~cytoplasm,GO:0005743~mitochondrial inner membrane,GO:0005886~plasma membrane,GO:0016020~membrane,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0019863~IgE binding,GO:0030246~carbohydrate binding,GO:0042056~chemoattractant activity,GO:0043236~laminin binding,GO:0044822~poly(A) RNA binding,	IPR001079:Galectin, carbohydrate recognition domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00276:GLECT,SM00908:SM00908,	3D-structure,Acetylation,Complete proteome,Cytoplasm,Differentiation,Disulfide bond,IgE-binding protein,Immunity,Innate immunity,Lectin,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Spliceosome,	chain:Galectin-3,disulfide bond,domain:Galectin,helix,modified residue,region of interest:8 X 9 AA tandem repeats of Y-P-G-X(3)-P- G-A,region of interest:Beta-galactoside binding,repeat:1,repeat:2,repeat:3,repeat:4; approximate,repeat:5,repeat:6; approximate,repeat:7; approximate,repeat:8; approximate,sequence conflict,sequence variant,strand,
32279_at	glutamate decarboxylase 2(GAD2)	Homo sapiens			Amino acid transport and metabolism,	GO:0006540~glutamate decarboxylation to succinate,GO:0007268~chemical synaptic transmission,GO:0007269~neurotransmitter secretion,GO:0019752~carboxylic acid metabolic process,GO:0042136~neurotransmitter biosynthetic process,GO:0042493~response to drug,	GO:0000139~Golgi membrane,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0030054~cell junction,GO:0030424~axon,GO:0030672~synaptic vesicle membrane,GO:0031225~anchored component of membrane,GO:0042734~presynaptic membrane,GO:0048471~perinuclear region of cytoplasm,GO:0060077~inhibitory synapse,GO:0061202~clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,	GO:0004351~glutamate decarboxylase activity,GO:0005515~protein binding,GO:0016595~glutamate binding,GO:0016831~carboxy-lyase activity,GO:0030170~pyridoxal phosphate binding,GO:0046982~protein heterodimerization activity,	IPR002129:Pyridoxal phosphate-dependent decarboxylase,IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1,IPR015422:Pyridoxal phosphate-dependent transferase, major region, subdomain 2,IPR015424:Pyridoxal phosphate-dependent transferase,IPR021115:Pyridoxal-phosphate binding site,	hsa00250:Alanine, aspartate and glutamate metabolism,hsa00410:beta-Alanine metabolism,hsa00430:Taurine and hypotaurine metabolism,hsa00650:Butanoate metabolism,hsa01100:Metabolic pathways,hsa04727:GABAergic synapse,hsa04940:Type I diabetes mellitus,				3D-structure,Cell junction,Cell membrane,Complete proteome,Cytoplasm,Cytoplasmic vesicle,Decarboxylase,Golgi apparatus,Lipoprotein,Lyase,Membrane,Neurotransmitter biosynthesis,Palmitate,Phosphoprotein,Polymorphism,Proteomics identification,Pyridoxal phosphate,Reference proteome,Synapse,	binding site:Substrate,chain:Glutamate decarboxylase 2,helix,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,region of interest:Substrate binding,sequence variant,strand,turn,
38236_at	glutamate ionotropic receptor NMDA type subunit 2A(GRIN2A)	Homo sapiens		h_nos1Pathway:Nitric Oxide Signaling Pathway,		GO:0000165~MAPK cascade,GO:0001964~startle response,GO:0001975~response to amphetamine,GO:0006810~transport,GO:0007215~glutamate receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007611~learning or memory,GO:0007613~memory,GO:0008104~protein localization,GO:0008542~visual learning,GO:0009611~response to wounding,GO:0019233~sensory perception of pain,GO:0022008~neurogenesis,GO:0030431~sleep,GO:0033058~directional locomotion,GO:0035235~ionotropic glutamate receptor signaling pathway,GO:0042177~negative regulation of protein catabolic process,GO:0042417~dopamine metabolic process,GO:0042428~serotonin metabolic process,GO:0042493~response to drug,GO:0043065~positive regulation of apoptotic process,GO:0043547~positive regulation of GTPase activity,GO:0045471~response to ethanol,GO:0051930~regulation of sensory perception of pain,GO:0060079~excitatory postsynaptic potential,GO:0060291~long-term synaptic potentiation,GO:0070588~calcium ion transmembrane transport,GO:1900273~positive regulation of long-term synaptic potentiation,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0008021~synaptic vesicle,GO:0009986~cell surface,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0017146~NMDA selective glutamate receptor complex,GO:0030054~cell junction,GO:0042734~presynaptic membrane,GO:0043005~neuron projection,GO:0045211~postsynaptic membrane,	GO:0004970~ionotropic glutamate receptor activity,GO:0004972~NMDA glutamate receptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005234~extracellular-glutamate-gated ion channel activity,GO:0005262~calcium channel activity,GO:0005515~protein binding,GO:0008270~zinc ion binding,	IPR001320:Ionotropic glutamate receptor,IPR001508:NMDA receptor,IPR001828:Extracellular ligand-binding receptor,IPR018884:Glutamate [NMDA] receptor, epsilon subunit, C-terminal,IPR019594:Glutamate receptor, L-glutamate/glycine-binding,	hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04020:Calcium signaling pathway,hsa04024:cAMP signaling pathway,hsa04080:Neuroactive ligand-receptor interaction,hsa04713:Circadian entrainment,hsa04720:Long-term potentiation,hsa04724:Glutamatergic synapse,hsa04728:Dopaminergic synapse,hsa05010:Alzheimer's disease,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05030:Cocaine addiction,hsa05031:Amphetamine addiction,hsa05033:Nicotine addiction,hsa05034:Alcoholism,hsa05322:Systemic lupus erythematosus,	245570~Epilepsy, focal, with speech disorder and with or without mental retardation,		SM00079:PBPe,SM00918:SM00918,	3D-structure,Alternative splicing,Calcium,Cell junction,Cell membrane,Chromosomal rearrangement,Complete proteome,Disease mutation,Disulfide bond,Epilepsy,Glycoprotein,Ion channel,Ion transport,Ligand-gated ion channel,Magnesium,Membrane,Metal-binding,Phosphoprotein,Polymorphism,Postsynaptic cell membrane,Proteomics identification,Receptor,Reference proteome,Signal,Synapse,Transmembrane,Transmembrane helix,Transport,Zinc,	binding site:Glutamate,binding site:Glutamate; via amide nitrogen,chain:Glutamate [NMDA] receptor subunit epsilon-1,glycosylation site:N-linked (GlcNAc...),modified residue,region of interest:Glutamate binding,sequence variant,short sequence motif:PDZ-binding,signal peptide,site:Functional determinant of NMDA receptors,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
36479_at	growth arrest specific 8(GAS8)	Homo sapiens				GO:0008285~negative regulation of cell proliferation,GO:0030317~sperm motility,GO:0034613~cellular protein localization,GO:0048870~cell motility,GO:0060294~cilium movement involved in cell motility,GO:1904526~regulation of microtubule binding,	GO:0005794~Golgi apparatus,GO:0005874~microtubule,GO:0005929~cilium,GO:0005930~axoneme,GO:0031514~motile cilium,GO:0036064~ciliary basal body,	GO:0008017~microtubule binding,GO:0017137~Rab GTPase binding,	IPR025593:Growth arrest-specific protein 8,					Alternative splicing,Cell projection,Ciliopathy,Cilium,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Flagellum,Golgi apparatus,Microtubule,Polymorphism,Primary ciliary dyskinesia,Proteomics identification,Reference proteome,	chain:Growth arrest-specific protein 8,region of interest:Microtubule-binding,region of interest:Regulates microtubule-binding,sequence variant,
1890_at	growth differentiation factor 15(GDF15)	Homo sapiens				GO:0007165~signal transduction,GO:0007179~transforming growth factor beta receptor signaling pathway,GO:0007267~cell-cell signaling,GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0042981~regulation of apoptotic process,GO:0043408~regulation of MAPK cascade,GO:0048468~cell development,GO:0060395~SMAD protein signal transduction,GO:1901741~positive regulation of myoblast fusion,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0070062~extracellular exosome,	GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0005515~protein binding,GO:0008083~growth factor activity,	IPR001839:Transforming growth factor-beta, C-terminal,IPR015615:Transforming growth factor-beta-related,				SM00204:TGFB,	Cleavage on pair of basic residues,Complete proteome,Cytokine,Disulfide bond,Glycoprotein,Growth factor,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Growth/differentiation factor 15,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,signal peptide,
31525_s_at	hemoglobin subunit alpha 1(HBA1)	Homo sapiens		h_ahspPathway:Hemoglobin's Chaperone,		GO:0006898~receptor-mediated endocytosis,GO:0010942~positive regulation of cell death,GO:0015671~oxygen transport,GO:0015701~bicarbonate transport,GO:0042542~response to hydrogen peroxide,GO:0042744~hydrogen peroxide catabolic process,GO:0051291~protein heterooligomerization,GO:0098869~cellular oxidant detoxification,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005833~hemoglobin complex,GO:0016020~membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0031838~haptoglobin-hemoglobin complex,GO:0070062~extracellular exosome,GO:0071682~endocytic vesicle lumen,GO:0072562~blood microparticle,	GO:0004601~peroxidase activity,GO:0005344~oxygen transporter activity,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0031720~haptoglobin binding,	IPR000971:Globin,IPR002338:Haemoglobin, alpha,IPR002339:Haemoglobin, pi,IPR009050:Globin-like,IPR012292:Globin, structural domain,	hsa05143:African trypanosomiasis,hsa05144:Malaria,	140700~Heinz body anemias, alpha-,604131~Thalassemias, alpha-,613978~Hemoglobin H disease, nondeletional,Erythremias, alpha-~Erythremias, alpha-,Methemoglobinemias, alpha-~Methemoglobinemias, alpha-,			3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Disease mutation,Glycation,Glycoprotein,Heme,Hereditary hemolytic anemia,Iron,Metal-binding,Oxygen transport,Phosphoprotein,Polymorphism,Reference proteome,Transport,	chain:Hemoglobin subunit alpha,glycosylation site:N-linked (Glc) (glycation),helix,metal ion-binding site:Iron (heme distal ligand),metal ion-binding site:Iron (heme proximal ligand),modified residue,sequence conflict,sequence variant,site:Not glycated,turn,
31687_f_at	hemoglobin subunit beta(HBB)	Homo sapiens		h_ahspPathway:Hemoglobin's Chaperone,		GO:0006898~receptor-mediated endocytosis,GO:0007596~blood coagulation,GO:0008217~regulation of blood pressure,GO:0010942~positive regulation of cell death,GO:0015671~oxygen transport,GO:0015701~bicarbonate transport,GO:0030185~nitric oxide transport,GO:0042542~response to hydrogen peroxide,GO:0042744~hydrogen peroxide catabolic process,GO:0045429~positive regulation of nitric oxide biosynthetic process,GO:0050880~regulation of blood vessel size,GO:0051291~protein heterooligomerization,GO:0070293~renal absorption,GO:0070527~platelet aggregation,GO:0098869~cellular oxidant detoxification,	GO:0005576~extracellular region,GO:0005829~cytosol,GO:0005833~hemoglobin complex,GO:0016021~integral component of membrane,GO:0031838~haptoglobin-hemoglobin complex,GO:0070062~extracellular exosome,GO:0071682~endocytic vesicle lumen,GO:0072562~blood microparticle,	GO:0004601~peroxidase activity,GO:0005344~oxygen transporter activity,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0019825~oxygen binding,GO:0020037~heme binding,GO:0030492~hemoglobin binding,GO:0031720~haptoglobin binding,	IPR000971:Globin,IPR002337:Haemoglobin, beta,IPR009050:Globin-like,IPR012292:Globin, structural domain,	hsa05143:African trypanosomiasis,hsa05144:Malaria,	140700~Heinz body anemias, beta-,141749~Delta-beta thalassemia,141749~Hereditary persistence of fetal hemoglobin,603902~Thalassemia-beta, dominant inclusion-body,603903~Sickle cell anemia,611162~Malaria, resistance to,613985~Thalassemias, beta-,Erythremias, beta-~Erythremias, beta-,Methemoglobinemias, beta-~Methemoglobinemias, beta-,			3D-structure,Acetylation,Complete proteome,Congenital dyserythropoietic anemia,Direct protein sequencing,Disease mutation,Glycation,Glycoprotein,Heme,Hereditary hemolytic anemia,Hypotensive agent,Iron,Membrane,Metal-binding,Oxygen transport,Phosphoprotein,Polymorphism,Proteomics identification,Pyruvate,Reference proteome,S-nitrosylation,Transmembrane,Transmembrane helix,Transport,Vasoactive,	binding site:2,3-bisphosphoglycerate,binding site:2,3-bisphosphoglycerate; via amino nitrogen,chain:Hemoglobin subunit beta,glycosylation site:N-linked (Glc) (glycation),glycosylation site:N-linked (Glc) (glycation); in Hb A1c,helix,metal ion-binding site:Iron (heme distal ligand),metal ion-binding site:Iron (heme proximal ligand),modified residue,peptide:LVV-hemorphin-7,sequence conflict,sequence variant,site:Aspirin-acetylated lysine,site:Not glycated,site:Susceptible to oxidation; associated with variant Atlanta, variant non-spherocytic haemolytic anemia and variant Christchurch,turn,
33516_at	hemoglobin subunit delta(HBD)	Homo sapiens				GO:0007596~blood coagulation,GO:0015671~oxygen transport,	GO:0005829~cytosol,GO:0005833~hemoglobin complex,GO:0072562~blood microparticle,	GO:0005344~oxygen transporter activity,GO:0005506~iron ion binding,GO:0005515~protein binding,GO:0019825~oxygen binding,GO:0020037~heme binding,	IPR000971:Globin,IPR002337:Haemoglobin, beta,IPR009050:Globin-like,IPR012292:Globin, structural domain,		Thalassemia due to Hb Lepore~Thalassemia due to Hb Lepore,Thalassemia, delta-~Thalassemia, delta-,			3D-structure,Acetylation,Complete proteome,Direct protein sequencing,Heme,Iron,Metal-binding,Oxygen transport,Phosphoprotein,Polymorphism,Reference proteome,Transport,	chain:Hemoglobin subunit delta,helix,metal ion-binding site:Iron (heme distal ligand),metal ion-binding site:Iron (heme proximal ligand),modified residue,sequence variant,turn,
40735_at	histidine ammonia-lyase(HAL)	Homo sapiens				GO:0006548~histidine catabolic process,GO:0019556~histidine catabolic process to glutamate and formamide,GO:0019557~histidine catabolic process to glutamate and formate,	GO:0005829~cytosol,	GO:0003824~catalytic activity,GO:0004397~histidine ammonia-lyase activity,GO:0016841~ammonia-lyase activity,	IPR001106:Aromatic amino acid lyase,IPR005921:Histidine ammonia-lyase,IPR008948:L-Aspartase-like,IPR021922:Protein of unknown function DUF3534,IPR022313:Phenylalanine/histidine ammonia-lyases, active site,IPR024083:Fumarase/histidase, N-terminal,	hsa00340:Histidine metabolism,hsa01100:Metabolic pathways,	235800~Histidinemia,			Alternative splicing,Complete proteome,Disease mutation,Histidine metabolism,Lyase,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Histidine ammonia-lyase,cross-link:5-imidazolinone (Ala-Gly),modified residue,sequence variant,
35566_f_at	immunoglobulin heavy variable 4-31(IGHV4-31)	Homo sapiens	78.B_Cell_Development,79.B_cell_Activation,						IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00406:IGv,	Complete proteome,Reference proteome,Signal,	chain:anti-RhD monoclonal T125 gamma1 heavy chain,chain:Ig gamma-1 chain C region,chain:Ig gamma-3 chain C region,chain:Ig mu chain C region,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,region of interest:CH1,region of interest:CH2,region of interest:CH3,region of interest:CH4,region of interest:Hinge,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
31512_at	immunoglobulin kappa constant(IGKC)	Homo sapiens				GO:0001895~retina homeostasis,GO:0006508~proteolysis,GO:0006898~receptor-mediated endocytosis,GO:0006910~phagocytosis, recognition,GO:0006911~phagocytosis, engulfment,GO:0006955~immune response,GO:0006956~complement activation,GO:0006958~complement activation, classical pathway,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0042742~defense response to bacterium,GO:0045087~innate immune response,GO:0050776~regulation of immune response,GO:0050853~B cell receptor signaling pathway,GO:0050871~positive regulation of B cell activation,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0042571~immunoglobulin complex, circulating,GO:0070062~extracellular exosome,GO:0072562~blood microparticle,	GO:0003823~antigen binding,GO:0004252~serine-type endopeptidase activity,GO:0034987~immunoglobulin receptor binding,	IPR003006:Immunoglobulin/major histocompatibility complex, conserved site,IPR003597:Immunoglobulin C1-set,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,		614102~Kappa light chain deficiency,		SM00406:IGv,SM00407:IGc1,SM00409:IG,	3D-structure,Adaptive immunity,Cell membrane,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Immunity,Immunoglobulin C region,Immunoglobulin domain,Immunoglobulin V region,Membrane,Polymorphism,Reference proteome,Secreted,Signal,	chain:anti-RhD monoclonal T125 kappa light chain,chain:Ig kappa chain C region,chain:Ig kappa chain V-I region HK101,chain:Ig kappa chain V-I region Walker,disulfide bond,domain:Ig-like,helix,region of interest:Complementarity-determining-1,region of interest:Complementarity-determining-2,region of interest:Complementarity-determining-3,region of interest:Framework-1,region of interest:Framework-2,region of interest:Framework-3,region of interest:Framework-4,sequence conflict,sequence variant,signal peptide,strand,turn,
34618_at	indian hedgehog(IHH)	Homo sapiens				GO:0001501~skeletal system development,GO:0001947~heart looping,GO:0007224~smoothened signaling pathway,GO:0007267~cell-cell signaling,GO:0007275~multicellular organism development,GO:0009968~negative regulation of signal transduction,GO:0016539~intein-mediated protein splicing,GO:0032332~positive regulation of chondrocyte differentiation,GO:0032355~response to estradiol,GO:0033085~negative regulation of T cell differentiation in thymus,GO:0033088~negative regulation of immature T cell proliferation in thymus,GO:0033089~positive regulation of T cell differentiation in thymus,GO:0042733~embryonic digit morphogenesis,GO:0043066~negative regulation of apoptotic process,GO:0045880~positive regulation of smoothened signaling pathway,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046638~positive regulation of alpha-beta T cell differentiation,GO:0046639~negative regulation of alpha-beta T cell differentiation,GO:0050679~positive regulation of epithelial cell proliferation,GO:0051216~cartilage development,GO:0060135~maternal process involved in female pregnancy,GO:0061053~somite development,	GO:0005615~extracellular space,GO:0005886~plasma membrane,	GO:0005113~patched binding,GO:0005509~calcium ion binding,GO:0008233~peptidase activity,	IPR000320:Hedgehog, N-terminal signaling domain,IPR001657:Hedgehog protein,IPR001767:Hint domain,IPR003586:Hint domain C-terminal,IPR003587:Hint domain N-terminal,IPR006141:Intein splice site,IPR009045:Hedgehog signalling/DD-peptidase zinc-binding domain,	hsa04340:Hedgehog signaling pathway,	112500~Brachydactyly, type A1,607778~Acrocapitofemoral dysplasia,	PIRSF009400:hedgehog protein,	SM00305:HintC,SM00306:HintN,	3D-structure,Autocatalytic cleavage,Calcium,Cell membrane,Complete proteome,Developmental protein,Disease mutation,Glycoprotein,Hydrolase,Lipoprotein,Membrane,Metal-binding,Palmitate,Protease,Reference proteome,Secreted,Signal,Zinc,	chain:Indian hedgehog protein,chain:Indian hedgehog protein C-product,chain:Indian hedgehog protein N-product,glycosylation site:N-linked (GlcNAc...),lipid moiety-binding region:Cholesterol glycine ester,lipid moiety-binding region:N-palmitoyl cysteine,sequence conflict,sequence variant,signal peptide,site:Cleavage; by autolysis,site:Essential for auto-cleavage,site:Involved in auto-cleavage,site:Involved in cholesterol transfer,
35915_at	inhibin beta C subunit(INHBC)	Homo sapiens				GO:0010862~positive regulation of pathway-restricted SMAD protein phosphorylation,GO:0042981~regulation of apoptotic process,GO:0043408~regulation of MAPK cascade,GO:0048468~cell development,GO:0060395~SMAD protein signal transduction,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0005125~cytokine activity,GO:0005160~transforming growth factor beta receptor binding,GO:0005179~hormone activity,GO:0008083~growth factor activity,	IPR001318:Inhibin, beta C subunit,IPR001839:Transforming growth factor-beta, C-terminal,IPR015615:Transforming growth factor-beta-related,IPR017948:Transforming growth factor beta, conserved site,	hsa04060:Cytokine-cytokine receptor interaction,hsa04350:TGF-beta signaling pathway,hsa04550:Signaling pathways regulating pluripotency of stem cells,			SM00204:TGFB,	Cleavage on pair of basic residues,Complete proteome,Disulfide bond,Glycoprotein,Growth factor,Hormone,Polymorphism,Reference proteome,Secreted,Signal,	chain:Inhibin beta C chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,
38674_at	kelch like family member 9(KLHL9)	Homo sapiens				GO:0000910~cytokinesis,GO:0007067~mitotic nuclear division,GO:0016567~protein ubiquitination,	GO:0030496~midbody,GO:0031463~Cul3-RING ubiquitin ligase complex,	GO:0004842~ubiquitin-protein transferase activity,	IPR000210:BTB/POZ-like,IPR006652:Kelch repeat type 1,IPR011333:BTB/POZ fold,IPR011705:BTB/Kelch-associated,IPR015916:Galactose oxidase, beta-propeller,IPR017096:Kelch-like protein, gigaxonin,	hsa04120:Ubiquitin mediated proteolysis,		PIRSF037037:kelch-like protein, gigaxonin type,	SM00225:BTB,SM00612:Kelch,SM00875:SM00875,	Cell cycle,Cell division,Complete proteome,Kelch repeat,Mitosis,Reference proteome,Repeat,Ubl conjugation pathway,	chain:Kelch-like protein 9,domain:BACK,domain:BTB,modified residue,repeat:Kelch 1,repeat:Kelch 2,repeat:Kelch 3,repeat:Kelch 4,repeat:Kelch 5,repeat:Kelch 6,
34012_at	keratin, type I cuticular Ha4(LOC100653049)	Homo sapiens				GO:0008544~epidermis development,	GO:0005615~extracellular space,GO:0005882~intermediate filament,GO:0070062~extracellular exosome,	GO:0005198~structural molecule activity,	IPR001664:Intermediate filament protein,IPR002957:Keratin, type I,IPR018039:Intermediate filament protein, conserved site,				SM01391:SM01391,	Coiled coil,Complete proteome,Intermediate filament,Keratin,Polymorphism,Proteomics identification,Reference proteome,	
36436_at	leukocyte cell derived chemotaxin 2(LECT2)	Homo sapiens				GO:0001501~skeletal system development,GO:0006935~chemotaxis,	GO:0005615~extracellular space,GO:0005737~cytoplasm,	GO:0042802~identical protein binding,	IPR008663:Leukocyte cell-derived chemotaxin 2,IPR016047:Peptidase M23,IPR017381:Leukocyte cell-derived chemotaxin 2, chordata,			PIRSF038085:leukocyte cell-derived chemotaxin 2,		3D-structure,Chemotaxis,Complete proteome,Cytoplasm,Disulfide bond,Polymorphism,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Leukocyte cell-derived chemotaxin-2,sequence variant,signal peptide,
32073_at	lysine demethylase 4A(KDM4A)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0010507~negative regulation of autophagy,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0016032~viral process,GO:0016577~histone demethylation,GO:0031667~response to nutrient levels,GO:0045666~positive regulation of neuron differentiation,GO:0045892~negative regulation of transcription, DNA-templated,GO:0048712~negative regulation of astrocyte differentiation,GO:0055114~oxidation-reduction process,GO:0060548~negative regulation of cell death,GO:0070544~histone H3-K36 demethylation,GO:1900113~negative regulation of histone H3-K9 trimethylation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005721~pericentric heterochromatin,GO:0005730~nucleolus,GO:0005737~cytoplasm,	GO:0003690~double-stranded DNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0031625~ubiquitin protein ligase binding,GO:0032452~histone demethylase activity,GO:0035064~methylated histone binding,GO:0051864~histone demethylase activity (H3-K36 specific),	IPR001965:Zinc finger, PHD-type,IPR002999:Tudor domain,IPR003347:JmjC domain,IPR003349:Transcription factor jumonji, JmjN,IPR011011:Zinc finger, FYVE/PHD-type,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00249:PHD,SM00333:TUDOR,SM00545:JmjN,SM00558:JmjC,	3D-structure,Acetylation,Alternative splicing,Chromatin regulator,Complete proteome,Dioxygenase,Host-virus interaction,Iron,Metal-binding,Nucleus,Oxidoreductase,Phosphoprotein,Polymorphism,Reference proteome,Repeat,Transcription,Transcription regulation,Ubl conjugation,Zinc,Zinc-finger,	binding site:Alpha-ketoglutarate,binding site:Histone H3-K4Me3,chain:Lysine-specific demethylase 4A,domain:JmjC,domain:JmjN,domain:Tudor 1,domain:Tudor 2,helix,metal ion-binding site:Iron; catalytic,metal ion-binding site:Zinc,modified residue,mutagenesis site,region of interest:Interaction with NCOR1,sequence variant,strand,turn,zinc finger region:PHD-type 1,zinc finger region:PHD-type 2,
37408_at	mannose receptor C type 2(MRC2)	Homo sapiens				GO:0001649~osteoblast differentiation,GO:0006897~endocytosis,GO:0007165~signal transduction,GO:0030574~collagen catabolic process,	GO:0005887~integral component of plasma membrane,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0004888~transmembrane signaling receptor activity,GO:0005515~protein binding,GO:0005518~collagen binding,GO:0030246~carbohydrate binding,	IPR000562:Fibronectin, type II, collagen-binding,IPR000772:Ricin B lectin domain,IPR001304:C-type lectin,IPR013806:Kringle-like fold,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,	hsa04145:Phagosome,hsa05152:Tuberculosis,			SM00034:CLECT,SM00059:FN2,SM00458:RICIN,	3D-structure,Calcium,Complete proteome,Direct protein sequencing,Disulfide bond,Endocytosis,Glycoprotein,Isopeptide bond,Lectin,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Signal,Transmembrane,Transmembrane helix,Ubl conjugation,	chain:C-type mannose receptor 2,disulfide bond,domain:C-type lectin 1,domain:C-type lectin 2,domain:C-type lectin 3,domain:C-type lectin 4,domain:C-type lectin 5,domain:C-type lectin 6,domain:C-type lectin 7,domain:C-type lectin 8,domain:Fibronectin type-II,domain:Ricin B-type lectin,glycosylation site:N-linked (GlcNAc...),mutagenesis site,sequence variant,signal peptide,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
38945_at	metal regulatory transcription factor 1(MTF1)	Homo sapiens			General function prediction only,Transcription / Cell division and chromosome partitioning,	GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006979~response to oxidative stress,GO:0010038~response to metal ion,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046686~response to cadmium ion,	GO:0005634~nucleus,GO:0005654~nucleoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0001047~core promoter binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0035035~histone acetyltransferase binding,GO:0046872~metal ion binding,	IPR007087:Zinc finger, C2H2,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,	Acetylation,Activator,Complete proteome,DNA-binding,Metal-binding,Nucleus,Phosphoprotein,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Metal regulatory transcription factor 1,compositionally biased region:Pro-rich,sequence conflict,short sequence motif:Nuclear localization signal,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,zinc finger region:C2H2-type 6,
41280_r_at	mitogen-activated protein kinase 8 interacting protein 1(MAPK8IP1)	Homo sapiens				GO:0006355~regulation of transcription, DNA-templated,GO:0007258~JUN phosphorylation,GO:0009967~positive regulation of signal transduction,GO:0016192~vesicle-mediated transport,GO:0043508~negative regulation of JUN kinase activity,GO:0046328~regulation of JNK cascade,GO:2001243~negative regulation of intrinsic apoptotic signaling pathway,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005829~cytosol,GO:0031966~mitochondrial membrane,GO:0044294~dendritic growth cone,GO:0044295~axonal growth cone,GO:0044297~cell body,GO:0044302~dentate gyrus mossy fiber,GO:0045202~synapse,GO:0048471~perinuclear region of cytoplasm,	GO:0004860~protein kinase inhibitor activity,GO:0005078~MAP-kinase scaffold activity,GO:0005515~protein binding,GO:0008432~JUN kinase binding,GO:0016301~kinase activity,GO:0019894~kinesin binding,GO:0031434~mitogen-activated protein kinase kinase binding,GO:0031435~mitogen-activated protein kinase kinase kinase binding,GO:0042802~identical protein binding,	IPR001452:Src homology-3 domain,IPR006020:Phosphotyrosine interaction domain,IPR011993:Pleckstrin homology-like domain,	hsa04010:MAPK signaling pathway,	125853~Diabetes mellitus, noninsulin-dependent,		SM00326:SH3,SM00462:PTB,	3D-structure,Complete proteome,Cytoplasm,Diabetes mellitus,Disease mutation,Endoplasmic reticulum,Kinase,Membrane,Mitochondrion,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,SH3 domain,Transferase,Ubl conjugation,	chain:C-jun-amino-terminal kinase-interacting protein 1,compositionally biased region:Asp/Glu-rich (acidic),compositionally biased region:Poly-Glu,compositionally biased region:Poly-Gly,compositionally biased region:Poly-Pro,domain:PID,domain:SH3,modified residue,mutagenesis site,region of interest:JNK-binding domain (JBD),region of interest:Minimal inhibitory domain (MID),sequence variant,short sequence motif:D-box 1,short sequence motif:D-box 2,
33284_at	myeloperoxidase(MPO)	Homo sapiens				GO:0001878~response to yeast,GO:0002149~hypochlorous acid biosynthetic process,GO:0002679~respiratory burst involved in defense response,GO:0006952~defense response,GO:0006979~response to oxidative stress,GO:0007568~aging,GO:0009612~response to mechanical stimulus,GO:0019430~removal of superoxide radicals,GO:0032094~response to food,GO:0032496~response to lipopolysaccharide,GO:0034374~low-density lipoprotein particle remodeling,GO:0042742~defense response to bacterium,GO:0042744~hydrogen peroxide catabolic process,GO:0043066~negative regulation of apoptotic process,GO:0044130~negative regulation of growth of symbiont in host,GO:0050832~defense response to fungus,GO:0055114~oxidation-reduction process,GO:1990268~response to gold nanoparticle,	GO:0005615~extracellular space,GO:0005634~nucleus,GO:0005739~mitochondrion,GO:0005764~lysosome,GO:0030141~secretory granule,GO:0042582~azurophil granule,GO:0070062~extracellular exosome,	GO:0003682~chromatin binding,GO:0004601~peroxidase activity,GO:0008201~heparin binding,GO:0020037~heme binding,GO:0046872~metal ion binding,	IPR010255:Haem peroxidase,IPR019791:Haem peroxidase, animal, subgroup,	hsa04145:Phagosome,hsa05202:Transcriptional misregulation in cancer,	104300~Alzheimer disease, susceptibility to,254600~Myeloperoxidase deficiency,Lung cancer, protection against, in smokers~Lung cancer, protection against, in smokers,			3D-structure,Alternative splicing,Calcium,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Glycoprotein,Heme,Hydrogen peroxide,Iron,Lysosome,Metal-binding,Nitration,Oxidation,Oxidoreductase,Peroxidase,Polymorphism,Proteomics identification,Reference proteome,Signal,	active site:Proton acceptor,binding site:Heme (covalent; via 3 links),chain:84 kDa myeloperoxidase,chain:89 kDa myeloperoxidase,chain:Myeloperoxidase,chain:Myeloperoxidase heavy chain,chain:Myeloperoxidase light chain,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,metal ion-binding site:Calcium,metal ion-binding site:Calcium; via carbonyl oxygen,metal ion-binding site:Iron (heme axial ligand),modified residue,sequence conflict,sequence variant,signal peptide,site:Transition state stabilizer,splice variant,strand,turn,
37711_at	myocyte enhancer factor 2C(MEF2C)	Homo sapiens		h_alkPathway:ALK in cardiac myocytes,h_at1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling,h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_mapkPathway:MAPKinase Signaling Pathway,h_mitrPathway:Signal Dependent Regulation of Myogenesis by Corepressor MITR,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_p38mapkPathway:p38 MAPK Signaling Pathway ,h_pgc1aPathway:Regulation of PGC-1a,	Transcription,	GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000165~MAPK cascade,GO:0001568~blood vessel development,GO:0001649~osteoblast differentiation,GO:0001764~neuron migration,GO:0001782~B cell homeostasis,GO:0001947~heart looping,GO:0001958~endochondral ossification,GO:0001974~blood vessel remodeling,GO:0002062~chondrocyte differentiation,GO:0002467~germinal center formation,GO:0002634~regulation of germinal center formation,GO:0002931~response to ischemia,GO:0003138~primary heart field specification,GO:0003139~secondary heart field specification,GO:0003151~outflow tract morphogenesis,GO:0003185~sinoatrial valve morphogenesis,GO:0003211~cardiac ventricle formation,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006915~apoptotic process,GO:0006959~humoral immune response,GO:0007399~nervous system development,GO:0007507~heart development,GO:0007517~muscle organ development,GO:0007519~skeletal muscle tissue development,GO:0007521~muscle cell fate determination,GO:0007611~learning or memory,GO:0009615~response to virus,GO:0010628~positive regulation of gene expression,GO:0010629~negative regulation of gene expression,GO:0010694~positive regulation of alkaline phosphatase activity,GO:0014033~neural crest cell differentiation,GO:0014898~cardiac muscle hypertrophy in response to stress,GO:0014902~myotube differentiation,GO:0021542~dentate gyrus development,GO:0030182~neuron differentiation,GO:0030220~platelet formation,GO:0030224~monocyte differentiation,GO:0030279~negative regulation of ossification,GO:0030318~melanocyte differentiation,GO:0030501~positive regulation of bone mineralization,GO:0030890~positive regulation of B cell proliferation,GO:0033197~response to vitamin E,GO:0035690~cellular response to drug,GO:0035914~skeletal muscle cell differentiation,GO:0035984~cellular response to trichostatin A,GO:0042100~B cell proliferation,GO:0043406~positive regulation of MAP kinase activity,GO:0043523~regulation of neuron apoptotic process,GO:0043524~negative regulation of neuron apoptotic process,GO:0045652~regulation of megakaryocyte differentiation,GO:0045663~positive regulation of myoblast differentiation,GO:0045666~positive regulation of neuron differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046928~regulation of neurotransmitter secretion,GO:0048167~regulation of synaptic plasticity,GO:0048643~positive regulation of skeletal muscle tissue development,GO:0048666~neuron development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0048703~embryonic viscerocranium morphogenesis,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050853~B cell receptor signaling pathway,GO:0051145~smooth muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051963~regulation of synapse assembly,GO:0051966~regulation of synaptic transmission, glutamatergic,GO:0055012~ventricular cardiac muscle cell differentiation,GO:0060021~palate development,GO:0060025~regulation of synaptic activity,GO:0060045~positive regulation of cardiac muscle cell proliferation,GO:0060079~excitatory postsynaptic potential,GO:0060290~transdifferentiation,GO:0060297~regulation of sarcomere organization,GO:0060536~cartilage morphogenesis,GO:0060998~regulation of dendritic spine development,GO:0061333~renal tubule morphogenesis,GO:0071222~cellular response to lipopolysaccharide,GO:0071277~cellular response to calcium ion,GO:0071300~cellular response to retinoic acid,GO:0071333~cellular response to glucose stimulus,GO:0071374~cellular response to parathyroid hormone stimulus,GO:0071498~cellular response to fluid shear stress,GO:0071560~cellular response to transforming growth factor beta stimulus,GO:0071864~positive regulation of cell proliferation in bone marrow,GO:0072102~glomerulus morphogenesis,GO:0072160~nephron tubule epithelial cell differentiation,GO:0090073~positive regulation of protein homodimerization activity,GO:2000111~positive regulation of macrophage apoptotic process,GO:2000310~regulation of N-methyl-D-aspartate selective glutamate receptor activity,GO:2000311~regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity,GO:2000727~positive regulation of cardiac muscle cell differentiation,GO:2000987~positive regulation of behavioral fear response,GO:2001013~epithelial cell proliferation involved in renal tubule morphogenesis,GO:2001016~positive regulation of skeletal muscle cell differentiation,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,GO:0005829~cytosol,GO:0016607~nuclear speck,GO:0043231~intracellular membrane-bounded organelle,GO:0043234~protein complex,GO:0098794~postsynapse,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000980~RNA polymerase II distal enhancer sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000983~transcription factor activity, RNA polymerase II core promoter sequence-specific,GO:0001046~core promoter sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001205~transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,GO:0003677~DNA binding,GO:0003680~AT DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0033613~activating transcription factor binding,GO:0035198~miRNA binding,GO:0042826~histone deacetylase binding,GO:0044212~transcription regulatory region DNA binding,GO:0046982~protein heterodimerization activity,GO:0071837~HMG box domain binding,	IPR002100:Transcription factor, MADS-box,IPR022102:Holliday junction regulator protein family C-terminal,	hsa04010:MAPK signaling pathway,hsa04022:cGMP-PKG signaling pathway,hsa04921:Oxytocin signaling pathway,hsa05202:Transcriptional misregulation in cancer,	613443~Chromosome 5q14.3 deletion syndrome,613443~Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations,		SM00432:MADS,	Acetylation,Activator,Alternative splicing,Apoptosis,Complete proteome,Developmental protein,Differentiation,DNA-binding,Epilepsy,Isopeptide bond,Mental retardation,Neurogenesis,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,Ubl conjugation,	chain:Myocyte-specific enhancer factor 2C,compositionally biased region:Lys-rich (basic),compositionally biased region:Ser-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),DNA-binding region:Mef2-type,domain:MADS-box,modified residue,mutagenesis site,region of interest:Beta domain,region of interest:Transcription repressor,site:Cleavage,splice variant,
35038_at	myosin binding protein C, cardiac(MYBPC3)	Homo sapiens				GO:0003007~heart morphogenesis,GO:0006942~regulation of striated muscle contraction,GO:0007155~cell adhesion,GO:0030049~muscle filament sliding,GO:0032781~positive regulation of ATPase activity,GO:0032971~regulation of muscle filament sliding,GO:0055010~ventricular cardiac muscle tissue morphogenesis,GO:0060048~cardiac muscle contraction,	GO:0005829~cytosol,GO:0005863~striated muscle myosin thick filament,GO:0014705~C zone,GO:0030017~sarcomere,GO:0031672~A band,	GO:0001671~ATPase activator activity,GO:0003779~actin binding,GO:0005515~protein binding,GO:0008307~structural constituent of muscle,GO:0017022~myosin binding,GO:0031432~titin binding,GO:0032036~myosin heavy chain binding,GO:0042802~identical protein binding,GO:0046872~metal ion binding,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,	hsa05410:Hypertrophic cardiomyopathy (HCM),hsa05414:Dilated cardiomyopathy,	115197~Cardiomyopathy, hypertrophic, 4,615396~Cardiomyopathy, dilated, 1MM,615396~Left ventricular noncompaction 10,		SM00060:FN3,SM00408:IGc2,SM00409:IG,	3D-structure,Acetylation,Actin-binding,Alternative splicing,Cardiomyopathy,Cell adhesion,Complete proteome,Disease mutation,Disulfide bond,Immunoglobulin domain,Metal-binding,Methylation,Muscle protein,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Thick filament,Ubl conjugation,Zinc,	chain:Myosin-binding protein C, cardiac-type,compositionally biased region:Pro-rich,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Fibronectin type-III 3,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,domain:Ig-like C2-type 6,domain:Ig-like C2-type 7,helix,modified residue,sequence conflict,sequence variant,strand,turn,
37968_at	natural cytotoxicity triggering receptor 3(NCR3)	Homo sapiens				GO:0002860~positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,GO:0006954~inflammatory response,GO:0006955~immune response,GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,GO:0008037~cell recognition,GO:0042271~susceptibility to natural killer cell mediated cytotoxicity,GO:0045954~positive regulation of natural killer cell mediated cytotoxicity,GO:0050776~regulation of immune response,GO:0060370~susceptibility to T cell mediated cytotoxicity,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0005913~cell-cell adherens junction,	GO:0004872~receptor activity,GO:0005102~receptor binding,GO:0042803~protein homodimerization activity,GO:0050839~cell adhesion molecule binding,	IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,	hsa04650:Natural killer cell mediated cytotoxicity,	609148~Malaria, mild, susceptibility to,		SM00409:IG,	3D-structure,Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Membrane,Polymorphism,Receptor,Reference proteome,Signal,Transmembrane,Transmembrane helix,	chain:Natural cytotoxicity triggering receptor 3,disulfide bond,domain:Ig-like,glycosylation site:N-linked (GlcNAc...),sequence variant,signal peptide,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
34233_i_at	natural killer cell triggering receptor(NKTR)	Homo sapiens				GO:0000413~protein peptidyl-prolyl isomerization,GO:0006457~protein folding,	GO:0016020~membrane,	GO:0003755~peptidyl-prolyl cis-trans isomerase activity,GO:0016018~cyclosporin A binding,	IPR002130:Cyclophilin-like peptidyl-prolyl cis-trans isomerase domain,IPR020892:Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site,IPR024936:Cyclophilin-type peptidyl-prolyl cis-trans isomerase,					3D-structure,Complete proteome,Cyclosporin,Isomerase,Isopeptide bond,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Rotamase,Ubl conjugation,	chain:NK-tumor recognition protein,compositionally biased region:Arg/Lys-rich (basic),compositionally biased region:Arg/Ser-rich,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),domain:PPIase cyclophilin-type,helix,modified residue,region of interest:Arg/Ser tandem repeat-rich,sequence variant,strand,turn,
1112_g_at	neural cell adhesion molecule 1(NCAM1)	Homo sapiens		h_PDZsPathway:Synaptic Proteins at the Synaptic Junction,		GO:0000165~MAPK cascade,GO:0007155~cell adhesion,GO:0007411~axon guidance,GO:0031175~neuron projection development,GO:0043547~positive regulation of GTPase activity,GO:0046718~viral entry into host cell,GO:0048167~regulation of synaptic plasticity,GO:0060333~interferon-gamma-mediated signaling pathway,	GO:0000139~Golgi membrane,GO:0005737~cytoplasm,GO:0005886~plasma membrane,GO:0009897~external side of plasma membrane,GO:0009986~cell surface,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0031225~anchored component of membrane,GO:0070062~extracellular exosome,	GO:0001618~virus receptor activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,	IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR003961:Fibronectin, type III,IPR007110:Immunoglobulin-like domain,IPR009138:Neural cell adhesion,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,	hsa04514:Cell adhesion molecules (CAMs),hsa05020:Prion diseases,			SM00060:FN3,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,Cell adhesion,Cell membrane,Complete proteome,Disulfide bond,Glycoprotein,GPI-anchor,Host cell receptor for virus entry,Host-virus interaction,Immunoglobulin domain,Lipoprotein,Membrane,Phosphoprotein,Polymorphism,Proteomics identification,Receptor,Reference proteome,Repeat,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Neural cell adhesion molecule 1,disulfide bond,domain:Fibronectin type-III 1,domain:Fibronectin type-III 2,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like C2-type 4,domain:Ig-like C2-type 5,glycosylation site:N-linked (GlcNAc...),helix,modified residue,sequence conflict,sequence variant,signal peptide,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
32717_at	neuralized E3 ubiquitin protein ligase 1(NEURL1)	Homo sapiens				GO:0006417~regulation of translation,GO:0006513~protein monoubiquitination,GO:0007219~Notch signaling pathway,GO:0007288~sperm axoneme assembly,GO:0007399~nervous system development,GO:0007420~brain development,GO:0007519~skeletal muscle tissue development,GO:0007595~lactation,GO:0008285~negative regulation of cell proliferation,GO:0030317~sperm motility,GO:0043065~positive regulation of apoptotic process,GO:0045741~positive regulation of epidermal growth factor-activated receptor activity,GO:0045746~negative regulation of Notch signaling pathway,GO:0048170~positive regulation of long-term neuronal synaptic plasticity,GO:0051491~positive regulation of filopodium assembly,GO:0060999~positive regulation of dendritic spine development,GO:0071230~cellular response to amino acid stimulus,GO:0090129~positive regulation of synapse maturation,	GO:0005886~plasma membrane,GO:0014069~postsynaptic density,GO:0030054~cell junction,GO:0043197~dendritic spine,GO:0043204~perikaryon,GO:0045211~postsynaptic membrane,GO:0048471~perinuclear region of cytoplasm,GO:0097440~apical dendrite,	GO:0004842~ubiquitin-protein transferase activity,GO:0008270~zinc ion binding,GO:0016874~ligase activity,GO:0045183~translation factor activity, non-nucleic acid binding,GO:0061630~ubiquitin protein ligase activity,	IPR001841:Zinc finger, RING-type,IPR006573:NEUZ,IPR013083:Zinc finger, RING/FYVE/PHD-type,				SM00588:NEUZ,	Alternative splicing,Cell junction,Cell membrane,Cell projection,Complete proteome,Cytoplasm,Ligase,Lipoprotein,Membrane,Metal-binding,Myristate,Notch signaling pathway,Postsynaptic cell membrane,Reference proteome,Repeat,Synapse,Translation regulation,Tumor suppressor,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Neuralized-like protein 1A,domain:NHR 1,domain:NHR 2,sequence conflict,splice variant,zinc finger region:RING-type,
35090_g_at, 35091_at	neuregulin 2(NRG2)	Homo sapiens		h_agrPathway:Agrin in Postsynaptic Differentiation,h_erbb4Pathway:g-Secretase mediated ErbB4 Signaling Pathway ,		GO:0000165~MAPK cascade,GO:0007165~signal transduction,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0035556~intracellular signal transduction,GO:0038128~ERBB2 signaling pathway,GO:0043547~positive regulation of GTPase activity,GO:0046854~phosphatidylinositol phosphorylation,GO:0048015~phosphatidylinositol-mediated signaling,GO:0048513~animal organ development,GO:2000145~regulation of cell motility,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005622~intracellular,GO:0005886~plasma membrane,GO:0016021~integral component of membrane,	GO:0004713~protein tyrosine kinase activity,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005102~receptor binding,GO:0008083~growth factor activity,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,	IPR000742:Epidermal growth factor-like domain,IPR002154:Neuregulin 1-related, C-terminal,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013032:EGF-like, conserved site,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,	hsa04012:ErbB signaling pathway,			SM00408:IGc2,SM00409:IG,	Alternative splicing,Cell membrane,Complete proteome,Disulfide bond,EGF-like domain,Glycoprotein,Growth factor,Immunoglobulin domain,Membrane,Reference proteome,Secreted,Signal,Transmembrane,Transmembrane helix,	chain:Neuregulin-2,chain:Pro-neuregulin-2, membrane-bound isoform,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,compositionally biased region:Poly-Ser,compositionally biased region:Ser/Thr-rich,disulfide bond,domain:EGF-like,domain:Ig-like C2-type,glycosylation site:N-linked (GlcNAc...),modified residue,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
936_s_at	neuron specific gene family member 1(NSG1)	Homo sapiens				GO:0001921~positive regulation of receptor recycling,GO:0007212~dopamine receptor signaling pathway,GO:0016197~endosomal transport,GO:0048268~clathrin coat assembly,	GO:0000139~Golgi membrane,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005768~endosome,GO:0016021~integral component of membrane,GO:0016328~lateral plasma membrane,GO:0045211~postsynaptic membrane,	GO:0005102~receptor binding,GO:0005515~protein binding,GO:0032051~clathrin light chain binding,	IPR009431:Calcyon neuron-specific vesicular protein,			PIRSF002383:neuron specific protein/calcyon,		Alternative splicing,Complete proteome,Golgi apparatus,Membrane,Proteomics identification,Reference proteome,Signal-anchor,Transmembrane,Transmembrane helix,	chain:Neuron-specific protein family member 1,topological domain:Cytoplasmic,topological domain:Lumenal,transmembrane region,
38604_at	neuropeptide Y(NPY)	Homo sapiens				GO:0001878~response to yeast,GO:0006816~calcium ion transport,GO:0006928~movement of cell or subcellular component,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007218~neuropeptide signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007586~digestion,GO:0007610~behavior,GO:0007631~feeding behavior,GO:0008015~blood circulation,GO:0008217~regulation of blood pressure,GO:0008283~cell proliferation,GO:0008343~adult feeding behavior,GO:0019731~antibacterial humoral response,GO:0019732~antifungal humoral response,GO:0021954~central nervous system neuron development,GO:0021987~cerebral cortex development,GO:0031175~neuron projection development,GO:0032098~regulation of appetite,GO:0032100~positive regulation of appetite,GO:0045087~innate immune response,GO:0050829~defense response to Gram-negative bacterium,GO:0050830~defense response to Gram-positive bacterium,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005623~cell,GO:0005794~Golgi apparatus,	GO:0001664~G-protein coupled receptor binding,GO:0004930~G-protein coupled receptor activity,GO:0005102~receptor binding,GO:0005184~neuropeptide hormone activity,GO:0005246~calcium channel regulator activity,	IPR001955:Pancreatic hormone-like,IPR020392:Pancreatic hormone-like, conserved site,	hsa04024:cAMP signaling pathway,hsa04920:Adipocytokine signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa05034:Alcoholism,			SM00309:PAH,	3D-structure,Amidation,Cleavage on pair of basic residues,Complete proteome,Neuropeptide,Phosphoprotein,Polymorphism,Reference proteome,Secreted,Signal,	helix,modified residue,peptide:C-flanking peptide of NPY,peptide:Neuropeptide Y,sequence conflict,sequence variant,signal peptide,strand,
1355_g_at	neurotrophic receptor tyrosine kinase 2(NTRK2)	Homo sapiens				GO:0001570~vasculogenesis,GO:0001764~neuron migration,GO:0001934~positive regulation of protein phosphorylation,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007528~neuromuscular junction development,GO:0007612~learning,GO:0007623~circadian rhythm,GO:0007631~feeding behavior,GO:0008284~positive regulation of cell proliferation,GO:0010628~positive regulation of gene expression,GO:0010976~positive regulation of neuron projection development,GO:0014047~glutamate secretion,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0021954~central nervous system neuron development,GO:0021987~cerebral cortex development,GO:0030182~neuron differentiation,GO:0031547~brain-derived neurotrophic factor receptor signaling pathway,GO:0033138~positive regulation of peptidyl-serine phosphorylation,GO:0035584~calcium-mediated signaling using intracellular calcium source,GO:0038179~neurotrophin signaling pathway,GO:0042490~mechanoreceptor differentiation,GO:0043087~regulation of GTPase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043524~negative regulation of neuron apoptotic process,GO:0046548~retinal rod cell development,GO:0046777~protein autophosphorylation,GO:0048709~oligodendrocyte differentiation,GO:0048935~peripheral nervous system neuron development,GO:0050772~positive regulation of axonogenesis,GO:0051896~regulation of protein kinase B signaling,GO:0051965~positive regulation of synapse assembly,GO:0060041~retina development in camera-type eye,GO:0060291~long-term synaptic potentiation,GO:0071230~cellular response to amino acid stimulus,GO:2000811~negative regulation of anoikis,	GO:0005768~endosome,GO:0005829~cytosol,GO:0005887~integral component of plasma membrane,GO:0010008~endosome membrane,GO:0014069~postsynaptic density,GO:0016021~integral component of membrane,GO:0043195~terminal bouton,GO:0043235~receptor complex,GO:0045211~postsynaptic membrane,	GO:0004714~transmembrane receptor protein tyrosine kinase activity,GO:0005030~neurotrophin receptor activity,GO:0005524~ATP binding,GO:0016301~kinase activity,GO:0042803~protein homodimerization activity,GO:0043121~neurotrophin binding,GO:0048403~brain-derived neurotrophic factor binding,GO:0060175~brain-derived neurotrophic factor-activated receptor activity,	IPR000372:Leucine-rich repeat-containing N-terminal,IPR000483:Cysteine-rich flanking region, C-terminal,IPR000719:Protein kinase, catalytic domain,IPR001245:Serine-threonine/tyrosine-protein kinase catalytic domain,IPR001611:Leucine-rich repeat,IPR002011:Tyrosine-protein kinase, receptor class II, conserved site,IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR008266:Tyrosine-protein kinase, active site,IPR011009:Protein kinase-like domain,IPR013098:Immunoglobulin I-set,IPR013783:Immunoglobulin-like fold,IPR017441:Protein kinase, ATP binding site,IPR020455:Tyrosine-protein kinase, neurotrophic receptor, type 2,IPR020635:Tyrosine-protein kinase, catalytic domain,IPR020777:Tyrosine-protein kinase, neurotrophic receptor,	hsa04010:MAPK signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa05034:Alcoholism,	613886~Obesity, hyperphagia, and developmental delay,		SM00013:LRRNT,SM00082:LRRCT,SM00219:TyrKc,SM00408:IGc2,SM00409:IG,	3D-structure,Alternative splicing,ATP-binding,Cell membrane,Complete proteome,Developmental protein,Differentiation,Disease mutation,Disulfide bond,Endosome,Glycoprotein,Immunoglobulin domain,Kinase,Leucine-rich repeat,Membrane,Neurogenesis,Nucleotide-binding,Obesity,Phosphoprotein,Polymorphism,Receptor,Reference proteome,Repeat,Signal,Transferase,Transmembrane,Transmembrane helix,Tyrosine-protein kinase,Ubl conjugation,	active site:Proton acceptor,binding site:ATP,chain:BDNF/NT-3 growth factors receptor,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Protein kinase,glycosylation site:N-linked (GlcNAc...),helix,modified residue,nucleotide phosphate-binding region:ATP,repeat:LRR 1,repeat:LRR 2,sequence variant,signal peptide,site:Interaction with PLC-gamma-1,site:Interaction with SHC1,splice variant,strand,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
1419_g_at	nitric oxide synthase 2(NOS2)	Homo sapiens	8.MonocytesIFNF_IL4,	h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),	Inorganic ion transport and metabolism,	GO:0001666~response to hypoxia,GO:0001912~positive regulation of leukocyte mediated cytotoxicity,GO:0002227~innate immune response in mucosa,GO:0006527~arginine catabolic process,GO:0006801~superoxide metabolic process,GO:0006809~nitric oxide biosynthetic process,GO:0007263~nitric oxide mediated signal transduction,GO:0007623~circadian rhythm,GO:0009617~response to bacterium,GO:0010629~negative regulation of gene expression,GO:0018119~peptidyl-cysteine S-nitrosylation,GO:0031284~positive regulation of guanylate cyclase activity,GO:0032310~prostaglandin secretion,GO:0035690~cellular response to drug,GO:0042127~regulation of cell proliferation,GO:0042177~negative regulation of protein catabolic process,GO:0042742~defense response to bacterium,GO:0043457~regulation of cellular respiration,GO:0045454~cell redox homeostasis,GO:0045776~negative regulation of blood pressure,GO:0045909~positive regulation of vasodilation,GO:0050796~regulation of insulin secretion,GO:0050829~defense response to Gram-negative bacterium,GO:0051712~positive regulation of killing of cells of other organism,GO:0055114~oxidation-reduction process,GO:0071222~cellular response to lipopolysaccharide,GO:0071346~cellular response to interferon-gamma,GO:0072604~interleukin-6 secretion,GO:0072606~interleukin-8 secretion,GO:1900015~regulation of cytokine production involved in inflammatory response,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005777~peroxisome,GO:0005829~cytosol,GO:0030863~cortical cytoskeleton,GO:0048471~perinuclear region of cytoplasm,	GO:0004517~nitric-oxide synthase activity,GO:0005102~receptor binding,GO:0005515~protein binding,GO:0005516~calmodulin binding,GO:0010181~FMN binding,GO:0020037~heme binding,GO:0034617~tetrahydrobiopterin binding,GO:0034618~arginine binding,GO:0042803~protein homodimerization activity,GO:0046872~metal ion binding,GO:0050660~flavin adenine dinucleotide binding,GO:0050661~NADP binding,	IPR001094:Flavodoxin,IPR001433:Oxidoreductase FAD/NAD(P)-binding,IPR001709:Flavoprotein pyridine nucleotide cytochrome reductase,IPR003097:FAD-binding, type 1,IPR004030:Nitric oxide synthase, oxygenase domain,IPR008254:Flavodoxin/nitric oxide synthase,IPR017927:Ferredoxin reductase-type FAD-binding domain,IPR017938:Riboflavin synthase-like beta-barrel,IPR023173:NADPH-cytochrome p450 reductase, FAD-binding, alpha-helical domain-3,	hsa00220:Arginine biosynthesis,hsa00330:Arginine and proline metabolism,hsa01100:Metabolic pathways,hsa04020:Calcium signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04146:Peroxisome,hsa05132:Salmonella infection,hsa05133:Pertussis,hsa05140:Leishmaniasis,hsa05142:Chagas disease (American trypanosomiasis),hsa05145:Toxoplasmosis,hsa05146:Amoebiasis,hsa05152:Tuberculosis,hsa05200:Pathways in cancer,hsa05222:Small cell lung cancer,	145500~Hypertension, susceptibility to,611162~Malaria, resistance to,			3D-structure,Alternative splicing,Calcium,Calmodulin-binding,Complete proteome,FAD,Flavoprotein,FMN,Heme,Iron,Metal-binding,NADP,Oxidoreductase,Phosphoprotein,Polymorphism,Reference proteome,Zinc,	chain:Nitric oxide synthase, inducible,domain:FAD-binding FR-type,domain:Flavodoxin-like,helix,metal ion-binding site:Iron (heme axial ligand),metal ion-binding site:Zinc,modified residue,nucleotide phosphate-binding region:FAD,nucleotide phosphate-binding region:FMN,nucleotide phosphate-binding region:NADP,region of interest:Calmodulin-binding,sequence conflict,sequence variant,splice variant,strand,turn,
34720_at	nuclear factor I B(NFIB)	Homo sapiens				GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0002062~chondrocyte differentiation,GO:0006260~DNA replication,GO:0006351~transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0010001~glial cell differentiation,GO:0021740~principal sensory nucleus of trigeminal nerve development,GO:0021960~anterior commissure morphogenesis,GO:0030902~hindbrain development,GO:0043392~negative regulation of DNA binding,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0060486~Clara cell differentiation,GO:0060509~Type I pneumocyte differentiation,GO:0060510~Type II pneumocyte differentiation,GO:0060662~salivary gland cavitation,GO:0060689~cell differentiation involved in salivary gland development,GO:0061141~lung ciliated cell differentiation,GO:0071679~commissural neuron axon guidance,GO:1902894~negative regulation of pri-miRNA transcription from RNA polymerase II promoter,GO:2000791~negative regulation of mesenchymal cell proliferation involved in lung development,GO:2000795~negative regulation of epithelial cell proliferation involved in lung morphogenesis,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0044300~cerebellar mossy fiber,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0001106~RNA polymerase II transcription corepressor activity,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,	IPR000647:CTF transcription factor/nuclear factor 1,IPR003619:MAD homology 1, Dwarfin-type,IPR019548:CTF transcription factor/nuclear factor 1, N-terminal,IPR019739:CTF transcription factor/nuclear factor 1, conserved site,IPR020604:CTF transcription factor/nuclear factor 1, DNA-binding domain,				SM00523:DWA,	Activator,Alternative splicing,Complete proteome,DNA replication,DNA-binding,Methylation,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Nuclear factor 1 B-type,DNA-binding region:CTF/NF-I,modified residue,sequence conflict,splice variant,
40271_at	nucleoporin 93(NUP93)	Homo sapiens				GO:0006406~mRNA export from nucleus,GO:0006409~tRNA export from nucleus,GO:0006606~protein import into nucleus,GO:0006810~transport,GO:0006998~nuclear envelope organization,GO:0007077~mitotic nuclear envelope disassembly,GO:0010827~regulation of glucose transport,GO:0016032~viral process,GO:0016925~protein sumoylation,GO:0016973~poly(A)+ mRNA export from nucleus,GO:0019083~viral transcription,GO:0031047~gene silencing by RNA,GO:0051292~nuclear pore complex assembly,GO:0060391~positive regulation of SMAD protein import into nucleus,GO:0060395~SMAD protein signal transduction,GO:0072001~renal system development,GO:0072015~glomerular visceral epithelial cell development,GO:0075733~intracellular transport of virus,GO:0090521~glomerular visceral epithelial cell migration,GO:1900034~regulation of cellular response to heat,GO:1903206~negative regulation of hydrogen peroxide-induced cell death,	GO:0005635~nuclear envelope,GO:0005643~nuclear pore,GO:0016020~membrane,GO:0031965~nuclear membrane,GO:0034399~nuclear periphery,	GO:0005515~protein binding,GO:0017056~structural constituent of nuclear pore,	IPR007231:Nucleoporin interacting component Nup93/Nic96,	hsa03013:RNA transport,				3D-structure,Alternative splicing,Complete proteome,Disease mutation,Membrane,mRNA transport,Nuclear pore complex,Nucleus,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Translocation,Transport,	chain:Nuclear pore complex protein Nup93,modified residue,sequence variant,
32418_at	phosphodiesterase 1C(PDE1C)	Homo sapiens				GO:0007165~signal transduction,GO:0007608~sensory perception of smell,	GO:0005829~cytosol,GO:0005929~cilium,	GO:0004114~3',5'-cyclic-nucleotide phosphodiesterase activity,GO:0004117~calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,GO:0005516~calmodulin binding,GO:0046872~metal ion binding,	IPR002073:3'5'-cyclic nucleotide phosphodiesterase, catalytic domain,IPR003607:HD/PDEase domain,IPR013706:3'5'-cyclic nucleotide phosphodiesterase N-terminal,IPR023088:3'5'-cyclic nucleotide phosphodiesterase,IPR023174:3'5'-cyclic nucleotide phosphodiesterase, conserved site,	hsa00230:Purine metabolism,hsa04020:Calcium signaling pathway,hsa04740:Olfactory transduction,hsa04924:Renin secretion,hsa05032:Morphine addiction,			SM00471:HDc,	3D-structure,Acetylation,Alternative splicing,Calmodulin-binding,cAMP,cGMP,Coiled coil,Complete proteome,Hydrolase,Metal-binding,Proteomics identification,Reference proteome,	active site:Proton donor,chain:Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C,helix,metal ion-binding site:Divalent metal cation 1,metal ion-binding site:Divalent metal cation 2,modified residue,region of interest:Catalytic,splice variant,strand,turn,
35373_at	phosphoinositide-3-kinase regulatory subunit 1(PIK3R1)	Homo sapiens	104.Insulin_signaling,105.Signaling_glucose_uptake,106.Glycogen_synthase-synthesis,107.mRNA_translation-protein_synthesis,2.Cytokine_Receptors,37.Akt-PKB_Effector_of_P13K_in_Vivo,63.LAT_couples_T-cell_receptor,	h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis,h_aktPathway:AKT Signaling Pathway,h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_badPathway:Regulation of BAD phosphorylation,h_bcellsurvivalPathway:B Cell Survival Pathway,h_cdc42racPathway:Role of PI3K subunit p85 in regulation of Actin Organization and Cell Migration,h_crebPathway:Transcription factor CREB and its extracellular signals,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation,h_cxcr4Pathway:CXCR4 Signaling Pathway,h_ecmPathway:Erk and PI-3 Kinase Are Necessary for Collagen Binding in Corneal Epithelia,h_edg1Pathway:Phospholipids as signalling intermediaries,h_egfPathway:EGF Signaling Pathway,h_eif4Pathway:Regulation of eIF4e and p70 S6 Kinase,h_erk5Pathway:Role of Erk5 in Neuronal Survival,h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,h_gcrpathway:Corticosteroids and cardioprotection,h_ghPathway:Growth Hormone Signaling Pathway,h_gleevecPathway:Inhibition of Cellular Proliferation by Gleevec,H_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK),h_her2Pathway:Role of ERBB2 in Signal Transduction and Oncology,h_igf1mtorPathway:Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,h_igf1Pathway:IGF-1 Signaling Pathway,h_igf1rPathway:Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il7Pathway:IL-7 Signal Transduction,h_insulinPathway:Insulin Signaling Pathway,h_longevityPathway:The IGF-1 Receptor and Longevity,h_metPathway:Signaling of Hepatocyte Growth Factor Receptor,h_mtorPathway:mTOR Signaling Pathway,h_nfatPathway:NFAT and Hypertrophy of the heart (Transcription in the broken heart),h_ngfPathway:Nerve growth factor pathway (NGF),h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity,h_par1pathway:Thrombin signaling and protease-activated receptors,h_pdgfPathway:PDGF Signaling Pathway,h_plcPathway:Phospholipase C Signaling Pathway,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_ptenPathway:PTEN dependent cell cycle arrest and apoptosis,h_rac1Pathway:Rac 1 cell motility signaling pathway,h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rasPathway:Ras Signaling Pathway,h_tcrPathway:T Cell Receptor Signaling Pathway,h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,h_tpoPathway:TPO Signaling Pathway,h_trkaPathway:Trka Receptor Signaling Pathway,h_vegfPathway:VEGF, Hypoxia, and Angiogenesis,	Cell division and chromosome partitioning,	GO:0001678~cellular glucose homeostasis,GO:0001953~negative regulation of cell-matrix adhesion,GO:0006468~protein phosphorylation,GO:0006661~phosphatidylinositol biosynthetic process,GO:0007165~signal transduction,GO:0007173~epidermal growth factor receptor signaling pathway,GO:0008286~insulin receptor signaling pathway,GO:0008625~extrinsic apoptotic signaling pathway via death domain receptors,GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage,GO:0014065~phosphatidylinositol 3-kinase signaling,GO:0014066~regulation of phosphatidylinositol 3-kinase signaling,GO:0016032~viral process,GO:0030168~platelet activation,GO:0030183~B cell differentiation,GO:0030335~positive regulation of cell migration,GO:0031295~T cell costimulation,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032869~cellular response to insulin stimulus,GO:0033120~positive regulation of RNA splicing,GO:0034644~cellular response to UV,GO:0034976~response to endoplasmic reticulum stress,GO:0036092~phosphatidylinositol-3-phosphate biosynthetic process,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038128~ERBB2 signaling pathway,GO:0042993~positive regulation of transcription factor import into nucleus,GO:0043066~negative regulation of apoptotic process,GO:0043551~regulation of phosphatidylinositol 3-kinase activity,GO:0045671~negative regulation of osteoclast differentiation,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046326~positive regulation of glucose import,GO:0046854~phosphatidylinositol phosphorylation,GO:0048009~insulin-like growth factor receptor signaling pathway,GO:0048010~vascular endothelial growth factor receptor signaling pathway,GO:0048015~phosphatidylinositol-mediated signaling,GO:0050821~protein stabilization,GO:0050852~T cell receptor signaling pathway,GO:0050900~leukocyte migration,GO:0051492~regulation of stress fiber assembly,GO:0051531~NFAT protein import into nucleus,GO:0060396~growth hormone receptor signaling pathway,GO:0090004~positive regulation of establishment of protein localization to plasma membrane,GO:1900103~positive regulation of endoplasmic reticulum unfolded protein response,GO:2001275~positive regulation of glucose import in response to insulin stimulus,	GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005801~cis-Golgi network,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005911~cell-cell junction,GO:0005942~phosphatidylinositol 3-kinase complex,GO:0005943~phosphatidylinositol 3-kinase complex, class IA,GO:0016020~membrane,GO:1990578~perinuclear endoplasmic reticulum membrane,	GO:0005068~transmembrane receptor protein tyrosine kinase adaptor activity,GO:0005158~insulin receptor binding,GO:0005159~insulin-like growth factor receptor binding,GO:0005168~neurotrophin TRKA receptor binding,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0016301~kinase activity,GO:0016303~1-phosphatidylinositol-3-kinase activity,GO:0019903~protein phosphatase binding,GO:0035014~phosphatidylinositol 3-kinase regulator activity,GO:0036312~phosphatidylinositol 3-kinase regulatory subunit binding,GO:0043125~ErbB-3 class receptor binding,GO:0043548~phosphatidylinositol 3-kinase binding,GO:0043559~insulin binding,GO:0043560~insulin receptor substrate binding,GO:0046934~phosphatidylinositol-4,5-bisphosphate 3-kinase activity,GO:0046935~1-phosphatidylinositol-3-kinase regulator activity,GO:0046982~protein heterodimerization activity,	IPR000198:Rho GTPase-activating protein domain,IPR000980:SH2 domain,IPR001452:Src homology-3 domain,IPR001720:PI3 kinase, P85 regulatory subunit,IPR008936:Rho GTPase activation protein,	hsa04012:ErbB signaling pathway,hsa04014:Ras signaling pathway,hsa04015:Rap1 signaling pathway,hsa04024:cAMP signaling pathway,hsa04062:Chemokine signaling pathway,hsa04066:HIF-1 signaling pathway,hsa04068:FoxO signaling pathway,hsa04070:Phosphatidylinositol signaling system,hsa04071:Sphingolipid signaling pathway,hsa04150:mTOR signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04152:AMPK signaling pathway,hsa04210:Apoptosis,hsa04370:VEGF signaling pathway,hsa04380:Osteoclast differentiation,hsa04510:Focal adhesion,hsa04550:Signaling pathways regulating pluripotency of stem cells,hsa04611:Platelet activation,hsa04620:Toll-like receptor signaling pathway,hsa04630:Jak-STAT signaling pathway,hsa04650:Natural killer cell mediated cytotoxicity,hsa04660:T cell receptor signaling pathway,hsa04662:B cell receptor signaling pathway,hsa04664:Fc epsilon RI signaling pathway,hsa04666:Fc gamma R-mediated phagocytosis,hsa04668:TNF signaling pathway,hsa04670:Leukocyte transendothelial migration,hsa04722:Neurotrophin signaling pathway,hsa04725:Cholinergic synapse,hsa04750:Inflammatory mediator regulation of TRP channels,hsa04810:Regulation of actin cytoskeleton,hsa04910:Insulin signaling pathway,hsa04914:Progesterone-mediated oocyte maturation,hsa04915:Estrogen signaling pathway,hsa04917:Prolactin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa04923:Regulation of lipolysis in adipocytes,hsa04930:Type II diabetes mellitus,hsa04931:Insulin resistance,hsa04932:Non-alcoholic fatty liver disease (NAFLD),hsa04960:Aldosterone-regulated sodium reabsorption,hsa04973:Carbohydrate digestion and absorption,hsa05100:Bacterial invasion of epithelial cells,hsa05142:Chagas disease (American trypanosomiasis),hsa05146:Amoebiasis,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05164:Influenza A,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05210:Colorectal cancer,hsa05211:Renal cell carcinoma,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05220:Chronic myeloid leukemia,hsa05221:Acute myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,hsa05231:Choline metabolism in cancer,	269880~SHORT syndrome,615214~Agammaglobulinemia 7, autosomal recessive,616005~Immunodeficiency 36,		SM00252:SH2,SM00324:RhoGAP,SM00326:SH3,	3D-structure,Acetylation,Alternative splicing,Coiled coil,Complete proteome,Disease mutation,Dwarfism,Host-virus interaction,Kinase,Phosphoprotein,Polymorphism,Protein transport,Proteomics identification,Reference proteome,Repeat,SH2 domain,SH3 domain,Stress response,Transferase,Transport,Ubl conjugation,	chain:Phosphatidylinositol 3-kinase regulatory subunit alpha,domain:Rho-GAP,domain:SH2 1,domain:SH2 2,domain:SH3,helix,modified residue,sequence conflict,sequence variant,splice variant,strand,turn,
40959_at	pleckstrin homology and RhoGEF domain containing G3(PLEKHG3)	Homo sapiens				GO:0035023~regulation of Rho protein signal transduction,GO:0043547~positive regulation of GTPase activity,		GO:0005089~Rho guanyl-nucleotide exchange factor activity,	IPR000219:Dbl homology (DH) domain,IPR001849:Pleckstrin homology domain,IPR011993:Pleckstrin homology-like domain,				SM00233:PH,SM00325:RhoGEF,	Alternative splicing,Complete proteome,Methylation,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Pleckstrin homology domain-containing family G member 3,compositionally biased region:Poly-Glu,compositionally biased region:Ser-rich,domain:DH,domain:PH,modified residue,sequence conflict,sequence variant,splice variant,
35956_s_at	pregnancy specific beta-1-glycoprotein 4(PSG4)	Homo sapiens				GO:0007565~female pregnancy,	GO:0070062~extracellular exosome,		IPR003598:Immunoglobulin subtype 2,IPR003599:Immunoglobulin subtype,IPR007110:Immunoglobulin-like domain,IPR013106:Immunoglobulin V-set,IPR013783:Immunoglobulin-like fold,				SM00408:IGc2,SM00409:IG,	Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Immunoglobulin domain,Polymorphism,Pregnancy,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,	chain:Pregnancy-specific beta-1-glycoprotein 4,chain:Pregnancy-specific beta-1-glycoprotein 8,chain:Putative pregnancy-specific beta-1- glycoprotein 7,disulfide bond,domain:Ig-like C2-type 1,domain:Ig-like C2-type 2,domain:Ig-like C2-type 3,domain:Ig-like V-type,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,
38948_at	protein phosphatase 1 regulatory subunit 3D(PPP1R3D)	Homo sapiens				GO:0005977~glycogen metabolic process,GO:0005979~regulation of glycogen biosynthetic process,GO:0005981~regulation of glycogen catabolic process,GO:0006470~protein dephosphorylation,	GO:0042587~glycogen granule,GO:0043231~intracellular membrane-bounded organelle,	GO:0004722~protein serine/threonine phosphatase activity,GO:0019899~enzyme binding,	IPR005036:Putative phosphatase regulatory subunit,IPR017434:Protein phosphatase 1, glycogen targeting subunit, Metazoa,	hsa04910:Insulin signaling pathway,hsa04931:Insulin resistance,		PIRSF038207:protein phosphatase 1, glycogen targeting subunit, animal type,		Carbohydrate metabolism,Complete proteome,Glycogen metabolism,Phosphoprotein,Reference proteome,	chain:Protein phosphatase 1 regulatory subunit 3D,domain:CBM21,modified residue,short sequence motif:PP1-binding motif,
38646_s_at	regenerating family member 1 alpha(REG1A)	Homo sapiens				GO:0008284~positive regulation of cell proliferation,	GO:0070062~extracellular exosome,	GO:0008083~growth factor activity,GO:0030246~carbohydrate binding,	IPR001304:C-type lectin,IPR016186:C-type lectin-like,IPR016187:C-type lectin fold,IPR018378:C-type lectin, conserved site,				SM00034:CLECT,	3D-structure,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Lectin,Pyrrolidone carboxylic acid,Reference proteome,Secreted,Signal,	chain:Lithostathine-1-alpha,disulfide bond,domain:C-type lectin,glycosylation site:O-linked (GlcNAc...),helix,modified residue,sequence conflict,signal peptide,strand,
36766_at	ribonuclease A family member 2(RNASE2)	Homo sapiens				GO:0006401~RNA catabolic process,GO:0006935~chemotaxis,GO:0090502~RNA phosphodiester bond hydrolysis, endonucleolytic,GO:1903955~positive regulation of protein targeting to mitochondrion,	GO:0005576~extracellular region,GO:0005764~lysosome,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0004519~endonuclease activity,GO:0004522~ribonuclease A activity,GO:0004540~ribonuclease activity,	IPR001427:Ribonuclease A,IPR023411:Ribonuclease A, active site,IPR023412:Ribonuclease A-domain,				SM00092:RNAse_Pc,	3D-structure,Chemotaxis,Complete proteome,Direct protein sequencing,Disulfide bond,Endonuclease,Glycoprotein,Hydrolase,Lysosome,Neurotoxin,Nitration,Nuclease,Polymorphism,Reference proteome,Signal,Toxin,	active site:Proton acceptor,active site:Proton donor,chain:Non-secretory ribonuclease,disulfide bond,glycosylation site:C-linked (Man),glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Substrate binding,sequence conflict,sequence variant,signal peptide,strand,turn,
33979_at	ribonuclease A family member 3(RNASE3)	Homo sapiens				GO:0002227~innate immune response in mucosa,GO:0006401~RNA catabolic process,GO:0019731~antibacterial humoral response,GO:0050830~defense response to Gram-positive bacterium,GO:0090501~RNA phosphodiester bond hydrolysis,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0070062~extracellular exosome,	GO:0003676~nucleic acid binding,GO:0004519~endonuclease activity,GO:0004540~ribonuclease activity,	IPR001427:Ribonuclease A,IPR023411:Ribonuclease A, active site,IPR023412:Ribonuclease A-domain,	hsa05310:Asthma,			SM00092:RNAse_Pc,	3D-structure,Antibiotic,Antimicrobial,Complete proteome,Direct protein sequencing,Disulfide bond,Endonuclease,Glycoprotein,Hydrolase,Nitration,Nuclease,Polymorphism,Reference proteome,Secreted,Signal,	active site:Proton acceptor,active site:Proton donor,chain:Eosinophil cationic protein,disulfide bond,glycosylation site:N-linked (GlcNAc...),helix,modified residue,region of interest:Substrate binding,sequence variant,signal peptide,strand,
32413_at	ribosomal protein S14(RPS14)	Homo sapiens				GO:0000028~ribosomal small subunit assembly,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000184~nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,GO:0000462~maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),GO:0006364~rRNA processing,GO:0006412~translation,GO:0006413~translational initiation,GO:0006417~regulation of translation,GO:0006614~SRP-dependent cotranslational protein targeting to membrane,GO:0019083~viral transcription,GO:0030218~erythrocyte differentiation,GO:0030490~maturation of SSU-rRNA,	GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005829~cytosol,GO:0005840~ribosome,GO:0005925~focal adhesion,GO:0016020~membrane,GO:0016021~integral component of membrane,GO:0022627~cytosolic small ribosomal subunit,GO:0031012~extracellular matrix,GO:0070062~extracellular exosome,	GO:0003723~RNA binding,GO:0003735~structural constituent of ribosome,GO:0005515~protein binding,GO:0044822~poly(A) RNA binding,GO:0045182~translation regulator activity,GO:0048027~mRNA 5'-UTR binding,GO:0070181~small ribosomal subunit rRNA binding,	IPR001971:Ribosomal protein S11,IPR018102:Ribosomal S11, conserved site,	hsa03010:Ribosome,	153550~Macrocytic anemia, refractory, due to 5q deletion, somatic,	PIRSF002131:ribosomal protein, S11p/S11a/S14e/organellar S11 types,		3D-structure,Complete proteome,Direct protein sequencing,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Ribonucleoprotein,Ribosomal protein,Transmembrane,Transmembrane helix,	chain:40S ribosomal protein S14,modified residue,
39187_at	runt related transcription factor 2(RUNX2)	Homo sapiens				GO:0001503~ossification,GO:0001649~osteoblast differentiation,GO:0001958~endochondral ossification,GO:0002051~osteoblast fate commitment,GO:0002062~chondrocyte differentiation,GO:0002063~chondrocyte development,GO:0002076~osteoblast development,GO:0006355~regulation of transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0008284~positive regulation of cell proliferation,GO:0030097~hemopoiesis,GO:0030182~neuron differentiation,GO:0030217~T cell differentiation,GO:0030509~BMP signaling pathway,GO:0032332~positive regulation of chondrocyte differentiation,GO:0035115~embryonic forelimb morphogenesis,GO:0040036~regulation of fibroblast growth factor receptor signaling pathway,GO:0042475~odontogenesis of dentin-containing tooth,GO:0042487~regulation of odontogenesis of dentin-containing tooth,GO:0045595~regulation of cell differentiation,GO:0045669~positive regulation of osteoblast differentiation,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0048469~cell maturation,GO:0048701~embryonic cranial skeleton morphogenesis,GO:0048863~stem cell differentiation,GO:0071773~cellular response to BMP stimulus,GO:1901522~positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005667~transcription factor complex,GO:0005737~cytoplasm,	GO:0000978~RNA polymerase II core promoter proximal region sequence-specific DNA binding,GO:0000979~RNA polymerase II core promoter sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001077~transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0019904~protein domain specific binding,GO:0043425~bHLH transcription factor binding,GO:0070491~repressing transcription factor binding,	IPR000040:Acute myeloid leukemia 1 protein (AML1)/Runt,IPR008967:p53-like transcription factor, DNA-binding,IPR012346:p53/RUNT-type transcription factor, DNA-binding domain,IPR013524:Runt domain,IPR013711:Runx, C-terminal  domain,IPR016554:Runt-related transcription factor RUNX,IPR027384:Runx, central domain,	hsa05202:Transcriptional misregulation in cancer,	119600~Cleidocranial dysplasia,119600~Cleidocranial dysplasia, forme fruste, dental anomalies only,119600~Cleidocranial dysplasia, forme fruste, with brachydactyly,156510~Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly,	PIRSF009374:runt-related transcription factor RUNX,		Alternative splicing,Coiled coil,Complete proteome,Disease mutation,DNA-binding,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Transcription,Transcription regulation,	chain:Runt-related transcription factor 2,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Gln,compositionally biased region:Pro/Ser/Thr-rich,domain:Runt,region of interest:Interaction with MYST3,region of interest:Interaction with MYST4,sequence conflict,sequence variant,splice variant,
36328_at	sex hormone binding globulin(SHBG)	Homo sapiens					GO:0005576~extracellular region,GO:0070062~extracellular exosome,	GO:0005496~steroid binding,GO:0005497~androgen binding,	IPR001791:Laminin G domain,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,				SM00282:LamG,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disulfide bond,Glycoprotein,Lipid-binding,Polymorphism,Proteomics identification,Reference proteome,Repeat,Secreted,Signal,Steroid-binding,	chain:Sex hormone-binding globulin,disulfide bond,domain:Laminin G-like 1,domain:Laminin G-like 2,glycosylation site:N-linked (GlcNAc...),glycosylation site:N-linked (GlcNAc...); when associated with variant N-356,glycosylation site:O-linked (GalNAc...),helix,sequence conflict,sequence variant,signal peptide,splice variant,strand,turn,
37097_at	solute carrier family 17 member 1(SLC17A1)	Homo sapiens				GO:0006811~ion transport,GO:0006817~phosphate ion transport,GO:0035435~phosphate ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0044341~sodium-dependent phosphate transport,GO:0046415~urate metabolic process,GO:0055085~transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016020~membrane,GO:0016021~integral component of membrane,	GO:0005436~sodium:phosphate symporter activity,GO:0015321~sodium-dependent phosphate transmembrane transporter activity,	IPR004745:Na-dependent inorganic phosphate cotransporter,IPR011701:Major facilitator superfamily,IPR020846:Major facilitator superfamily domain,					Alternative splicing,Complete proteome,Glycoprotein,Ion transport,Membrane,Polymorphism,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium-dependent phosphate transport protein 1,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,splice variant,transmembrane region,
34436_at	solute carrier family 17 member 3(SLC17A3)	Homo sapiens				GO:0006814~sodium ion transport,GO:0006817~phosphate ion transport,GO:0006855~drug transmembrane transport,GO:0015711~organic anion transport,GO:0015747~urate transport,GO:0015760~glucose-6-phosphate transport,GO:0015893~drug transport,GO:0034220~ion transmembrane transport,GO:0035435~phosphate ion transmembrane transport,GO:0035725~sodium ion transmembrane transport,GO:0044341~sodium-dependent phosphate transport,GO:0046415~urate metabolic process,GO:0055085~transmembrane transport,GO:1901998~toxin transport,GO:1903825~organic acid transmembrane transport,GO:1903959~regulation of anion transmembrane transport,	GO:0005737~cytoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0031526~brush border membrane,GO:0048471~perinuclear region of cytoplasm,	GO:0005436~sodium:phosphate symporter activity,GO:0008308~voltage-gated anion channel activity,GO:0008514~organic anion transmembrane transporter activity,GO:0015143~urate transmembrane transporter activity,GO:0015238~drug transmembrane transporter activity,GO:0015321~sodium-dependent phosphate transmembrane transporter activity,GO:0015562~efflux transmembrane transporter activity,GO:0019534~toxin transporter activity,	IPR011701:Major facilitator superfamily,IPR017373:Sodium-dependent phosphate transport protein 4 , predicted,IPR020846:Major facilitator superfamily domain,		612671~Gout susceptibility 4,612671~Uric acid concentration, serum, QTL4,	PIRSF038072:sodium-dependent phosphate transport protein 4 ,		Alternative splicing,Cell membrane,Complete proteome,Endoplasmic reticulum,Glycoprotein,Ion transport,Membrane,Polymorphism,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium-dependent phosphate transport protein 4,glycosylation site:N-linked (GlcNAc...),sequence conflict,sequence variant,transmembrane region,
32084_at	solute carrier family 22 member 5(SLC22A5)	Homo sapiens				GO:0006814~sodium ion transport,GO:0006855~drug transmembrane transport,GO:0009437~carnitine metabolic process,GO:0015697~quaternary ammonium group transport,GO:0015879~carnitine transport,GO:0015893~drug transport,GO:0052106~quorum sensing involved in interaction with host,GO:0060731~positive regulation of intestinal epithelial structure maintenance,GO:0070715~sodium-dependent organic cation transport,GO:0098655~cation transmembrane transport,GO:1902603~carnitine transmembrane transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0031526~brush border membrane,GO:0070062~extracellular exosome,	GO:0005515~protein binding,GO:0005524~ATP binding,GO:0015226~carnitine transmembrane transporter activity,GO:0015238~drug transmembrane transporter activity,GO:0015293~symporter activity,GO:0015491~cation:cation antiporter activity,GO:0015651~quaternary ammonium group transmembrane transporter activity,GO:0022857~transmembrane transporter activity,GO:0030165~PDZ domain binding,	IPR004749:Organic cation transport protein,IPR005828:General substrate transporter,IPR005829:Sugar transporter, conserved site,IPR020846:Major facilitator superfamily domain,	hsa05231:Choline metabolism in cancer,	212140~Carnitine deficiency, systemic primary,			Alternative splicing,ATP-binding,Complete proteome,Disease mutation,Glycoprotein,Ion transport,Membrane,Nucleotide-binding,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Sodium,Sodium transport,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Solute carrier family 22 member 5,glycosylation site:N-linked (GlcNAc...),modified residue,mutagenesis site,nucleotide phosphate-binding region:ATP,sequence conflict,sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
35121_at	solute carrier family 6 member 6(SLC6A6)	Homo sapiens			General function prediction only,	GO:0003333~amino acid transmembrane transport,GO:0006520~cellular amino acid metabolic process,GO:0006810~transport,GO:0006836~neurotransmitter transport,GO:0006865~amino acid transport,GO:0015734~taurine transport,	GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,	GO:0005328~neurotransmitter:sodium symporter activity,GO:0005369~taurine:sodium symporter activity,GO:0015171~amino acid transmembrane transporter activity,	IPR000175:Sodium:neurotransmitter symporter,IPR002434:Sodium:neurotransmitter symporter, taurine,					Alternative splicing,Cell membrane,Complete proteome,Glycoprotein,Membrane,Neurotransmitter transport,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Signal,Symport,Transmembrane,Transmembrane helix,Transport,	chain:Sodium- and chloride-dependent taurine transporter,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
35439_at	splicing factor 1(SF1)	Homo sapiens			RNA processing and modification,	GO:0000245~spliceosomal complex assembly,GO:0000389~mRNA 3'-splice site recognition,GO:0000398~mRNA splicing, via spliceosome,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0030238~male sex determination,GO:0033327~Leydig cell differentiation,GO:0048662~negative regulation of smooth muscle cell proliferation,GO:0050810~regulation of steroid biosynthetic process,GO:1903507~negative regulation of nucleic acid-templated transcription,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005681~spliceosomal complex,GO:0005840~ribosome,	GO:0003714~transcription corepressor activity,GO:0003723~RNA binding,GO:0005515~protein binding,GO:0008270~zinc ion binding,GO:0042802~identical protein binding,GO:0044822~poly(A) RNA binding,GO:0045131~pre-mRNA branch point binding,	IPR001878:Zinc finger, CCHC-type,IPR004087:K Homology domain,IPR004088:K Homology domain, type 1,				SM00322:KH,SM00343:ZnF_C2HC,	3D-structure,Acetylation,Alternative splicing,Complete proteome,Direct protein sequencing,Metal-binding,Methylation,mRNA processing,mRNA splicing,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,RNA-binding,Spliceosome,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Splicing factor 1,compositionally biased region:Pro-rich,domain:KH,helix,modified residue,mutagenesis site,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,splice variant,strand,turn,zinc finger region:CCHC-type,
38691_s_at	surfactant protein C(SFTPC)	Homo sapiens				GO:0007585~respiratory gaseous exchange,GO:0044267~cellular protein metabolic process,	GO:0005576~extracellular region,GO:0005615~extracellular space,GO:0005789~endoplasmic reticulum membrane,GO:0016021~integral component of membrane,GO:0042599~lamellar body,GO:0045334~clathrin-coated endocytic vesicle,GO:0097486~multivesicular body lumen,	GO:0005515~protein binding,GO:0042802~identical protein binding,	IPR001729:Surfactant-associated polypeptide,IPR007084:BRICHOS domain,IPR015091:Surfactant protein C, N-terminal propeptide,IPR018051:Surfactant-associated polypeptide, palmitoylation site,		610913~Surfactant metabolism dysfunction, pulmonary, 2,		SM00019:SF_P,SM01039:SM01039,	3D-structure,Alternative splicing,Complete proteome,Direct protein sequencing,Disease mutation,Disulfide bond,Gaseous exchange,Lipoprotein,Membrane,Palmitate,Polymorphism,Proteomics identification,Reference proteome,Secreted,Surface film,Transmembrane,Transmembrane helix,	chain:Pulmonary surfactant-associated protein C,domain:BRICHOS,lipid moiety-binding region:S-palmitoyl cysteine,modified residue,sequence conflict,sequence variant,splice variant,
38508_s_at	tenascin XA (pseudogene)(TNXA)	Homo sapiens				GO:0030199~collagen fibril organization,	GO:0005578~proteinaceous extracellular matrix,GO:0070062~extracellular exosome,		IPR003961:Fibronectin, type III,IPR013783:Immunoglobulin-like fold,				SM00060:FN3,	Complete proteome,Reference proteome,Repeat,	chain:Putative tenascin-XA,chain:Tenascin-X,disulfide bond,domain:EGF-like 10,domain:EGF-like 11,domain:EGF-like 12,domain:EGF-like 13,domain:EGF-like 14,domain:EGF-like 15,domain:EGF-like 16,domain:EGF-like 17,domain:EGF-like 18,domain:EGF-like 19,domain:EGF-like 1; incomplete,domain:EGF-like 2,domain:EGF-like 3,domain:EGF-like 4,domain:EGF-like 5,domain:EGF-like 6,domain:EGF-like 7,domain:EGF-like 8,domain:EGF-like 9,domain:Fibrinogen C-terminal,domain:Fibronectin type-III 1,domain:Fibronectin type-III 10,domain:Fibronectin type-III 11,domain:Fibronectin type-III 12,domain:Fibronectin type-III 13,domain:Fibronectin type-III 14,domain:Fibronectin type-III 15,domain:Fibronectin type-III 16,domain:Fibronectin type-III 17,domain:Fibronectin type-III 18,domain:Fibronectin type-III 19,domain:Fibronectin type-III 2,domain:Fibronectin type-III 20,domain:Fibronectin type-III 21,domain:Fibronectin type-III 22,domain:Fibronectin type-III 23,domain:Fibronectin type-III 24,domain:Fibronectin type-III 25,domain:Fibronectin type-III 26,domain:Fibronectin type-III 27,domain:Fibronectin type-III 28,domain:Fibronectin type-III 29,domain:Fibronectin type-III 3,domain:Fibronectin type-III 30,domain:Fibronectin type-III 31,domain:Fibronectin type-III 32,domain:Fibronectin type-III 4,domain:Fibronectin type-III 5,domain:Fibronectin type-III 6,domain:Fibronectin type-III 7,domain:Fibronectin type-III 8,domain:Fibronectin type-III 9,glycosylation site:N-linked (GlcNAc...),modified residue,sequence conflict,sequence variant,short sequence motif:Cell attachment site,signal peptide,splice variant,strand,turn,
31715_at	testis expressed 28(TEX28)	Homo sapiens					GO:0016021~integral component of membrane,		IPR017387:Testis-specific TEX28,IPR019394:Predicted transmembrane/coiled-coil 2 protein,			PIRSF038100:testis-specific protein TEX28,		Coiled coil,Complete proteome,Membrane,Reference proteome,Transmembrane,Transmembrane helix,	chain:Testis-specific protein TEX28,transmembrane region,
39198_s_at	trafficking protein particle complex 12(TRAPPC12)	Homo sapiens				GO:0006508~proteolysis,GO:0016192~vesicle-mediated transport,GO:0051310~metaphase plate congression,GO:0090234~regulation of kinetochore assembly,GO:1902426~negative regulation of mitotic spindle assembly checkpoint,	GO:0000776~kinetochore,GO:0005634~nucleus,GO:0005793~endoplasmic reticulum-Golgi intermediate compartment,	GO:0004175~endopeptidase activity,GO:0005515~protein binding,	IPR011990:Tetratricopeptide-like helical,IPR013026:Tetratricopeptide repeat-containing domain,IPR019734:Tetratricopeptide repeat,				SM00028:TPR,	Complete proteome,ER-Golgi transport,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,TPR repeat,Transport,	chain:Tetratricopeptide repeat protein 15,modified residue,repeat:TPR 1,repeat:TPR 2,repeat:TPR 3,repeat:TPR 4,sequence conflict,sequence variant,
41489_at	transducin like enhancer of split 1(TLE1)	Homo sapiens		h_wntPathway:WNT Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0007165~signal transduction,GO:0007275~multicellular organism development,GO:0009887~organ morphogenesis,GO:0010628~positive regulation of gene expression,GO:0016055~Wnt signaling pathway,GO:0030178~negative regulation of Wnt signaling pathway,GO:0043124~negative regulation of I-kappaB kinase/NF-kappaB signaling,GO:0045892~negative regulation of transcription, DNA-templated,GO:1904837~beta-catenin-TCF complex assembly,GO:2000811~negative regulation of anoikis,	GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005829~cytosol,	GO:0001106~RNA polymerase II transcription corepressor activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0042802~identical protein binding,	IPR001680:WD40 repeat,IPR005617:Groucho/TLE, N-terminal Q-rich domain,IPR009146:Groucho/transducin-like enhancer,IPR015943:WD40/YVTN repeat-like-containing domain,IPR017986:WD40-repeat-containing domain,IPR019775:WD40 repeat, conserved site,				SM00320:WD40,	3D-structure,Coiled coil,Complete proteome,Direct protein sequencing,Nucleus,Phosphoprotein,Proteomics identification,Reference proteome,Repeat,Repressor,Transcription,Transcription regulation,Ubl conjugation,WD repeat,Wnt signaling pathway,	chain:Transducin-like enhancer protein 1,compositionally biased region:Gln-rich,compositionally biased region:Gly/Pro-rich,compositionally biased region:Pro/Ser-rich,modified residue,mutagenesis site,region of interest:CCN domain,repeat:WD 1,repeat:WD 2,repeat:WD 3,repeat:WD 4,repeat:WD 5,repeat:WD 6,sequence conflict,short sequence motif:Nuclear localization signal,strand,turn,
38816_at	transforming acidic coiled-coil containing protein 2(TACC2)	Homo sapiens				GO:0000226~microtubule cytoskeleton organization,GO:0008283~cell proliferation,GO:0021987~cerebral cortex development,	GO:0005634~nucleus,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005815~microtubule organizing center,GO:0015630~microtubule cytoskeleton,	GO:0035257~nuclear hormone receptor binding,	IPR007707:Transforming acidic coiled-coil,					Alternative splicing,Coiled coil,Complete proteome,Cytoplasm,Cytoskeleton,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,	chain:Transforming acidic coiled-coil- containing protein 2,compositionally biased region:Poly-Lys,compositionally biased region:Pro-rich,domain:SPAZ,modified residue,sequence conflict,sequence variant,splice variant,
37898_r_at	trefoil factor 3(TFF3)	Homo sapiens		h_tffPathway:Trefoil Factors Initiate  Mucosal Healing,		GO:0006952~defense response,GO:0007586~digestion,GO:0010906~regulation of glucose metabolic process,GO:0042060~wound healing,	GO:0005576~extracellular region,GO:0005578~proteinaceous extracellular matrix,GO:0005615~extracellular space,GO:0005737~cytoplasm,GO:0030141~secretory granule,GO:0070062~extracellular exosome,	GO:0005515~protein binding,	IPR000519:P-type trefoil,IPR017957:P-type trefoil, conserved site,IPR017994:P-type trefoil, chordata,				SM00018:PD,	3D-structure,Complete proteome,Cytoplasm,Direct protein sequencing,Disulfide bond,Extracellular matrix,Proteomics identification,Reference proteome,Secreted,Signal,	chain:Trefoil factor 3,disulfide bond,domain:P-type,helix,sequence conflict,signal peptide,strand,turn,
36713_at	tripartite motif containing 58(TRIM58)	Homo sapiens				GO:0016567~protein ubiquitination,	GO:0005622~intracellular,	GO:0008270~zinc ion binding,GO:0016874~ligase activity,	IPR000315:Zinc finger, B-box,IPR001841:Zinc finger, RING-type,IPR001870:B30.2/SPRY domain,IPR003877:SPla/RYanodine receptor SPRY,IPR003879:Butyrophylin-like,IPR006574:SPRY-associated,IPR013083:Zinc finger, RING/FYVE/PHD-type,IPR013320:Concanavalin A-like lectin/glucanase, subgroup,IPR017907:Zinc finger, RING-type, conserved site,				SM00184:RING,SM00336:BBOX,SM00449:SPRY,SM00589:PRY,	Coiled coil,Complete proteome,Ligase,Metal-binding,Polymorphism,Reference proteome,Ubl conjugation pathway,Zinc,Zinc-finger,	chain:Tripartite motif-containing protein 58,domain:B30.2/SPRY,sequence conflict,sequence variant,zinc finger region:B box-type,zinc finger region:RING-type,
34629_at	tumor protein p53 inducible protein 11(TP53I11)	Homo sapiens				GO:0006950~response to stress,GO:0008285~negative regulation of cell proliferation,	GO:0016021~integral component of membrane,							Complete proteome,Membrane,Phosphoprotein,Proteomics identification,Reference proteome,Transmembrane,Transmembrane helix,	
1974_s_at	tumor protein p53(TP53)	Homo sapiens	1.RBphosphoE2F,152.altered_synaptic_signalling-neurodegenerative_disorders,157.14-3-3_Cell_Cycle,38.Cell_cycle_arrest_and_apoptosis_ceramide,94.E2F_transcriptional_activity_cell_cycle,99.NF-kB_activation,	h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_atmPathway:ATM Signaling Pathway,h_atrbrcaPathway:Role of BRCA1,  BRCA2 and ATR in Cancer Susceptibility,h_btg2Pathway:BTG family proteins and cell cycle regulation,h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage,h_ctcfPathway:CTCF: First Multivalent Nuclear Factor,h_EfpPathway:Estrogen-responsive protein Efp controls cell cycle and breast tumors growth,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_g2Pathway:Cell Cycle: G2/M Checkpoint,h_p53hypoxiaPathway:Hypoxia and p53 in the Cardiovascular system,h_p53Pathway:p53 Signaling Pathway,h_plk3Pathway:Regulation of cell cycle progression by Plk3,h_pmlPathway:Regulation of transcriptional activity by PML,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,h_rnaPathway:Double Stranded RNA Induced Gene Expression,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,h_tertPathway:Overview of telomerase protein component gene hTert Transcriptional Regulation ,h_tidPathway:Chaperones modulate interferon Signaling Pathway,		GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000733~DNA strand renaturation,GO:0006284~base-excision repair,GO:0006289~nucleotide-excision repair,GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,GO:0006366~transcription from RNA polymerase II promoter,GO:0006461~protein complex assembly,GO:0006915~apoptotic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,GO:0006983~ER overload response,GO:0007049~cell cycle,GO:0007050~cell cycle arrest,GO:0007265~Ras protein signal transduction,GO:0007275~multicellular organism development,GO:0007569~cell aging,GO:0008104~protein localization,GO:0008283~cell proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008340~determination of adult lifespan,GO:0010165~response to X-ray,GO:0010332~response to gamma radiation,GO:0010628~positive regulation of gene expression,GO:0016032~viral process,GO:0016925~protein sumoylation,GO:0030154~cell differentiation,GO:0030308~negative regulation of cell growth,GO:0030330~DNA damage response, signal transduction by p53 class mediator,GO:0031065~positive regulation of histone deacetylation,GO:0031497~chromatin assembly,GO:0031571~mitotic G1 DNA damage checkpoint,GO:0032461~positive regulation of protein oligomerization,GO:0034613~cellular protein localization,GO:0034644~cellular response to UV,GO:0035690~cellular response to drug,GO:0042149~cellular response to glucose starvation,GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042981~regulation of apoptotic process,GO:0043065~positive regulation of apoptotic process,GO:0043066~negative regulation of apoptotic process,GO:0043153~entrainment of circadian clock by photoperiod,GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043525~positive regulation of neuron apoptotic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0046677~response to antibiotic,GO:0046827~positive regulation of protein export from nucleus,GO:0046902~regulation of mitochondrial membrane permeability,GO:0048147~negative regulation of fibroblast proliferation,GO:0048512~circadian behavior,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0051097~negative regulation of helicase activity,GO:0051262~protein tetramerization,GO:0051974~negative regulation of telomerase activity,GO:0070245~positive regulation of thymocyte apoptotic process,GO:0071158~positive regulation of cell cycle arrest,GO:0071456~cellular response to hypoxia,GO:0071479~cellular response to ionizing radiation,GO:0072332~intrinsic apoptotic signaling pathway by p53 class mediator,GO:0090200~positive regulation of release of cytochrome c from mitochondria,GO:0090399~replicative senescence,GO:0090403~oxidative stress-induced premature senescence,GO:0097193~intrinsic apoptotic signaling pathway,GO:0097252~oligodendrocyte apoptotic process,GO:1900119~positive regulation of execution phase of apoptosis,GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,GO:1901796~regulation of signal transduction by p53 class mediator,GO:1902749~regulation of cell cycle G2/M phase transition,GO:1990440~positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,GO:2000379~positive regulation of reactive oxygen species metabolic process,GO:2001244~positive regulation of intrinsic apoptotic signaling pathway,	GO:0000790~nuclear chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005657~replication fork,GO:0005669~transcription factor TFIID complex,GO:0005730~nucleolus,GO:0005737~cytoplasm,GO:0005739~mitochondrion,GO:0005759~mitochondrial matrix,GO:0005783~endoplasmic reticulum,GO:0005829~cytosol,GO:0016021~integral component of membrane,GO:0016363~nuclear matrix,GO:0016604~nuclear body,GO:0016605~PML body,GO:0043234~protein complex,	GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0001046~core promoter sequence-specific DNA binding,GO:0001085~RNA polymerase II transcription factor binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0002020~protease binding,GO:0002039~p53 binding,GO:0003677~DNA binding,GO:0003682~chromatin binding,GO:0003684~damaged DNA binding,GO:0003690~double-stranded DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0005507~copper ion binding,GO:0005515~protein binding,GO:0005524~ATP binding,GO:0008134~transcription factor binding,GO:0008270~zinc ion binding,GO:0019899~enzyme binding,GO:0019901~protein kinase binding,GO:0019903~protein phosphatase binding,GO:0030971~receptor tyrosine kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0035035~histone acetyltransferase binding,GO:0042802~identical protein binding,GO:0043565~sequence-specific DNA binding,GO:0043621~protein self-association,GO:0044212~transcription regulatory region DNA binding,GO:0046872~metal ion binding,GO:0046982~protein heterodimerization activity,GO:0047485~protein N-terminus binding,GO:0051087~chaperone binding,GO:0051721~protein phosphatase 2A binding,	IPR002117:p53 tumour suppressor family,IPR008967:p53-like transcription factor, DNA-binding,IPR010991:p53, tetramerisation domain,IPR011615:p53, DNA-binding domain,IPR012346:p53/RUNT-type transcription factor, DNA-binding domain,IPR013872:p53 transactivation domain,IPR015155:PLAA family ubiquitin binding, PFU,	hsa04010:MAPK signaling pathway,hsa04071:Sphingolipid signaling pathway,hsa04110:Cell cycle,hsa04115:p53 signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04210:Apoptosis,hsa04310:Wnt signaling pathway,hsa04722:Neurotrophin signaling pathway,hsa04919:Thyroid hormone signaling pathway,hsa05014:Amyotrophic lateral sclerosis (ALS),hsa05016:Huntington's disease,hsa05160:Hepatitis C,hsa05161:Hepatitis B,hsa05162:Measles,hsa05166:HTLV-I infection,hsa05168:Herpes simplex infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05202:Transcriptional misregulation in cancer,hsa05203:Viral carcinogenesis,hsa05205:Proteoglycans in cancer,hsa05206:MicroRNAs in cancer,hsa05210:Colorectal cancer,hsa05212:Pancreatic cancer,hsa05213:Endometrial cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05216:Thyroid cancer,hsa05217:Basal cell carcinoma,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,hsa05230:Central carbon metabolism in cancer,	114480~Breast cancer,114500~Colorectal cancer,114550~Hepatocellular carcinoma,137800~Glioma susceptibility 1,151623~Li-Fraumeni syndrome,202300~Adrenal cortical carcinoma,259500~Osteosarcoma,260350~Pancreatic cancer,260500~Choroid plexus papilloma,607107~Nasopharyngeal carcinoma,614740~Basal cell carcinoma 7,			3D-structure,Acetylation,Activator,Alternative promoter usage,Alternative splicing,Apoptosis,Biological rhythms,Cell cycle,Complete proteome,Cytoplasm,Disease mutation,DNA-binding,Endoplasmic reticulum,Glycoprotein,Host-virus interaction,Isopeptide bond,Li-Fraumeni syndrome,Membrane,Metal-binding,Methylation,Mitochondrion,Necrosis,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,somatic,Transcription,Transcription regulation,Transmembrane,Transmembrane helix,Tumor suppressor,Ubl conjugation,Zinc,ZincFT   VARIANT     247    248       NR -> KW (in sporadic cancers,	chain:Cellular tumor antigen p53,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO),cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),helix,metal ion-binding site:Zinc,modified residue,mutagenesis site,region of interest:Basic (repression of DNA-binding),region of interest:Interaction with AXIN1,region of interest:Interaction with CARM1,region of interest:Interaction with E4F1,region of interest:Interaction with HIPK1,region of interest:Interaction with HIPK2,region of interest:Interaction with HRMT1L2,region of interest:Interaction with USP7,region of interest:Interaction with WWOX,region of interest:Interacts with the 53BP2 SH3 domain,region of interest:Oligomerization,region of interest:Required for interaction with FBXO42,region of interest:Transcription activation (acidic),sequence variant,short sequence motif:[KR]-[STA]-K motif,short sequence motif:Bipartite nuclear localization signal,short sequence motif:Nuclear export signal,splice variant,strand,turn,
36378_at	uroplakin 1A(UPK1A)	Homo sapiens				GO:0007166~cell surface receptor signaling pathway,GO:0030855~epithelial cell differentiation,GO:0051259~protein oligomerization,	GO:0005783~endoplasmic reticulum,GO:0005886~plasma membrane,GO:0005887~integral component of plasma membrane,GO:0016021~integral component of membrane,GO:0016324~apical plasma membrane,GO:0070062~extracellular exosome,	GO:0042803~protein homodimerization activity,GO:0048029~monosaccharide binding,	IPR000301:Tetraspanin,IPR008952:Tetraspanin, EC2 domain,IPR018499:Tetraspanin/Peripherin,			PIRSF002419:tetraspanin,		Alternative splicing,Complete proteome,Disulfide bond,Glycoprotein,Membrane,Polymorphism,Reference proteome,Transmembrane,Transmembrane helix,	chain:Uroplakin-1a,glycosylation site:N-linked (GlcNAc...),sequence variant,splice variant,topological domain:Cytoplasmic,topological domain:Extracellular,transmembrane region,
41113_at	zinc finger protein 500(ZNF500)	Homo sapiens			General function prediction only,	GO:0006351~transcription, DNA-templated,GO:0006355~regulation of transcription, DNA-templated,	GO:0005622~intracellular,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005737~cytoplasm,	GO:0003676~nucleic acid binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0043565~sequence-specific DNA binding,GO:0046872~metal ion binding,	IPR001909:Krueppel-associated box,IPR003309:Transcription regulator SCAN,IPR007087:Zinc finger, C2H2,IPR008916:Retrovirus capsid, C-terminal,IPR013087:Zinc finger C2H2-type/integrase DNA-binding domain,IPR015880:Zinc finger, C2H2-like,				SM00355:ZnF_C2H2,SM00431:SCAN,	Alternative splicing,Complete proteome,DNA-binding,Metal-binding,Nucleus,Proteomics identification,Reference proteome,Repeat,Transcription,Transcription regulation,Zinc,Zinc-finger,	chain:Zinc finger protein 500,domain:KRAB,domain:SCAN box,zinc finger region:C2H2-type 1,zinc finger region:C2H2-type 2,zinc finger region:C2H2-type 3,zinc finger region:C2H2-type 4,zinc finger region:C2H2-type 5,
